10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-39394

Montrose Environmental Group, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware	46-4195044
( State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
5120 Northshore Drive, North Little Rock, Arkansas	72118
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (501) 900-6400

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.000004 per share	MEG	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 4, 2023, the registrant had 30,078,195 shares of common stock, $0.000004 par value per share, outstanding.

Table of Contents

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Unaudited Condensed Consolidated Statements of Financial Position	1
	Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss	2
	Unaudited Condensed Consolidated Statements of Convertible and Redeemable Series A-2 Preferred Stock and Stockholders’ Equity	3
	Unaudited Condensed Consolidated Statements of Cash Flows	4
	Notes to Unaudited Condensed Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	33
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	44
Item 4.	Controls and Procedures	44
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	45
Item 1A.	Risk Factors	45
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45
Item 3.	Defaults Upon Senior Securities	45
Item 4.	Mine Safety Disclosures	45
Item 5.	Other Information	45
Item 6.	Exhibits	46
Signatures		47

i

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

MONTROSE ENVIRONMENTAL GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(In thousands, except share data)

	March 31,			December 31,
	2023			2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	76,794		$	89,828
Accounts receivable—net		85,472			94,711
Contract assets		53,563			52,403
Prepaid and other current assets		15,178			10,986
Total current assets		231,007			247,928
NON-CURRENT ASSETS:
Property and equipment—net		40,685			36,045
Operating lease right-of-use asset—net		31,214			26,038
Finance lease right-of-use asset—net		11,391			9,840
Goodwill		326,498			323,868
Other intangible assets—net		137,271			142,107
Other assets		5,111			6,088
TOTAL ASSETS	$	783,177		$	791,914
LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND    STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and other accrued liabilities	$	55,420		$	63,412
Accrued payroll and benefits		16,352			20,528
Business acquisitions contingent consideration, current		4,734			3,801
Current portion of operating lease liabilities		8,570			7,895
Current portion of finance lease liabilities		4,130			3,775
Current portion of long-term debt		13,125			12,031
Total current liabilities		102,331			111,442
NON-CURRENT LIABILITIES:
Business acquisitions contingent consideration, long-term		3,121			4,454
Other non-current liabilities		3			13
Deferred tax liabilities—net		7,111			5,742
Conversion option		26,636			25,731
Operating lease liability—net of current portion		24,093			19,437
Finance lease liability—net of current portion		7,507			6,486
Long-term debt—net of deferred financing fees		149,342			152,494
Total liabilities	$	320,144		$	325,799
COMMITMENTS AND CONTINGENCIES
CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK $0.0001    PAR VALUE—
Authorized, issued and outstanding shares: 17,500 at March 31, 2023 and    December 31, 2022; aggregate liquidation preference of $182.2 million at March 31, 2023 and    December 31, 2022		152,928			152,928
STOCKHOLDERS’ EQUITY:
Common stock, $0.000004 par value; authorized shares: 190,000,000 at    March 31, 2023 and December 31, 2022; issued and outstanding shares: 29,961,364 and    29,619,921 at March 31, 2023 and December 31, 2022, respectively		—			—
Additional paid-in-capital		504,301			492,676
Accumulated deficit		(194,216	)		(179,497	)
Accumulated other comprehensive income		20			8
Total stockholders’ equity		310,105			313,187
TOTAL LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK    AND STOCKHOLDERS’ EQUITY	$	783,177		$	791,914

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1

MONTROSE ENVIRONMENTAL GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE LOSS

(In thousands, except per share data)

	Three Months Ended
	March 31,
	2023			2022
REVENUES	$	131,428		$	134,680
COST OF REVENUES (exclusive of depreciation and    amortization shown below)		81,633			88,386
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE		49,613			41,807
FAIR VALUE CHANGES IN BUSINESS ACQUISITION    CONTINGENCIES		(398	)		(21	)
DEPRECIATION AND AMORTIZATION		10,555			12,144
LOSS FROM OPERATIONS		(9,975	)		(7,636	)
OTHER (EXPENSE) INCOME
Other (expense) income		(1,836	)		2,461
Interest expense—net		(1,541	)		(1,092	)
Total other (expense) income—net		(3,377	)		1,369
LOSS BEFORE EXPENSE FROM    INCOME TAXES		(13,352	)		(6,267	)
INCOME TAX EXPENSE		1,367			1,269
NET LOSS	$	(14,719	)	$	(7,536	)
EQUITY ADJUSTMENT FROM FOREIGN    CURRENCY TRANSLATION		12			81
COMPREHENSIVE LOSS		(14,707	)		(7,455	)
CONVERTIBLE AND REDEEMABLE SERIES A-2    PREFERRED STOCK DIVIDEND		(4,100	)		(4,100	)
NET LOSS ATTRIBUTABLE TO    COMMON STOCKHOLDERS		(18,819	)		(11,636	)
WEIGHTED AVERAGE COMMON SHARES    OUTSTANDING— BASIC AND DILUTED		29,857			29,662
NET LOSS PER SHARE ATTRIBUTABLE TO    COMMON STOCKHOLDERS— BASIC AND DILUTED	$	(0.63	)	$	(0.39	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

MONTROSE ENVIRONMENTAL GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

(In thousands, except share data)

	Convertible and Redeemable
	Series A-2 Preferred Stock				Common Stock
	Shares		Amount		Shares		Amount		Additional Paid-In Capital			Accumulated Deficit			Accumulated Other Comprehensive Income		Total Stockholders' Equity
BALANCE—December 31, 2021		17,500	$	152,928		29,619,921	$	—	$	464,143		$	(147,678	)	$	36	$	316,501
Net loss		—		—		—		—		—			(7,536	)		—		(7,536	)
Stock-based compensation		—		—		—		—		10,425			—			—		10,425
Dividend payment to the Series A-2    preferred shareholders		—		—		—		—		(4,100	)		—			—		(4,100	)
Common stock issued		—		—		55,896		—		429			—			—		429
Accumulated other comprehensive income		—		—		—		—		—			—			45		45
BALANCE—March 31, 2022		17,500	$	152,928		29,675,817	$	—	$	470,897		$	(155,214	)	$	81	$	315,764
BALANCE—December 31, 2022		17,500	$	152,928		29,746,793	$	—	$	492,676		$	(179,497	)	$	8	$	313,187
Net loss		—		—		—		—		—			(14,719	)		—		(14,719	)
Stock-based compensation		—		—		—		—		13,035			—			—		13,035
Dividend payment to the Series A-2    preferred shareholders		—		—		—		—		(4,100	)		—			—		(4,100	)
Common stock issued		—		—		214,571		—		2,690			—			—		2,690
Accumulated other comprehensive income		—		—		—		—		—			—			12		12
BALANCE—March 31, 2023		17,500	$	152,928		29,961,364	$	—	$	504,301		$	(194,216	)	$	20	$	310,105

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

MONTROSE ENVIRONMENTAL GROUP, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	Three Months Ended March 31,
	2023			2022
OPERATING ACTIVITIES:
Net loss	$	(14,719	)	$	(7,536	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Provision (recovery) for bad debt		444			(528	)
Depreciation and amortization		10,555			12,144
Amortization of right-of-use asset		2,491			2,271
Stock-based compensation expense		13,035			10,425
Fair value changes in financial instruments		1,873			(2,449	)
Fair value changes in business acquisition contingencies		(398	)		(21	)
Deferred income taxes		1,367			1,269
Other		458			143
Changes in operating assets and liabilities—net of acquisitions:
Accounts receivable and contract assets		9,615			10,037
Prepaid expenses and other current assets		(3,363	)		(1,776	)
Accounts payable and other accrued liabilities		(11,643	)		(12,852	)
Accrued payroll and benefits		(4,350	)		(7,876	)
Payment of contingent consideration		—			(19,457	)
Change in operating leases		(2,336	)		(2,122	)
Net cash provided by (used in) operating activities		3,029			(18,328	)
INVESTING ACTIVITIES:
Purchases of property and equipment		(4,134	)		(262	)
Proprietary software development and other software costs		(638	)		(50	)
Proceeds from insurance		75			266
Payment of purchase price true ups		(505	)		(631	)
Cash paid for acquisitions—net of cash acquired		(6,525	)		(14,328	)
Net cash used in investing activities		(11,727	)		(15,005	)
FINANCING ACTIVITIES:
Repayment of term loan		(2,188	)		(4,375	)
Payment of contingent consideration		(27	)		(10,543	)
Repayment of finance leases		(1,029	)		(943	)
Proceeds from issuance of common stock for exercised stock options		2,690			429
Dividend payment to the Series A-2 shareholders		(4,100	)		(4,100	)
Payments of deferred offering costs		—			(183	)
Net cash used in financing activities		(4,654	)		(19,715	)
CHANGE IN CASH AND CASH EQUIVALENTS		(13,352	)		(53,048	)
Foreign exchange impact on cash balance		318			98
CASH AND CASH EQUIVALENTS:
Beginning of year		89,828			146,741
End of period	$	76,794		$	93,791
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:
Cash paid for interest	$	1,347		$	184
Cash paid for income tax	$	155		$	—
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued purchases of property and equipment	$	3,096		$	1,144
Property and equipment purchased under finance leases	$	2,405		$	512
Acquisitions unpaid contingent consideration	$	7,855		$	6,995

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

MONTROSE ENVIRONMENTAL GROUP, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except where otherwise indicated)

1. DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

Description of the Business—Montrose Environmental Group, Inc. (“Montrose” or the “Company”) is a corporation formed on November 2013, under the laws of the State of Delaware. The Company has approximately 80 offices across the United States, Canada and Australia and approximately 3,000 employees as of March 31, 2023.

Montrose is an environmental services company serving the recurring environmental needs of a diverse client base, including Fortune 500 companies and federal, state and local governments through the following three segments:

Assessment, Permitting and Response—Through its Assessment, Permitting and Response segment, Montrose provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects and development projects. The Company’s technical advisory and consulting offerings include regulatory compliance support and planning, environmental, ecosystem and toxicological assessments and support during responses to environmental disruption. Montrose helps clients navigate regulations at the local, state, provincial and federal levels.

Measurement and Analysis—Through its Measurement and Analysis segment, Montrose’s teams test and analyze air, water and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna and human health. Montrose’s offerings include source and ambient air testing and monitoring, leak detection and repair and advanced analytical laboratory services such as air, storm water, wastewater and drinking water analysis.

Remediation and Reuse—Through its Remediation and Reuse segment, Montrose provides clients with engineering, design, and implementation services, primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. The Company does not own the properties or facilities at which it implements these projects or the underlying liabilities, nor does it own material amounts of the equipment used in projects; instead, the Company assists clients in designing solutions, managing projects and mitigating their environmental risks and liabilities at their locations.

Basis of Presentation—The unaudited condensed consolidated financial statements include the operations of the Company and its wholly-owned subsidiaries. These unaudited condensed consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The unaudited condensed consolidated financial statements include all accounts of the Company and, in the opinion of management, include all recurring adjustments and normal accruals necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the dates and periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended December 31, 2022. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. All intercompany transactions, accounts and profits, have been eliminated in the unaudited condensed consolidated financial statements.

5

2. SUMMARY OF NEW ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements—In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance was adopted as of January 1, 2022 and did not have a material impact on the Company’s unaudited condensed consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what contract assets and/or contract liabilities it would have recorded under ASC 606 (the revenue guidance) as of the acquisition date, as if the acquirer had entered into the original contract at the same date and on the same terms as the acquiree. The new guidance was adopted as of January 1, 2023 and did not have a material impact on the Company’s unaudited condensed consolidated financial statements; however it may impact the accounting for future acquisitions. The future impact of this new guidance will be primarily a function of the facts and circumstances specific to any acquisitions consummated after adoption and therefore cannot be predicted.

6

3. REVENUES AND ACCOUNTS RECEIVABLE

The Company’s main revenue sources derive from the following revenue streams:

Assessment, Permitting and Response Revenues—Assessment, Permitting and Response revenues are generated from multidisciplinary environmental consulting services. The majority of the contracts are fixed-price or time and material based.

Measurement and Analysis Revenues—Measurement and Analysis revenues are generated from emissions sampling, testing and reporting services, leak detection services, ambient air monitoring services and laboratory testing services. The majority of the contracts are fixed-price or time-and-materials based.

Remediation and Reuse Revenues—Remediation and Reuse revenues are generated from engineering, design, implementation and operating and maintenance (“O&M”) services primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. Engineering, design and implementation contracts are predominantly fixed-fee and time-and-materials based. Services on the majority of O&M contracts are provided under long-term fixed-fee contracts.

Disaggregation of Revenue—The Company disaggregates revenue by its operating segments. The Company believes disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, and uncertainty of revenue and cash flows are affected by economic factors. Disaggregated revenue disclosures are provided in Note 18.

Contract Balances—The Company presents contract balances for unbilled receivables (contract assets), as well as customer advances, deposits and deferred revenue (contract liabilities) within contract assets and accounts payable and other accrued expenses, respectively, on the unaudited condensed consolidated statements of financial position. Amounts are generally billed at periodic intervals (e.g. weekly, bi-weekly or monthly) as work progresses in accordance with agreed-upon contractual terms. The Company utilizes the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component as the period between when the Company transfers services to a customer and when the customer pays for those services is one year or less. Amounts recorded as unbilled receivables are generally for services the Company is not entitled to bill based on the passage of time. Under certain contracts, billing occurs subsequent to revenue recognition, resulting in contract assets. The Company sometimes receives advances or deposits from customers before revenue is recognized, resulting in contract liabilities.

The following table presents the Company’s contract balances:

	March 31,		December 31,
	2023		2022
Contract assets	$	53,563	$	52,403
Contract liabilities		10,932		18,549

Contract assets acquired through business acquisitions amounted to $0.2 million and $1.7 million as of March 31, 2023 and December 31, 2022, respectively. No contract liabilities were acquired through business acquisitions as of March 31, 2023 and December 31, 2022.

Revenue recognized during the three months ended March 31, 2023, included in the contract liabilities balance at the beginning of the year was $12.8 million. The revenue recognized from the contract liabilities consisted of the Company satisfying performance obligations during the normal course of business.

The amount of revenue recognized from changes in the transaction price associated with performance obligations satisfied in prior periods during the three months ended March 31, 2023 was not material.

Remaining Unsatisfied Performance Obligations—Remaining unsatisfied performance obligations represent the total dollar value of work to be performed on contracts awarded and in progress. The amount of remaining unsatisfied performance obligations increases with new contracts or additions to existing contracts and decreases as revenue is recognized on existing contracts. Contracts are included in the amount of remaining unsatisfied performance obligations when an enforceable agreement has been reached. As of March 31, 2023 and December 31, 2022, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $98.2 million and $100.4 million, respectively. As of March 31, 2023, the Company expected to recognize approximately $79.1 million of this amount as revenue within a year and $19.1 million the year after.

7

Accounts Receivable, Net—The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business. Accounts receivable, net consisted of the following:

	March 31, 2023			December 31, 2022
Accounts receivable, invoiced	$	87,261		$	95,055
Accounts receivable, other		503			1,571
Allowance for doubtful accounts		(2,292	)		(1,915	)
Accounts receivable—net	$	85,472		$	94,711

The Company did not have any customers that exceeded 10.0% of its gross receivables as of March 31, 2023 and December 31, 2022. During the three months ended March 31, 2023 the Company did not have any customers that exceeded 10.0% of its revenue. During the three months ended March 31, 2022, the Company had one customer who accounted for 17.3% of revenue. The Company performs ongoing credit evaluations and based on past collection experience, the Company believes that the receivable balances from these largest customers do not represent a significant credit risk.

The allowance for doubtful accounts consisted of the following:

	Beginning Balance		Bad Debt Expense (Recovery)			Charged to Allowance			Other(1)		Ending Balance
There months ended March 31, 2023	$	1,915	$	444		$	(67	)	$	—	$	2,292
Year ended December 31, 2022		4,581		(1,097	)		(1,696	)		127		1,915

____________________

(1)This amount consists of additions to the allowance due to business acquisitions.

4. PREPAID AND OTHER CURRENT ASSETS

Prepaid and other current assets consisted of the following:

	March 31,		December 31,
	2023		2022
Deposits	$	1,366	$	1,394
Prepaid expenses		9,167		5,266
Supplies		4,074		3,632
Income tax receivable		571		694
Prepaid and other current assets	$	15,178	$	10,986

8

5. PROPERTY AND EQUIPMENT, NET

Property and equipment are stated at cost or estimated fair value for assets acquired through business combinations. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term, including options that are deemed to be reasonably assured, or the estimated useful life of the improvement.

Property and equipment, net, consisted of the following:

	Estimated	March 31,			December 31,
	Useful Life	2023			2022
Lab and test equipment	7 years	$	22,992		$	21,171
Vehicles	5 years		5,841			5,732
Equipment	3-7 years		42,819			40,940
Furniture and fixtures	7 years		2,853			2,841
Leasehold improvements	7 years		8,837			8,576
Aircraft	10 years		—			931
Building	39 years		6,112			2,975
			89,454			83,166
Land			725			725
Construction in progress			3,092			3,150
Less accumulated depreciation			(52,586	)		(50,996	)
Total property and equipment—    net		$	40,685		$	36,045

Total depreciation expense included in the unaudited condensed consolidated statements of operations was $2.2 million and $1.8 million for the three months ended March 31, 2023 and March 31, 2022, respectively.

9

6. LEASES

Leases are classified as either finance leases or operating leases based on criteria in ASC 842. The Company has finance leases for its vehicle and equipment leases and operating leases for its real estate space and office equipment leases. The Company’s operating and finance leases generally have original lease terms between 1 year and 15 years, and in some instances include one or more options to renew. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company currently considers some of its renewal options to be reasonably certain to be exercised. Some leases also include early termination options, which can be exercised under specific conditions. The Company does not have material residual value guarantees or restrictive covenants associated with its leases.

Finance and operating lease assets represent the right to use an underlying asset for the lease term, and finance and operating lease liabilities represent the obligation to make lease payments arising from the lease.

The Company calculates the present value of its finance and operating leases using an estimated incremental borrowing rate (“IBR”), which requires judgment. For real estate operating leases, the Company estimates the IBR based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. For all other leases, the Company estimates the IBR based on the stated interest rate on the contract. Since many of the inputs used to calculate the rate implicit in the leases are not readily determinable from the lessee’s perspective, the Company does not use the implicit interest rate.

Certain leases contain variable payments, these payments are expensed as incurred and not included in the Company’s operating lease right-of-use assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance and are excluded from the present value of the Company’s lease obligations.

The Company does not record operating lease right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also combines lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.

The components of lease expense were as follows:

		For the Three Months Ended March 31,
	Statement of Operations Location	2023		2022
Operating lease cost
Lease cost	Selling, general and administrative expense	$	2,741	$	2,451
Variable lease cost	Selling, general and administrative expense		326		367
Total operating lease cost			3,067		2,818
Finance lease cost
Amortization of right of use assets	Depreciation and amortization		1,154		939
Interest on lease liabilities	Interest expense—net		130		112
Total finance lease cost			1,284		1,051
Total lease cost		$	4,351	$	3,869

Supplemental cash flows information related to leases was as follows:

	For the Three Months Ended March 31,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in operating leases	$	2,557	$	2,302
Operating cash flows used in finance leases		130		112
Financing cash flows used in finance leases		1,029		944
Lease liabilities arising from new ROU assets:
Operating leases		7,999		8,815
Finance leases		2,405		512

10

Weighted average remaining lease terms and weighted average discount rates were:

	March 31, 2023
	Operating Leases			Finance Leases
Weighted average remaining lease term (years)	4.62				3.43
Weighted average discount rate		3.31	%		5.57	%
	March 31, 2022
	Operating Leases			Finance Leases
Weighted average remaining lease term (years)	4.86				3.03
Weighted average discount rate		2.50	%		4.98	%

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year:

	Operating Leases			Finance Leases
Remainder of 2023	$	7,117		$	3,657
2024		8,554			3,543
2025		6,507			2,612
2026		5,006			1,902
2027		3,385			967
2028 and thereafter		4,787			135
Total undiscounted future minimum lease payments		35,356			12,816
Less imputed interest		(2,693	)		(1,179	)
Total discounted future minimum lease payments	$	32,663		$	11,637

11

7. BUSINESS ACQUISITIONS

In line with the Company’s strategic growth initiatives, the Company acquired certain businesses during the three months ended March 31, 2023 and during the year ended December 31, 2022. The results of each of those acquired businesses are included in the unaudited condensed consolidated financial statements beginning on the acquisition date. Each transaction qualified as an acquisition of a business and was accounted for as a business combination. All acquisitions resulted in the recognition of goodwill. The Company paid these premiums resulting in such goodwill for a number of reasons, including expected synergies from combining operations of the acquiree and the Company while also growing the Company’s customer base, acquiring assembled workforces, expanding its presence in certain markets and expanding and advancing its product and service offerings. The Company recorded the assets acquired and liabilities assumed at their acquisition date fair value, with the difference between the fair value of the net assets acquired and the acquisition consideration reflected as goodwill.

The identifiable intangible assets for significant acquisitions are valued using the excess earnings method discounted cash flow approach for customer relationships, the relief from royalty method for trade names, the patent and external proprietary software and developed technology, the “with and without” method for covenants not to compete and the replacement cost method for the internal proprietary software by incorporating Level 3 inputs as described under the fair value hierarchy of ASC 820. These unobservable inputs reflect the Company’s own assumptions about which assumptions market participants would use in pricing an asset on a non-recurring basis. These assets will be amortized over their respective estimated useful lives.

Other purchase price obligations (primarily deferred purchase price liabilities and target working capital liabilities or receivables) are included on the unaudited condensed consolidated statements of financial position in accounts payable and other accrued liabilities, other non-current liabilities or accounts receivable-net in the case of working capital deficits. Contingent consideration outstanding from acquisitions are included on the unaudited condensed consolidated statements of financial position in business acquisition contingent consideration, current or in business acquisitions contingent consideration, long-term. The contingent consideration elements of the purchase price of the acquisitions are related to earn-outs which are based on the expected achievement of revenue or earnings thresholds as of the date of the acquisition and for which the maximum potential amount is limited.

The Company considers several factors when determining whether or not contingent consideration liabilities are part of the purchase price, including the following: (i) the valuation of its acquisitions is not supported solely by the initial consideration paid, (ii) the former stockholders of acquired companies that remain as key employees receive compensation other than contingent consideration payments at a reasonable level compared with the compensation of the Company’s other key employees and (iii) contingent consideration payments are not affected by employment termination. The Company reviews and assesses the estimated fair value of contingent consideration at each reporting period.

The Company may be required to make up to $9.5 million in aggregate earn-out payments between the years 2023 and 2026 in connection with certain of its business acquisitions, of which up to $2.6 million may be paid only in cash, up to $5.5 million may be paid only in common stock and up to $1.5 million may be paid, at the Company’s option, in cash or common stock.

Transaction costs related to business combinations totaled $0.8 million and $0.5 million for the three months ended March 31, 2023 and March 31, 2022, respectively. These costs are expensed within selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations.

Acquisitions Completed During the Three Months Ended March 31, 2023

Frontier Analytical Laboratories (“Frontier”) —In January 2023, the Company completed the acquisition of Frontier by acquiring certain of its assets and operations. Frontier is a specialized environmental laboratory based in El Dorado Hills, CA.

Environmental Alliance, Inc. (“EAI”)—In February 2023, the Company completed the acquisition of EAI by acquiring 100.0% of its common stock. EAI provides environmental remediation and consulting services, and is based in Wilmington, DE.

The following table summarizes the elements of the purchase price of the acquisitions completed during the three months ended March 31, 2023:

	Cash		Common Stock		Other Purchase Price Components			Contingent Consideration		Total Purchase Price
Frontier	$	1,146	$	—	$	—		$	—	$	1,146
EAI		5,390		—		(342	)		25		5,073
Total	$	6,536	$	—	$	(342	)	$	25	$	6,219

12

The upfront cash payment made to acquire both of these acquisitions was funded through cash on hand. The other purchase price components of the EAI purchase price mainly consist of surplus working capital amounts.

The preliminary purchase price attributable to the acquisitions was allocated as follows:

	Frontier		EAI		Total(1)
Cash	$	—	$	11	$	11
Accounts receivable		—		1,502		1,502
Other current assets		—		121		121
Current assets		—		1,634		1,634
Property and equipment		302		191		493
Customer relationships		—		1,402		1,402
Trade names		—		106		106
Covenants not to compete		—		263		263
Goodwill		844		1,965		2,809
Total assets		1,146		5,561		6,707
Current liabilities		—		488		488
Total liabilities		—		488		488
Purchase price	$	1,146	$	5,073	$	6,219

___________________________________

(1) The Company is continuing to obtain information to complete the valuation of certain of these acquisitions' assets and liabilities.

Goodwill associated with the Frontier acquisition is deductible for income tax purposes. The weighted average useful lives for EAI identifiable customer relationships, tradenames and covenants not to compete are 7 years, 2 years and 5 years, respectively.

Frontier is included in the Company’s Measurement and Analysis segment and EAI is included in the Remediation and Reuse segment.

For the acquisitions completed during the three months ended March 31, 2023, the results of operations since the acquisition dates have been combined with those of the Company. The Company’s unaudited condensed consolidated statement of operations for the three months ended March 31, 2023 includes revenue of $1.0 million, and pre-tax income of $0.1 million, related to these acquisitions.

13

Acquisitions Completed During the Year Ended December 31, 2022

Environmental Standards, Inc. (“Environmental Standards”)—In January 2022, the Company completed the acquisition of Environmental Standards, Inc. by acquiring 100.0% of its common stock. Environmental Standards is a provider of environmental consulting and data validation services. Environmental Standards is based in Valley Forge, PA with satellite locations nationwide.

Industrial Automation Group, Inc. (“IAG”)—In January 2022, the Company completed the acquisition of Industrial Automation Group, Inc. by acquiring certain of its employees and a covenant not to compete. IAG is based in Atlanta, GA. IAG provides highly specialized engineering services which are additive to the Company’s water treatment and renewable energy technology implementations.

TriAD Environmental Consultants, Inc. (“TriAD”)—In August 2022, the Company completed the acquisition of TriAD Environmental Consultants, Inc. by acquiring 100.0% of its common stock. TriAD is a provider of environmental consulting services. TriAD is based in Nashville, TN.

AirKinetics, Inc. (“AirKinetics”)—In September 2022, the Company completed the acquisition of AirKinetics, Inc. by acquiring 100.0% of its common stock. AirKinetics is a provider of emissions testing services. AirKinetics is based in Anaheim, CA.

Huco Consulting, Inc. (“Huco”)—In November 2022, the Company completed the acquisition of Huco Consulting, Inc. by acquiring 100.0% of its common stock. Huco primarily specializes in the implementation of environment, health and safety software for industrial, commercial and government clients. Huco is based in Houston, TX.

Environmental Standards and Huco are included in the Company’s Assessment, Permitting and Response segment, IAG and TriAD are included in the Remediation and Reuse segment and AirKinetics is included in the Measurement and Analysis segment.

For the acquisitions completed during the three months ended March 31, 2022, the results of operations since the acquisition dates have been combined with those of the Company. The Company’s unaudited condensed consolidated statement of operations for the three months ended March 31, 2022 includes revenue of $3.3 million and pre-tax income of $0.8 million.

During the three months ended March 31, 2023, measurement period adjustments of $0.2 million were recorded to goodwill as a result of the Company’s efforts to complete the valuation of certain acquired assets and assumed liabilities (Note 8).

Supplemental Unaudited Pro-Forma—The unaudited condensed consolidated financial information summarized in the following table gives effect to the 2023 and the 2022 acquisitions discussed above assuming they occurred on January 1, 2022. These unaudited consolidated pro forma operating results do not assume any impact from revenue, cost or other operating synergies that are expected or may have been realized as a result of the acquisitions. These unaudited consolidated pro forma operating results are presented for illustrative purposes only and are not indicative of the operating results that would have been achieved had the acquisitions occurred on January 1, 2022, nor does the information purport to reflect results for any future period.

	For the Three Months Ended March 31,
	2023									2022
	As reported			Acquisitions Pro-Forma (Unaudited)			Consolidated Pro-Forma (Unaudited)			As reported			Acquisitions Pro-Forma (Unaudited)		Consolidated Pro-Forma (Unaudited)
Revenues	$	131,428		$	433		$	131,861		$	134,680		$	5,625	$	140,305
Net (loss) income		(14,719	)		(67	)		(14,786	)		(7,536	)		722		(6,814	)

14

8. GOODWILL AND INTANGIBLE ASSETS

Amounts related to goodwill are as follows:

	Assessment, Permitting and Response			Measurement and Analysis			Remediation and Reuse		Total
Balance as of December 31, 2022	$	185,116		$	86,205		$	52,547	$	323,868
Goodwill acquired during the period		—			844			1,965		2,809
Acquisitions measurement period adjustments		(169	)		(10	)		—		(179	)
Balance as of March 31, 2023	$	184,947		$	87,039		$	54,512	$	326,498

Amounts related to finite-lived intangible assets are as follows:

March 31, 2023	Estimated Useful Life	Gross Balance		Accumulated Amortization		Total Intangible Assets—Net
Finite lived intangible assets
Customer relationships	2-15 years	$	209,426	$	100,404	$	109,022
Covenants not to compete	4-5 years		33,805		29,020		4,785
Trade names	1-5 years		22,167		18,708		3,459
Proprietary software	3-5 years		23,324		16,942		6,382
Patent	16 years		17,479		3,856		13,623
Total other intangible assets    —net		$	306,201	$	168,930	$	137,271

December 31, 2022	Estimated Useful Life	Gross Balance		Accumulated Amortization		Total Intangible Assets—Net
Finite lived intangible assets
Customer relationships	2-15 years	$	208,024	$	95,768	$	112,256
Covenants not to compete	4-5 years		33,542		28,280		5,262
Trade names	1-5 years		22,061		18,256		3,805
Proprietary software	3-5 years		22,698		15,810		6,888
Patent	16 years		17,479		3,583		13,896
Total other intangible assets    —net		$	303,804	$	161,697	$	142,107

Intangible assets with finite lives are stated at cost, less accumulated amortization and impairment losses, if any. These intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.

Amortization expense was $7.2 million and $9.4 million for the three months ended March 31, 2023 and March 31, 2022, respectively.

Future amortization expense is estimated to be as follows for each of the five following years and thereafter:

December 31,
2023 (remaining)		20,920
2024		24,607
2025		17,727
2026		13,952
2027		13,429
Thereafter		46,636
Total	$	137,271

15

9. ACCOUNTS PAYABLE AND OTHER ACCRUED LIABILITIES

Accounts payable and other accrued liabilities consisted of the following:

	March 31,		December 31,
	2023		2022
Accounts payable	$	24,399	$	25,353
Accrued expenses		16,311		14,754
Other business acquisitions purchase    price obligations		450		1,185
Contract liabilities		10,932		18,549
Other current liabilities		3,328		3,571
Total accounts payable and    other accrued liabilities	$	55,420	$	63,412

10. ACCRUED PAYROLL AND BENEFITS

Accrued payroll and benefits consisted of the following:

	March 31,		December 31,
	2023		2022
Accrued bonuses	$	3,559	$	8,624
Accrued paid time off		1,161		1,088
Accrued payroll		9,084		8,410
Accrued other		2,548		2,406
Total accrued payroll and benefits	$	16,352	$	20,528

16

11. INCOME TAXES

The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting (“ASC 270”), and ASC 740. The Company’s effective tax rate (“ETR”) from continuing operations was (10.2)% and (20.2)% for the three months ended March 31, 2023 and March 31, 2022, respectively. Income tax expense recorded by the Company during the three months ended March 31, 2023 and March 31, 2022 was $1.4 million and $1.3 million, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to items recorded for U.S. GAAP but permanently disallowed for U.S. federal income tax purposes, recognition of a U.S. federal and state valuation allowance and state and foreign income tax provisions.

A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. As of March 31, 2023, the Company’s U.S. federal, state and various foreign net deferred tax assets are not more-likely-than-not to be realized and a full valuation allowance is maintained.

The Company records uncertain tax positions in accordance with ASC 740, on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it has no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense.

12. DEBT

Debt consisted of the following:

	March 31,			December 31,
	2023			2022
Term loan facility	$	164,062		$	166,250
Revolving line of credit		—			—
Less deferred debt issuance costs		(1,595	)		(1,725	)
Total debt		162,467			164,525
Less current portion of long-term debt		(13,125	)		(12,031	)
Long-term debt, less current portion	$	149,342		$	152,494

Deferred Financing Costs—Costs relating to debt issuance have been deferred and are presented as discounted against the underlying debt instrument. These costs are amortized to interest expense over the terms of the underlying debt instruments.

2021 Credit Facility—On April 27, 2021, the Company entered into a Senior Secured Credit Agreement providing for a $300.0 million credit facility comprised of a $175.0 million term loan and a $125.0 million revolving line of credit (the “2021 Credit Facility”), and used a portion of the proceeds from the 2021 Credit Facility to repay all amounts outstanding under the prior credit facility. The revolving line of credit portion of the 2021 Credit Facility includes a $20.0 million sublimit for the issuance of letters of credit. Subject to certain exceptions, all amounts under the 2021 Credit Facility will become due on April 27, 2026. The Company has the option to borrow incremental term loans or request an increase in the aggregate commitments under the revolving credit facility up to an aggregate amount of $150.0 million subject to the satisfaction of certain conditions.

The 2021 Credit Facility term loan must be repaid in quarterly installments and shall amortize at the following future quarterly rates:

17

Date	Quarterly Installment Rate
June 30, 2023	1.25%
September 30, 2023	1.25%
December 31, 2023	1.88%
March 31, 2024	1.88%
June 30, 2024	1.88%
September 30, 2024	1.88%
December 31, 2024	1.88%
March 31, 2025	1.88%
June 30, 2025	1.88%
September 30, 2025	1.88%
December 31, 2025	2.50%
March 31, 2026	2.50%
April 27, 2026	Remaining balance

Repayments of quarterly installments were scheduled to begin with the quarter ended December 31, 2021. The first quarterly installment repayment, amounting to $2.2 million, was paid in January 2022. Exclusive of the payment made in respect of the quarter ended December 31, 2021, the quarterly installment repayments for the three months ended March 31, 2022 amounted to $2.2 million. The December 31, 2022 installment repayment, amounting to $2.2 million, was paid in January 2023. The March 31, 2023 installment repayment, amounting to $2.2 million, was paid in April 2023.

The 2021 Credit Facility term loan and the revolver bear interest subject to the Company’s leverage ratio and LIBOR as follows:

Pricing Tier	Consolidated Leverage Ratio	Senior Credit Facilities LIBOR			Senior Credit Facilities Base Rate			Commitment Fee			Letter of Credit Fee
1	≥ 3.75x to 1.0		2.50	%		1.50	%		0.25	%		2.50	%
2	< 3.75x to 1.0 but ≥ 3.25 to 1.0		2.25			1.25			0.23			2.25
3	<3.25x to 1.0 but ≥ 2.50 to 1.0		2.00			1.00			0.20			2.00
4	<2.50x to 1.0 but ≥ 1.75 to 1.0		1.75			0.75			0.15			1.75
5	<1.75x to 1.0		1.50			0.50		0.15				1.50

The Company is currently in discussions regarding the transition of LIBOR to an adjusted benchmark rate to be effective on or before June 30, 2023. The transition to an adjusted interest rate is not expected to materially impact the interest rate paid by the Company.

On January 27, 2022, the Company entered into an interest rate swap transaction fixing the floating component of the interest rate on $100.0 million of borrowings to 1.39% until January 27, 2025. Additionally, effective September 1, 2022, the Company received an interest rate reduction of 0.05% under the 2021 Credit Facility based on the Company’s achievement of certain sustainability and environmental, social and governance related objectives as provided for in the 2021 Credit Facility.

The 2021 Credit Facility includes a number of covenants imposing certain restrictions on the Company’s business, including, among other things, restrictions on the Company’s ability, subject to certain exceptions and baskets, to incur indebtedness, incur liens on its assets, agree to any additional negative pledges, pay dividends or repurchase stock, limit the ability of its subsidiaries to pay dividends or distribute assets, make investments, enter into any transaction of merger or consolidation, liquidate, wind-up or dissolve, or convey any part of its business, assets or property, or acquire the business, property or assets of another person, enter into sale and leaseback transactions, enter into certain transactions with affiliates, engage in any material line of business substantially different from those engaged on the closing date, modify the terms of indebtedness subordinated to the loans incurred under the 2021 Credit Facility and modify the terms of its organizational documents. The 2021 Credit Facility also includes financial covenants which required the Company to remain below a maximum total net leverage ratio of 4.25 times until the fiscal quarter ended September 31, 2022, which stepped down to 4.00 times during the fiscal quarter ending December 31, 2022 and applies through and including the fiscal quarter ending September 30, 2023 and then further steps down to 3.75 times beginning with the fiscal quarter ending December 31, 2023, and a minimum fixed charge coverage ratio of 1.25 times. As of March 31, 2023 and December 31, 2022, the Company’s consolidated total leverage ratio (as defined in the 2021 Credit Facility) was 1.4 times and 1.3 times, respectively, and the Company was in compliance with all covenants under the 2021 Credit Facility.

18

The 2021 Credit Facility requires customary mandatory prepayments of the term loan and revolver and cash collateralization of letters of credit, subject to customary exceptions, including 100.0% of the proceeds of debt not permitted by the 2021 Credit Facility, 100.0% of the proceeds of certain dispositions, subject to customary reinvestment rights, where applicable, and 100.0% of insurance or condemnation proceeds, subject to customary reinvestment rights, where applicable. The 2021 Credit Facility also includes customary events of default and related acceleration and termination rights.

The weighted average interest rate on the 2021 Credit Facility for the three months ended March 31, 2023 and March 31, 2022 was 6.1% and 1.8%, respectively.

The Company’s obligations under the 2021 Credit Facility are guaranteed by certain of the Company’s existing and future direct and indirect subsidiaries, and such obligations are secured by substantially all of the Company’s assets, including the capital stock or other equity interests in those subsidiaries.

Equipment Line of Credit—The Company had a $10.0 million equipment leasing facility for the purchase of equipment and related freight, installation costs and taxes paid. Any unused capacity on this equipment leasing facility expired on March 31, 2023. Interest on the line of credit was determined based on a three-year swap rate at the time of funding. Equipment leased through this line of credit met the finance lease criteria as per ASC 842 and accordingly is accounted for as finance lease right-of-use assets and finance lease liabilities (Note 6).

The following is a schedule of the aggregate annual maturities of long-term debt presented on the unaudited condensed consolidated statement of financial position, based on the terms of the 2021 Credit Facility:

March 31,
2024	$	13,125
2025		13,125
2026		15,312
2027		122,500
2028		—
Total	$	164,062

19

13. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following financial instruments are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):

	March 31,		December 31,
	2023		2022
Interest rate swap(1)	$	5,078	$	6,046
Total assets	$	5,078	$	6,046
Business acquisitions contingent consideration,    current	$	4,734	$	3,801
Business acquisitions contingent consideration,    long-term		3,121		4,454
Conversion option		26,636		25,731
Total liabilities	$	34,491	$	33,986

_____________________________
 

(1) Included in other assets in the unaudited condensed consolidated statement of financial position.

The estimated fair value amounts shown above are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instrument.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis:

	Interest Rate Swap			Total Assets			Business Acquisitions Contingent Consideration, Current			Business Acquisitions Contingent Consideration, Long-term			Conversion    Option		Total Liabilities
Balance—at January 1, 2022	$	—		$	—		$	31,450		$	4,350		$	23,081	$	58,881
Acquisitions		—			—			—			1,216			—		1,216
Changes in fair value included in earnings		3,005			3,005			(21	)		—			556		535
Payment of contingent consideration        payable		—			—			(30,000	)		—			—		(30,000	)
Balance—at March 31, 2022	$	3,005		$	3,005		$	1,429		$	5,566		$	23,637	$	30,632
Balance—at January 1, 2023	$	6,046		$	6,046		$	3,801		$	4,454		$	25,731	$	33,986
Acquisitions		—			—			25			—			—		25
Changes in fair value included in earnings		(968	)		(968	)		(515	)		117			905		507
Payment of contingent consideration        payable		—			—			(27	)		—			—		(27	)
Reclass of long term to short term       contingent liabilities		—			—			1,450			(1,450	)		—		—
Balance—at March 31, 2023	$	5,078		$	5,078		$	4,734		$	3,121		$	26,636	$	34,491

Quantitative Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3):

Interest Rate Swap—The interest rate swap fair value is estimated based on a mid-market price for the swap as of the close of business of the reporting period. The fair value is prepared by discounting future cash flows of the swap to arrive at a current value of the swap. Forward curves and volatility levels inputs are determined on the basis of observable market inputs when available and on the basis of estimates when observable market inputs are not available. The Company does not apply hedge accounting but instead recognizes the instrument at fair value on the unaudited condensed consolidated statement of financial position within other assets, with changes in fair value recognized as other income (expense) in each reporting period.

Business Acquisitions Contingent Consideration—The fair value of the contingent consideration payable associated with the acquisitions of CTEH and Sensible was determined using a Monte Carlo simulation of earnings in a risk-neutral Geometric Brownian Motion framework. The fair value of the contingent consideration payable associated with the acquisition of Environmental Standards was determined using a Probabilistic (Scenario Based) method. The fair values of the contingent consideration payables for the other acquisitions were calculated based on expected target achievement amounts, which are measured quarterly and then subsequently adjusted to actuals at the target measurement date. The method used to price these liabilities is considered level 3 due to the subjective nature of the unobservable inputs used to determine the fair value. The input is the expected achievement of earn-out thresholds.

20

Conversion Option—The fair value of the conversion option associated with the issuance of the Convertible and Redeemable Series A-2 Preferred Stock (Note 15) was estimated using a “with-and-without” method. The “with-and-without” methodology considers the value of the security on an as-is basis and then without the embedded conversion premium. The difference between the two scenarios is the implied fair value of the embedded derivative. The unobservable input is the required rate of return on the Series A-2. The considerable quantifiable inputs in the valuation relate to the timing of conversions or redemptions.

14. COMMITMENTS AND CONTINGENCIES

Leases—The Company leases office facilities over various terms expiring through 2031. Certain of these operating leases contain rent escalation clauses. The Company also has office equipment leases that expire through 2028 (Note 6 and 12).

Other Commitments—The Company has commitments under the 2021 Credit Facility, its equipment line of credit and its lease obligations (Note 6 and 12).

Contingencies—The Company is subject to purchase price contingencies related to earn-outs associated with certain acquisitions (Note 7 and 13).

Legal—In the normal course of business, the Company is at times subject to pending and threatened legal actions. In management’s opinion, the potential loss resulting from the resolution of these matters is not expected to have a material effect on the unaudited condensed consolidated results of operations, financial position or cash flows of the Company.

21

15. CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK

On April 13, 2020, the Company entered into an agreement to issue 17,500 shares of the Convertible and Redeemable Series A-2 Preferred Stock with a par value of $0.0001 per share and a detachable warrant to purchase shares of the Company’s common stock with a 10-year life, in exchange for gross proceeds of $175.0 million, net of $1.3 million debt issuance costs. The Convertible and Redeemable Series A-2 Preferred Stock warrants were exercised in full on July 30, 2020. The Company paid dividends on shares of the Convertible and Redeemable Series A-2 Preferred Stock of $4.1 million during both the three months ended March 31, 2023 and March 31, 2022.

The Convertible and Redeemable Series A-2 Preferred Stock terms include the following: (i) no mandatory redemption, (ii) no stated value cash repayment obligation other than in the event of certain defined liquidation events, (iii) only redeemable at the Company’s option, (iv) convertible into common stock beginning on the four year anniversary of issuance at a 15.0% discount to the common stock market price (with a limit of $60.0 million in stated value of Convertible and Redeemable Series A-2 Preferred Stock eligible to be converted in any 60-day period prior to the seventh anniversary of issuance and the amount of stated value of the Convertible and Redeemable Series A-2 Preferred Stock eligible for conversion limited to $60.0 million during year 5 and $120.0 million (which includes the aggregate amount of the stated value of the Convertible and Redeemable Series A-2 Preferred Stock and any accrued but unpaid dividends added to such stated value of any shares of Convertible and Redeemable Series A-2 Preferred Stock converted in year 5) during year 6), (v) 9.0% dividend rate per year with required quarterly cash payments, (vi) in an event of noncompliance, the dividend rate shall increase to 12.0% per annum for the first 90-day period from and including the date the noncompliance event occurred, and thereafter shall increase to 14.0% per annum, (vii) debt incurrence test ratio of 4.5 times, and (viii) minimum repayment amount of $25.0 million.

The Company may, at its option on any one or more dates, redeem all or a minimum portion (the lesser of (i) $25.0 million in aggregate stated value of the Convertible and Redeemable Series A-2 Preferred Stock and (ii) all of the Convertible and Redeemable Series A-2 Preferred Stock then outstanding) of the outstanding Convertible and Redeemable Series A-2 Preferred Stock in cash.

With respect to any redemption of any share of the Convertible and Redeemable Series A-2 Preferred Stock prior to the third-year anniversary, the Company is subject to a make whole penalty in which the holders of the Convertible and Redeemable Series A-2 Preferred Stock are guaranteed a minimum repayment equal to outstanding redeemed stated value plus three years of dividends accrued or accruable thereon.

The Convertible and Redeemable Series A-2 Preferred Stock does not meet the definition of a liability pursuant to “ASC 480- Distinguishing Liabilities from Equity.” However, as (i) the instrument is redeemable upon a change of control as defined in the certificate of designations governing the terms of the Convertible and Redeemable Series A-2 Preferred Stock, and (ii) the Company cannot assert it would have sufficient authorized and unissued shares of common stock to settle all future conversion requests due to the variable conversion terms, the instrument is redeemable upon the occurrence of events that are not solely within the control of the Company, and therefore the Company classifies the Convertible and Redeemable Series A-2 Preferred Stock as mezzanine equity. Subsequent adjustment of the carrying value of the instrument is required if the instrument is probable of becoming redeemable. As of March 31, 2023, the Company has determined that a change of control is not probable. Additionally, as of March 31, 2023, the Company has determined that it is not probable that there will be a future conversion request that the Company is unable to settle with authorized and issued shares based on the Company’s current stock price and available shares as well as the Company’s monitoring efforts to ensure there are a sufficient number of shares available to settle any conversion request. Therefore, as of March 31, 2023, the Company has determined that the instrument is not probable of becoming redeemable, and does not believe subsequent adjustment of the carrying value of the instrument will be necessary.

The Convertible and Redeemable Series A-2 Preferred Stock contains a conversion option of the preferred shares to shares of common stock beginning on the fourth-year anniversary of the issuance date. As of March 31, 2023 and December 31, 2022, this conversion embedded feature had a net fair value of $26.6 million and $25.7 million, respectively. The change in net fair value of $0.9 million and $0.6 million for the three months ended March 31, 2023 and March 31, 2022, respectively, was recorded to other expense.

22

16. STOCKHOLDERS’ EQUITY

Authorized Capital Stock—The Company was authorized to issue 190,000,000 shares of common stock, with a par value of $0.000004 per share as of March 31, 2023 and December 31, 2022.

Common Stock Issuances—The Company issued the following shares of common stock:

	Three Months Ended March 31,
	2023						2022
	Shares		Average Price per Share		Total		Shares		Average Price per Share		Total
Exercise of options		124,455	$	21.61	$	2,690		30,607	$	14.03	$	429
Restricted shares, net (1)		90,116		36.81		—		25,289		66.58		—
Total		214,571	$	27.99	$	2,690		55,896	$	37.81	$	429

(1) Represents the non-cash release of common shares due to the vesting of restricted stock.

Employee Equity Incentive Plans—The Company has two plans under which stock-based awards have been issued: (i) the Montrose Amended & Restated 2017 Stock Incentive Plan (“2017 Plan”) and (ii) the Montrose Amended & Restated 2013 Stock Option Plan (“2013 Plan”) (collectively the “Plans”).

As of March 31, 2023, and March 31, 2022, there was $146.6 million and $173.1 million, respectively, of total unrecognized stock compensation expense related to unvested options, restricted stock and stock appreciation rights granted under the Plans. Such unrecognized expense is expected to be recognized over a weighted-average four year period. The following number of shares were authorized to be issued and available for grant:

	March 31, 2023
	2017 Plan		2013 Plan		Total
Shares authorized to be issued		6,329,913		2,037,019		8,366,932
Shares available for grant(1)		893,522		—		893,522
	March 31, 2022
	2017 Plan		2013 Plan		Total
Shares authorized to be issued		8,272,487		1,904,644		10,177,131
Shares available for grant(1)		577,139		—		577,139

(1) In January 2023 and January 2022 the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. Shares available for grant exclude awards of stock appreciation rights approved in December 2021 that are subject to vesting based on the achievement of certain market conditions, which have not yet been, and may not be, achieved. See footnote 1 to the table in Common Stock Reserved for Future Issuance below for additional information on stock appreciation rights.

Total stock compensation expense for the Plans was as follows:

	Three Months Ended March 31,
	2023										2022
	2017 plan						2013 plan				2017 plan						2013 plan
	Options		Restricted Stock		SARs		Options		Total		Options		Restricted Stock		SARs		Options		Total
Cost of revenue	$	349	$	543	$	—	$	—	$	892	$	294	$	—	$	—	$	—	$	294
Selling, general and    administrative expense		1,724		8,154		2,265		—		12,143		1,979		5,792		2,360		—		10,131
Total	$	2,073	$	8,697	$	2,265	$	—	$	13,035	$	2,273	$	5,792	$	2,360	$	—	$	10,425

Montrose Amended & Restated 2017 Stock Incentive Plan

Restricted Stock Awards and Restricted Stock Units—The Company issues restricted stock awards ("RSAs") to certain 2017 Plan participants as Director’s compensation. There were 17,346 and 10,920 RSAs granted during the three months ended March 31, 2023 and March 31, 2022, respectively. These RSAs vest one year from the date of grant, or, in each case, in full upon a change in control, subject to the

23

participant’s continued service as a Director throughout such date, or upon retirement. Members of the Board of Directors that receive stock-based compensation are treated as employees for accounting purposes.

In the first quarter of 2023, the Board of Directors approved the grant of 200,423 restricted stock units (“RSUs”) to certain senior non-executive employees of the Company, in lieu of options. These RSUs represent the right to receive one share of the Company’s common stock upon vesting. These RSUs vest annually over a 4-year period from the date of grant, subject to continued service through each such date.

In the first quarter of 2023 and 2022, the Board of Directors approved the grant of RSUs under certain supplemental incentive plans ("SI Plans"). There were 246,417 and 95,404 RSUs issued under these SI Plans during the three months ended March 31, 2023 and March 31, 2022, respectively. The majority of the RSUs issued in the first quarter of 2023 vested 1/3 on the date of grant, and will vest 1/3 on the one-year anniversary of the grant, and 1/3 on the two-year anniversary of the grant, subject to continued service through each such date. The remaining RSUs vest annually over a 4-year period from the date of grant, subject to continued service through each such date.

24

RSAs and RSUs activity was as follows:

	Three Months Ended March 31,
	2023						2022
	Shares		Average Price per Share		Fair Value		Shares		Average Price per Share		Fair Value
Awards granted		464,186	$	32.62	$	15,140		106,324	$	46.82	$	4,978

There were an aggregate of 90,116 and 25,289 shares underlying RSAs and RSUs that became fully vested and were released as unrestricted shares of common stock during the three months ended March 31, 2023 and March 31, 2022, respectively. There were no forfeitures of RSAs or RSUs during the three months ended March 31, 2023 and March 31, 2022. There were an aggregate of 2,528,383 and 2,064,197 shares underlying outstanding RSAs and RSUs awards as of March 31, 2023 and March 31, 2022, respectively.

Stock Appreciation Rights— As of March 31, 2023, there were 3,000,000 units of stock appreciation rights (“SARs”) outstanding under the 2017 Plan. These SARs represent the right to receive, upon exercise, a payment equal to the excess of (a) the fair market value of one share of the Company’s common stock, over (b) an exercise price of $66.79, payable, at the Company’s election, in cash or shares of common stock. These SARs vest on the 5th anniversary of the date of grant based on achievement of performance hurdles over a five year period, subject to continued service on the vesting date. The performance hurdles are as follows:

SARs Stock Price Performance Hurdle		Portion of SARs Subject to Performance Hurdle
$	133.58	1/3
$	166.98	1/3
$	200.37	1/3

The performance hurdles shall be deemed achieved if the average trading price per share of the Company’s common stock equals or exceeds the applicable stock price performance hurdle set forth above for the trading days falling in a consecutive 20-day period prior to the vesting date. None of the market conditions have been achieved as of March 31, 2023.

The SARs expire 10 years after the grant date. The fair value of these SARs at the grant date was $46.0 million. The weighted average remaining contract life of these SARs as of March 31, 2023 was 8.71 years.

Options—Options issued to all optionees under the 2017 Plan vest over 4-years from the date of issuance (or earlier vesting start date, as determined by the Board of Directors) as follows: one half on the second anniversary of date of grant and the remaining half on the fourth anniversary of the date of grant, with the exception of certain annual grants to certain executive officers, which vest annually over a 3-year and 1-year period. The following summarizes the options activity of the 2017 Plan:

	Options to Purchase Common Stock			Weighted- Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The- Money Options (in Thousands)
Outstanding as of January 1, 2022		2,036,729		$	26	$	14		8.30	$	91,030
Granted		547,884			44		16		—		—
Forfeited/ cancelled		(23,082	)		36		—		—		—
Exercised		(11,547	)		27		—		—		313
Outstanding as of March 31, 2022		2,549,984			30		14		8.46		59,955
Outstanding as of January 1, 2023		2,579,566		$	31	$	15		7.76	$	37,292
Granted		233,955			32		14		—		—
Forfeited/ cancelled		(34,619	)		35		—		—		—
Exercised		(101,279	)		25		—		—		2,467
Outstanding as of March 31, 2023		2,677,623		$	31	$	15		7.78	$	21,127
Exercisable at March 31, 2023		1,305,511			29		—		7.19		11,880

25

The following weighted-average assumptions were used in the Black-Sholes option-pricing model calculation:

	March 31,			March 31,
	2023			2022
Common stock value (per share)	$	32.16		$	44.11
Expected volatility		33.79	%		33.45	%
Risk-free interest rate		3.72	%		1.74	%
Expected life (years)		7.00			6.33
Forfeiture rate	None			None
Dividend rate	None			None

Montrose Amended & Restated 2013 Stock Option Plan—The following summarizes the activity of the 2013 Plan:

	Options to Purchase Common Stock			Weighted- Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The- Money Options (in Thousands)
Outstanding as of January 1, 2022		897,674		$	6	$	2		4.37	$	57,529
Exercised		(19,060	)		6		—		—		821
Outstanding as of March 31, 2022		878,614			6		2		4.13		40,860
Outstanding as of January 1, 2023		855,695		$	6	$	2		3.31	$	32,478
Exercised		(23,176	)		9		—		—		963
Outstanding as of March 31, 2023		832,519		$	6	$	2		3.03	$	24,393
Exercisable at March 31, 2023		832,519			6		—		3.03		24,393

Total shares outstanding from exercised options were 1,434,885 shares and 1,239,697 shares as of March 31, 2023 and March 31, 2022, respectively.

Common Stock Reserved for Future Issuances—The Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:

	March 31,
	2023		2022
Montrose 2013 Stock Incentive Plan		832,519		878,614
Montrose 2017 Stock Incentive Plan(1)		8,722,930		7,893,918
Total		9,555,449		8,772,532

(1) In January 2023 and 2022, the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards. Shares reserved for future issuance include 3,000,000 shares underlying the 3,000,000 performance SARs granted in December 2021 that are subject to vesting based on the achievement of certain market conditions. Assuming achievement at the highest price performance hurdle, approximately 2,000,000 shares of common stock would be issued upon vesting of these performance SARs. To date, none of the market conditions have been achieved.

26

17. NET LOSS PER SHARE

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during each period. The Convertible and Redeemable Series A-2 Preferred Stock is considered a participating security during the applicable period. Net losses are not allocated to the Convertible and Redeemable Series A-2 stockholders, as they were not contractually obligated to share in the Company’s losses.

Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding for the period using the treasury-stock method or the as-converted method. Potentially dilutive shares are comprised of RSAs, RSUs, SARs and shares of common stock underlying stock options outstanding under the Plans. During the three months ended March 31, 2023 and March 31, 2022, there is no difference in the number of shares used to calculate basic and diluted shares outstanding during the applicable period due to the Company’s net loss attributable to common stockholders and potentially dilutive shares being anti-dilutive.

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:

	Three Months Ended
	March 31,
(In thousands, except for net loss per share)	2023			2022
Net loss	$	(14,719	)	$	(7,536	)
Convertible and redeemable series A-2 preferred    stock dividend		(4,100	)		(4,100	)
Net loss attributable to common stockholders    –basic and diluted		(18,819	)		(11,636	)
Weighted-average common shares outstanding –    basic and diluted		29,857			29,662
Net loss per share attributable to common    stockholders –basic and diluted	$	(0.63	)	$	(0.39	)

The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive:

	March 31,
	2023(1)		2022(1)
Stock options		3,510,142		2,034,041
Restricted stock		2,151,785		1,777,958
Series A-2		4,735,220		4,329,640
SARs		3,000,000		3,000,000

_____________________________

(1) Includes 7,362,459 and 5,008,269 common stock equivalents that are out of the money as of March 31, 2023 and March 31, 2022, respectively.

27

18. SEGMENT INFORMATION

The Company has three operating and reportable segments: Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. These segments are monitored separately by management for performance against budget and prior year and are consistent with internal financial reporting. The Company’s operating segments are organized based upon primary services provided, the nature of the production process, their type of customers, methods used to distribute the products and the nature of the regulatory environment.

Segment Adjusted EBITDA is the primary measure of operating performance for all three operating segments. Segment Adjusted EBITDA is the calculated Company’s Earnings before Interest, Tax, Depreciation and Amortization (“EBITDA”), adjusted to exclude certain transactions such as stock-based compensation, acquisition costs and fair value changes in financial instruments, amongst others. Beginning in the first quarter of 2023, the calculation of Segment adjusted EBITDA no longer adjusts for start-up losses and investment in new services as the Chief Operating Decision Maker (“CODM”) no longer reviews the Segment Adjusted EBITDA measure without these costs. The CODM does not review segment assets as a measure of segment performance.

During the first quarter of 2023, the Company determined to sell one of its specialty service lines within the lab testing business (the "Discontinuing Specialty Lab"), whose performance has been sporadic and whose service offering is non-core to the Company’s business. The Company expects the sale process to be completed by December 31, 2023. The discontinuation of this specialty service line, which is part of the Company's Measurement and Analysis segment, did not represent a strategic shift that had (or will have) a major effect on the Company’s operations and financial results, therefore it did not meet the requirements to be classified as discontinued operations.

Corporate and Other includes costs associated with general corporate overhead (including executive, legal, finance, safety, human resources, marketing and IT related costs) that are not directly related to supporting operations. Overhead costs that are directly related to supporting operations (such as insurance, software, licenses, shared services and payroll processing costs) are allocated to the operating segments on a basis that reasonably approximates an estimate of the use of these services.

Segment revenues and Adjusted EBITDA consisted of the following:

	Three Months Ended March 31,
	2023						2022
				Segment						Segment
	Segment			Adjusted			Segment			Adjusted
	Revenues			EBITDA			Revenues			EBITDA(3)
Assessment, Permitting and Response	$	52,214		$	14,266		$	45,600		$	9,623
Measurement and Analysis		42,527	(1)		6,387			39,761	(1)		6,322		(2)
Remediation and Reuse		36,687			5,278			49,319			7,993
Total Operating Segments		131,428			25,931			134,680			23,938
Corporate and Other		—			(9,328	)		—			(7,487	)
Total	$	131,428		$	16,603		$	134,680		$	16,451

28

_____________________________________

(1) Includes revenue of $1.4 million and $5.6 million from the Discontinuing Specialty Lab, for the three months ended March 31, 2023 and March 31, 2022, respectively.
(2) Includes Adjusted EBITDA of $1.3 million from the Discontinuing Specialty Lab.

(3) Includes the add back of start-up losses and investment in new services of $0.8 million.

Presented below is a reconciliation of the Company’s segment measure to net loss:

	For the Three Months Ended March 31,
	2023				2022
Total	$	16,603			$	16,451
Interest expense, net		(1,541	)			(1,092	)
Income tax expense		(1,367	)			(1,269	)
Depreciation and amortization		(10,555	)			(12,144	)
Stock-based compensation		(13,035	)			(10,425	)
Start-up losses and investment in new services		—				(786	)
Acquisition costs		(775	)			(467	)
Fair value changes in financial instruments		(1,873	)			2,449
Fair value changes in business acquisition    contingencies		398				21
Expenses related to financing transactions		(4	)			(7	)
Discontinuing Specialty Lab		(2,436	)	(1)		—
Other losses or expenses		(134	)			(267	)
Net loss	$	(14,719	)		$	(7,536	)

__________________________

(1) Amounts consist of operating losses before depreciation related to the Discontinuing Specialty Lab.

19. RELATED-PARTY TRANSACTIONS

The Company did not have any related party transactions during the three months ended March 31, 2023 and March 31, 2022.

20. DEFINED CONTRIBUTION PLAN

On January 1, 2014, the Company established the Montrose Environmental Group 401(k) Savings Plan (the “401(k) Savings Plan”). As of March 31, 2023, and December 31, 2022, plan participants may defer up to 85.0% of their eligible wages for the year, up to the Internal Revenue Service dollar limit and catch-up contribution allowed by law. The Company provided employer matching contributions equal to 100.0% of the first 3.0% of the participant’s compensation and 50.0% of the participant’s elective deferrals that exceed 3.0% but do not exceed 5.0% of the participant’s compensation. Employer contributions under the 401(k) Savings Plan were $2.1 million and $1.7 million for the three months ended March 31, 2023 and March 31, 2022, respectively, and are included within selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.

29

21. SUBSEQUENT EVENTS

Business Acquisitions—On May 1, 2023, the Company completed the business acquisition of GreenPath Energy LTD ("GreenPath") by acquiring 100.0% of its common stock. GreenPath is a leading optical gas imaging and fugitive emissions management services firm and is based in Calgary, Canada.

On April 28, 2023, the Company signed an arrangement agreement which provides for the acquisition of Matrix Solutions, Inc. ("Matrix") by acquiring 100.0% of its common stock. Matrix is one of Canada’s leading environmental and engineering consulting companies and is based in Calgary, Canada. This business acquisition is expected to close by the end of the second quarter 2023.

These transactions qualify as business acquisitions and will be accounted for as business combinations. The following table summarizes the main elements of the purchase price of these acquisitions:

						Total
	Cash (in CAD Dollars)			Common Stock (in CAD Dollars)		Purchase Price (in CAD Dollars)
GreenPath	$	16,580	(1)		3,520	$	20,100
Matrix		65,191	(2)		—		65,191

_________________________________________
(1) The cash portion of this acquisition's purchase price was funded through cash on hand.

(2) Upon closing, the cash portion of this acquisition's purchase price will funded through a combination of cash on hand and proceeds received from our revolving credit facility.

30

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity, capital resources and other financial and operating information. We use words such as “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “future,” “intend,” “may,” “plan,” “position,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will” and similar terms and phrases to identify forward-looking statements in this filing. All of our forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we are expecting, including:

•our history of losses and ability to achieve profitability;

•general global economic, business and other conditions, including inflationary pressures and rising interest rates, the cyclical nature of our industry and the significant fluctuations in events that impact our business;

•the parts of our business that depend on difficult to predict natural or manmade events and the fluctuations in our revenue and customer concentration as a result thereof;

•the highly competitive nature of our business;

•our limited operating history;

•our ability to execute on our acquisition strategy and successfully integrate and realize benefits from our acquisitions;

•any failure in or breach of our networks and systems or other forms of cyber-attack;

•our ability to promote and develop our brands;

•our ability to maintain and expand our client base;

•our ability to maintain necessary accreditations and other authorizations in varying jurisdictions;

•significant environmental governmental regulation and liabilities;

•our ability to attract and retain qualified managerial and skilled technical personnel;

•safety-related issues;

•the impact of the COVID-19 pandemic on our business operations and on local, national and global economies;

•allegations regarding compliance with professional standards, duties and statutory obligations and our ability to provide accurate results;

•the lack of formal long-term agreements with many of our clients;

•our ability to adapt to changing technology, industry standards or regulatory requirements;

•government clients and contracts;

•our ability to maintain our prices and manage costs;

•our ability to protect our intellectual property or claims that we infringe on the intellectual property rights of others;

•laws and regulations regarding handling of confidential information;

•our international operations;

•product related risks; and

•additional factors discussed in our filings with the Securities and Exchange Commission, or the SEC.

31

The forward-looking statements in this Quarterly Report on Form 10-Q are based on historical performance and management’s current plans, estimates and expectations in light of information currently available to us and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting us will be those that we have anticipated. Actual results or outcomes may differ materially from these expectations due to changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors, many of which are beyond our control, as well as the other factors described in Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 1, 2022, or the 2022 Form 10-K.

Additional factors or events that could cause our actual results or outcomes to differ may also emerge from time to time, and it is not possible for us to predict all of them. In addition, historical, current and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove to be incorrect, our actual results or outcomes may vary in material respects from what we may have expressed or implied by any forward-looking statement and, therefore, you should not regard any forward-looking statement as a representation or warranty by us or any other person that we will successfully achieve the expectation, plan or objective expressed in such forward-looking statement in any specified time frame, or at all. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement made by us speaks only as of the date on which we make it. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.

32

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our historical audited and unaudited consolidated financial statements and related notes and other information included elsewhere in this filing and our other filings with the SEC, including our unaudited condensed consolidated financial statements and the accompanying notes as of and for the three months ended March 31, 2023 and March 31, 2022 included in Part I, Item 1. “Financial Statements” in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from such forward-looking statements. Factors that could cause or contribute to those differences include, but are not limited to, those identified below and those discussed in the section entitled “Forward-Looking Statements”, and elsewhere in this filing and our other filings with the SEC, including in Item 1A. Risk Factors in the 2022 Form 10-K.

Overview

Since our inception in 2012, our mission has been to help clients and communities meet their environmental goals and needs. According to data derived from a 2022 Environmental Industry Study prepared by Environmental Business International, Inc., or EBI, which we commissioned, the global environmental industry is estimated to be approximately $1.34 trillion, with $444.0 billion concentrated in the United States.

Our Segments

We provide environmental services to our clients through three business segments—Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. For more information on each of our operating segments, see Item 1. “Business” in the 2022 Form 10-K.

Assessment, Permitting and Response

Through our Assessment, Permitting and Response segment, we provide scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects and development projects. Our technical advisory and consulting offerings include regulatory compliance support and planning, environmental, ecosystem and toxicological assessments and support during responses to environmental disruption. We help clients navigate regulations at the local, state, provincial and federal levels. In addition to environmental toxicology, and given our expertise in helping businesses plan for and respond to disruptions, our scientists and response teams have helped clients navigate their preparation for and response to the COVID-19 pandemic.

Measurement and Analysis

Through our Measurement and Analysis segment, our highly credentialed teams test and analyze air, water and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna and human health. Our offerings include source and ambient air testing and monitoring, leak detection and advanced analytical laboratory services such as air, storm water, wastewater and drinking water analysis.

Remediation and Reuse

Through our Remediation and Reuse segment, we provide clients with engineering, design, and implementation services, primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. We do not own the properties or facilities at which we implement these projects or the underlying liabilities, nor do we own material amounts of the equipment used in projects; instead, we assist our clients in designing solutions, managing projects and mitigating their environmental risks and liabilities.
 

These operating segments have been structured and organized to align with how we view and manage the business with the full lifecycle of our clients’ targeted environmental concerns and needs in mind. Within each segment, we cover similar service offerings, regulatory frameworks, internal operating structures and client types. Corporate activities not directly related to segment performance, including general corporate expenses, interest and taxes, are reported separately.

Key Factors that Affect Our Business and Our Results

Our operating results and financial performance are influenced by a variety of internal and external trends and other factors. Some of the more important factors are discussed briefly below.

33

Acquisitions

We have been, and expect to continue to be, an acquisitive company. Acquisitions have expanded our environmental service capabilities across all three segments, our access to technology, as well as our geographic reach in the United States, Canada and Australia. The table below sets forth the number of acquisitions completed, revenues generated by and the percentage of total revenues attributable to those acquisitions completed during the three months ended March 31, 2023 and March 31, 2022:

	Three Months Ended March 31,
(Revenues in thousands)	2023			2022
Acquisitions completed		2		2
Revenues attributable to    acquisitions in the period	$	967		$	3,333
Percentage of revenues		0.7	%		2.5	%

Revenues from acquired companies exclude intercompany revenues from revenue synergies realized between business lines within operating segments, as these are eliminated at the consolidated segment and Company level. We expect our revenue growth to continue to be driven in significant part by acquisitions. See Note 7 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

As a result of our acquisitions, goodwill and other intangible assets represent a significant proportion of our total assets, and amortization of intangible assets has historically been a significant expense. Our historical financial statements also include other acquisition-related costs, including costs relating to external legal support, diligence and valuation services and other transaction and integration-related matters. In addition, in any year gains and losses from changes in the fair value of business acquisition contingencies such as earn outs could be significant. The amount of each for the three months ended March 31, 2023 and March 31, 2022, was:

	Three Months Ended March 31,
(in thousands)	2023			2022
Amortization expense	$	7,240		$	9,419
Acquisition-related costs		775			467
Fair value changes in business    acquisition contingencies gain		(398	)		(21	)

We expect that amortization of identifiable intangible assets and other acquisition-related costs, assuming we continue to acquire, will continue to be significant.

Additionally, we made earn-out payments of $30.0 million in March 2022 in connection with our CTEH acquisition. In connection with our Vista, Sensible, Environmental Standards, Huco and EAI acquisitions, we may make up to $9.5 million in aggregate earn-out payments between the years 2023 and 2026, of which up to $2.6 million may be paid only in cash, up to $5.5 million may be paid only in common stock and up to $1.5 million may be paid, at our option, in cash or common stock. See Note 7 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

COVID-19

To date, COVID-19 related adverse impacts such as temporarily delayed project start dates, particularly within our Remediation and Reuse segment, exiting certain service lines and employee quarantines have not had a material adverse effect on our reported results or our liquidity. On the other hand, we have seen benefits from COVID-19 given client demand for CTEH’s toxicology and response services, which represented a meaningful revenue stream, particularly in the year ended December 31, 2021 and, to a lesser extent, in 2022. COVID-19 revenues have continued to decline as the pandemic has subsided, which we may not be able to replace in future periods. Although many parts of our business saw some impact from COVID-19, in the aggregate, our overall business benefitted from COVID-19 during the three months ended March 31, 2023 and March 31, 2022, primarily as a result of COVID-19 response work performed by CTEH. COVID-19 has had an impact on our historical seasonality trends.
 

34

Organic Growth

We define organic growth as the change in revenues excluding revenues from CTEH, from acquisitions for the first twelve months following the date of acquisition and excluding revenues from businesses held for sale, disposed of or discontinued. As a result of the potential annual volatility in CTEH’s revenues due to the emergency response aspect of their business, we will no longer be including CTEH revenues in the calculation of organic growth. Management uses organic growth as one of the means by which it assesses our results of operations. Organic growth is not, however, a measure of revenue growth calculated in accordance with U.S. generally accepted accounting principles, or GAAP, and should be considered in conjunction with revenue growth calculated in accordance with GAAP. We have grown organically over the long term and expect to continue to do so.

Discontinued Operations

Periodically, or when circumstances warrant, we evaluate the performance of our business services to ensure that performance and outlook are consistent with expectations, and that the services offered are consistent with the Company’s mission.

As part of this evaluation, during the first quarter of 2023, we determined to sell one of our specialty service lines within our lab testing business, the Discontinuing Specialty Lab, whose service offering is non-core to the Company’s business. The Discontinuing Specialty Lab, which is part of our Measurement and Analysis segment, generated revenues of $1.4 million and $5.6 million in the three months ended March 31, 2023 and March 31, 2022, respectively. We expect the sale process to be completed around December 31, 2023. The discontinuation of this specialty service line did not represent a strategic shift that had (or will have) a major effect on the Company’s operations and financial results, therefore it did not meet the requirements to be classified as discontinued operations.

During the fourth quarter of 2022, we determined to exit our lab in Berkley, California and terminate the related positions. This discontinued start-up, which was included in our Measurement and Analysis segment, did not generate any material revenue during the three months ended March 31, 2022.

During the second quarter of 2022, we determined to exit all legacy water treatment and biogas operations and maintenance contracts, collectively, the Discontinued O&M Contracts, as well as the related positions. The work associated with these contracts is non-specialized and commoditized, and it was determined that the risk of facility failure taken on by the Company as the O&M contractor no longer justified the low margins in these contracts. Revenue from our water treatment and biogas operations and maintenance contracts, which were included in the results of our Remediation and Reuse segment, were $1.4 million in the three months ended March 31, 2022. This decision did not impact the Company’s specialized PFAS water treatment operations and maintenance contracts.

Revenue Mix

Our segments generate different levels of profitability and, accordingly, shifts in the mix of revenues between segments can impact our consolidated reported net income, net loss margin, Segment Adjusted EBITDA and Segment Adjusted EBITDA margin from quarter to quarter and year to year. Inter-company revenues between business lines within segments have been eliminated. See Note 18 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements.”

Financing Costs

On April 27, 2021, we entered into the 2021 Credit Facility and repaid all amounts outstanding under our prior credit facility. The 2021 Credit Facility consists of a $175.0 million term loan and a $125.0 million revolving credit facility. The revolving credit facility includes a $20.0 million sublimit for the issuance of letters of credit. The interest rate on the 2021 Credit Facility varies depending on leverage, with a minimum of LIBOR plus 1.5% and a maximum of LIBOR plus 2.5%. Effective January 27, 2022, we entered into an interest rate swap transaction fixing the floating component of the interest rate on $100.0 million of borrowings to 1.39% until January 27, 2025.

Interest expense, net was $1.5 million and $1.1 million in the three months ended March 31, 2023 and March 31, 2022, respectively. We expect interest expense to remain a significant cost as we continue to leverage our credit facility to support our operations and future acquisitions.

See Note 12 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements” and “Liquidity and Capital Resources.”

35

Corporate and Operational Infrastructure Investments

Our historical operating results reflect the impact of our ongoing investments in our corporate infrastructure to support our growth. We have made and expect to continue to make investments in our business platform that we believe have laid the foundation for continued growth. Investments in logistics, quality, risk management, sales and marketing, safety, human resources, research and development, finance and information technology and other areas enable us to support continued growth. These investments should allow us to improve our margins over time.

Seasonality

Due to the field-based nature of certain of our services, weather patterns generally impact our field-based teams’ ability to operate in the winter months. As a result, our operating results in our Measurement and Analysis segment experience some quarterly variability with generally lower revenues and lower earnings in the first and fourth quarters and higher overall revenues and earnings in the second and third quarters. As we continue to grow and expand into new geographies and service lines, quarterly variability in our Measurement and Analysis segment may deviate from historical trends.

Earnings Volatility

In addition to the impact of seasonality on earnings, the acquisition of CTEH exposes us to potentially significant revenue and earnings fluctuations tied both to the timing of large environmental emergency response projects following an incident or natural disaster, and the benefit from COVID-19 related work. The benefit from COVID-19 related work peaked in the quarter ended March 31, 2021 and has declined in each subsequent quarter. COVID-19 related revenue was $3.8 million and $21.4 million in the quarter ended March 31, 2023 and March 31, 2022, respectively. Demand for environmental emergency response or, to a lesser extent, COVID-19 related services provided by CTEH remains difficult to predict and as a result, we may have experienced revenues and earnings in prior years that are not indicative of future results, making those periods particularly difficult comparisons for future periods. We do however expect that, looking forward, the expectedly declining COVID-19 response revenues as compared to prior year periods will continue to be offset by other CTEH service line revenues, such as environmental emergency responses, as internal resources are freed up from the COVID-19 response work. Earnings volatility is also driven by the timing of large projects, particularly in our Remediation and Reuse segment, and the impact of acquisitions. As a result of these factors, and because demand for environmental services is not driven by specific or predictable patterns in one or more fiscal quarters, our business is better assessed based on yearly results.

Cybersecurity

As previously disclosed, on June 11, 2022 we were the target of an organized ransomware attack on our IT systems that led to the temporary disruption of our regular operations. The Company's financial systems are cloud based and were not affected. We engaged third party experts, including cyber legal counsel and a cybersecurity firm, to perform a fulsome forensic investigation of this attack and we promptly notified federal law enforcement. Based on the results of the investigation, we do not believe there has been any misuse of confidential or sensitive client data, have made notifications to clients, and have proactively addressed client concerns regarding our security environment. Furthermore, we have identified a limited number of individuals whose personally identifiable information may have been accessed from our systems and have made appropriate notifications to such individuals and required regulators. The Company has insurance coverage, subject to a $0.3 million deductible, against recovery costs and business interruption resulting from cyber-attacks. In January 2023, the Company received $1.0 million in business interruption insurance proceeds related to the cyber-attack. These proceeds partially offset the estimated $1.5 million cost of the cyber-attack recognized in the second and third quarter of 2022.

36

Results of Operations

For Three Months Ended March 31, 2023 Compared to the Three Months Ended March 31, 2022

	Three Months Ended March 31,
(in thousands, except per share data)	2023			2022
Statements of operations data:
Revenues	$	131,428		$	134,680
Cost of revenues (exclusive of depreciation and amortization)		81,633			88,386
Selling, general and administrative expense		49,613			41,807
Fair value changes in business acquisition contingencies		(398	)		(21	)
Depreciation and amortization		10,555			12,144
Loss from operations	$	(9,975	)	$	(7,636	)
Other (expense) income		(1,836	)		2,461
Interest expense, net		(1,541	)		(1,092	)
Loss before income taxes		(13,352	)		(6,267	)
Income tax expense		1,367			1,269
Net loss	$	(14,719	)	$	(7,536	)
Series A-2 dividend payment		(4,100	)		(4,100	)
Net loss attributable to common stockholders	$	(18,819	)	$	(11,636	)
Weighted average number of shares — basic and diluted		29,857			29,662
Loss per share — basic and diluted	$	(0.63	)	$	(0.39	)

Revenues

For the three months ended March 31, 2023, we generated revenues of $131.4 million, a decrease of $3.3 million, or 2.4% over the three months ended March 31, 2022. The period over period decrease in revenues was driven by expected and significantly lower revenue from COVID-19 related services from our CTEH business, lower revenues in the Discontinuing Specialty Lab, the exiting of the Discontinued O&M Contracts, and the timing of projects in our Remediation and Reuse segment. These decreases were partially offset by organic growth in our Assessment, Permitting and Response and Measurement and Analysis segments, an increase in CTEH environmental response revenues unrelated to COVID-19, and acquisitions completed subsequent to the quarter ended March 31, 2022, which contributed revenues of $2.9 million. Revenue from CTEH was $30.8 million in the three months ended March 31, 2023 compared to $29.9 million in the three months ended March 31, 2022. Total revenue from COVID-19 related services was $3.8 million and $21.4 million in the three months ended March 31, 2023 and March 31, 2022, respectively. Revenue from the Discontinuing Specialty Lab, was $1.4 million and $5.6 million in the three months ended March 31, 2023 and March 31, 2022, respectively. The Discontinued O&M Contracts generated revenues of zero and $1.4 million in the three months ended March 31, 2023 and March 31, 2022, respectively. Revenue by segment and as a percentage of total revenues was as follows:

	Three Months Ended March 31,
	2023					2022
(Revenues in thousands)	Revenues		% of Total Revenues			Revenues		% of Total Revenues
Assessment, Permitting and    Response	$	52,214		39.7	%	$	45,600		33.9	%
Measurement and Analysis(1)		42,527		32.4			39,761		29.5
Remediation and Reuse		36,687		27.9			49,319		36.6
Total	$	131,428				$	134,680

_________________________________

(1)Includes revenue of $1.4 million and $5.6 million from the Discontinuing Specialty Lab, for the three months ended March 31, 2023 and March 31, 2022, respectively. See “—Discontinued Operations” above.

See “—Segment Results of Operations” below.

Cost of Revenues

Cost of revenues consists of all direct costs required to provide services, including fixed and variable direct labor costs, equipment rental and other outside services, field and lab supplies, vehicle costs and travel-related expenses. Variable costs of revenues generally follow the same trends as revenue, while fixed costs tend to change primarily as a result of acquisitions.

For the three months ended March 31, 2023, cost of revenues was $81.6 million or 62.1% of revenues, and was comprised of direct labor of $42.6 million, outside services (including contracted labor, laboratory, shipping and freight and other outside services) of $16.0 million, field

37

supplies, testing supplies and equipment rental costs of $13.5 million, project-related travel expenses of $4.8 million and other direct costs of $4.7 million.

For the three months ended March 31, 2022, cost of revenues was $88.4 million or 65.6% of revenues, and was comprised of direct labor of $38.8 million, outside services (including contracted labor, laboratory, shipping and freight and other outside services)
of $19.1 million, field supplies, testing supplies and equipment rental costs of $21.8 million, project-related travel expenses of $4.0 million and other direct costs of $4.7 million.

For the three months ended March 31, 2023, cost of revenues as a percentage of revenue decreased 3.5% from the three months ended March 31, 2022, primarily as a result of a $8.3 million decrease in field and testing supplies and equipment rental costs due to a decline in the percentage of total revenue from certain large Remediation and Reuse projects and a decrease in direct labor attributable to a shift in roles and responsibilities as described under the Selling, General and Administrative Expense section below, partially offset by an increase in direct labor related to CTEH environmental response work unrelated to COVID-19 when compared to the prior year period.

Selling, General and Administrative Expense

Selling, general and administrative expense consists of general corporate overhead, including executive, legal, finance, safety, risk management, human resource, marketing and information technology related costs, as well as indirect operational costs of labor, rent, insurance and stock-based compensation.

For the three months ended March 31, 2023, selling, general and administrative expense was $49.6 million, an increase of $7.8 million or 18.7% versus the three months ended March 31, 2022. This increase was primarily driven by an increase of approximately $4.4 million related to the impact of the shift of employee roles and responsibilities of certain employees from providing direct field support (and therefore included in cost of sales in 2022), to providing more specialized, multi-location overhead support functions (such as accounting, HR and management) and therefore included in selling general and administrative expenses in the current year. This change was driven by acquisitions and growth in our business. The increase was also driven by higher labor and medical benefit costs, primarily reflecting inflationary increases, an increase of $2.0 million in stock compensation expense, $1.0 million related to an increase in bad debt expense (which was a charge of $0.4 million in the current year, versus a credit of $0.6 million in the prior year), $0.5 million from selling, general and administrative expense pertaining to companies we acquired subsequent to the first quarter of 2022, $0.3 million related to an increase in the defined contribution plan, an increase in acquisition-related costs of $0.3 million, and the timing of certain external expenditures, which occurred later in the year in 2022. See Part I, Item 3. “Quantitative and Qualitative Disclosures About Market Risk” for additional information regarding the impact of inflation on our business.

For the three months ended March 31, 2023, selling, general and administrative expense of $49.6 million was comprised of indirect labor of $24.7 million, stock-based compensation of $12.1 million, facilities costs of $4.9 million, and other costs (including software, travel, insurance, legal, consulting, audit services, bad debt and acquisition-related costs) of $7.9 million.

For the three months ended March 31, 2022, selling, general and administrative expense of $41.8 million was comprised of indirect labor of $19.5 million, stock-based compensation of $10.1 million, facilities costs of $4.4 million, and other costs (including software, travel, insurance, legal, consulting and audit services) of $7.8 million.

Fair Value Changes in Business Acquisition Contingencies

For the three months ended March 31, 2023, fair value changes in business acquisition contingencies resulted in a gain of $0.4 million. For the three months ended March 31, 2022, fair value changes in business acquisitions contingent consideration were not material.

See “—Key Factors that Affect Our Business and Our Results—Acquisitions” and Notes 7 and 13 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Depreciation and Amortization

Depreciation and amortization expense for the three months ended March 31, 2023, was $10.6 million and was comprised of amortization of finite lived intangibles of $7.2 million, arising as a result of our acquisition activity, depreciation of property and equipment of $2.2 million and finance leases right-of-use asset amortization of $1.2 million.

Depreciation and amortization expense for the three months ended March 31, 2022, was $12.1 million and was comprised of amortization of finite lived intangibles of $9.4 million, arising as a result of our acquisition activity, depreciation of property and equipment of $1.8 million and finance leases right-of-use asset amortization of $0.9 million.

The decrease in amortization was primarily a result of lower intangible assets outstanding during the three months ended March 31, 2023 when compared to the three months ended March 31, 2022. The increases in depreciation of property and equipment and the amortization of

38

finance leases were primarily a result of higher property and equipment and right of use assets outstanding during the three months ended March 31, 2023 when compared to the three months ended March 31, 2022. See Notes 5 and 6 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”

Other (Expense) Income

Other expense for the three months ended March 31, 2023 of $1.8 million was driven by a fair value adjustment on our interest rate swap of $1.0 million and by a fair value adjustment to the Series A-2 preferred stock conversion option of $0.9 million.

Other income of $2.5 million for the three months ended March 31, 2022 was driven by a gain related to the fair value adjustment on our interest rate swap of $3.0 million, which was partially offset by an expense of $0.6 million related to the fair value adjustment of the Series A-2 preferred stock conversion option.

See Notes 13 and 15 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”

Interest Expense, Net

Interest expense, net incurred in the three months ended March 31, 2023, was $1.5 million, compared to $1.1 million for the three months ended March 31, 2022. The increase in interest expense was primarily due to the higher interest rate on the 2021 Credit Facility, partially offset by lower debt balances. Weighted average interest rates as of March 31, 2023 and March 31, 2022 were 6.1% and 1.8%, respectively. See “—Key Factors that Affect Our Business and Our Results—Financing Costs” and Notes 12 and 13 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Income Tax Expense

Income tax expense was $1.4 million and $1.3 million during the three months ended March 31, 2023 and March 31, 2022.

Segment Results of Operations

For Three Months Ended March 31, 2023 Compared to the Three Months Ended March 31, 2022

	Three Months Ended March 31,
	2023									2022
(in thousands, except percentages)	Segment Revenues			Segment Adjusted EBITDA (1)			Segment Adjusted EBITDA Margin(2)			Segment Revenues			Segment Adjusted EBITDA(1)(5)				Segment Adjusted EBITDA Margin(2)
Assessment, Permitting and Response	$	52,214		$	14,266			27.3	%	$	45,600		$	9,623				21.1	%
Measurement and Analysis		42,527	(3)		6,387			15.0			39,761	(3)		6,322		(4)		15.9
Remediation and Reuse		36,687			5,278			14.4			49,319			7,993				16.2
Total Operating Segments	$	131,428		$	25,931			19.7	%	$	134,680		$	23,938				17.8	%
Corporate and Other		—			(9,328	)	n/a				—			(7,487	)		n/a

(1)For purposes of evaluating segment profit, the Company’s chief operating decision maker reviews Segment Adjusted EBITDA as a basis for making the decisions to allocate resources and assess performance. See Note 18 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

(2)Represents Segment Adjusted EBITDA as a percentage of segment revenues.

(3)Includes revenue of $1.4 million and $5.6 million from the Discontinuing Specialty Lab, for the three months ended March 31, 2023 and March 31, 2022, respectively. See “—Discontinued Operations” above.

(4)Includes Adjusted EBITDA of $1.3 million from the Discontinuing Specialty Lab. See “—Discontinued Operations” above.

(5)Includes the add back of start-up losses and investment in new services of $0.8 million. See Note 18 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

39

Revenues

Assessment, Permitting and Response segment revenues for the three months ended March 31, 2023 were $52.2 million, an increase of $6.6 million or 14.5% compared to $45.6 million for the three months ended March 31, 2022. The increase was driven by organic growth, growth in environmental response revenues from CTEH unrelated to COVID-19 of $18.5 million, and revenues of $1.2 million from acquisitions completed subsequent to the quarter ended March 31, 2022, partially offset by expected significantly lower COVID-19 related services. CTEH revenues were $30.8 million in the three months ended March 31, 2023 compared to $29.9 million in the three months ended March 31, 2022. Total revenue from COVID-19 related services was $3.8 million and $21.4 million in the three months ended March 31, 2023 and March 31, 2022, respectively.

Measurement and Analysis segment revenues for the three months ended March 31, 2023 were $42.5 million, an increase of $2.7 million or 7.0% compared to revenues for the three months ended March 31, 2022 of $39.8 million. The increase was driven primarily by organic growth as a result of strong demand for our testing services, partially offset by a $4.1 million decline in revenues from the Discontinuing Specialty Lab.

Remediation and Reuse segment revenues for the three months ended March 31, 2023 were $36.7 million, a decrease of $12.6 million or 25.6% compared to revenues for the three months ended March 31, 2022 of $49.3 million. The expected decrease was a result of the timing of the completion of certain high dollar value projects throughout 2022 when compared to the 2023 period, as well as the exiting of Discontinued O&M Contracts in the second quarter of 2022, which generated revenues of $1.4 million in the three months ended March 31, 2022. The decrease was partially offset by $1.7 million in revenues from acquisitions completed subsequent to the quarter ended March 31, 2022.

Segment Adjusted EBITDA

Assessment, Permitting and Response Segment Adjusted EBITDA was $14.3 million for the three months ended March 31, 2023, compared to $9.6 million for the three months ended March 31, 2022. For the three months ended March 31, 2023 and March 31, 2022, Segment Adjusted EBITDA margin was 27.3% and 21.1%, respectively. The increase in Segment Adjusted EBITDA and Segment Adjusted EBITDA margin was primarily due to favorable revenue mix (e.g., CTEH environmental response revenues generate higher margins than COVID-19 related revenues, and select advisory services with higher margins and higher growth rates) during the three months ended March 31, 2023 when compared to the three months ended March 31, 2022.

Measurement and Analysis Segment Adjusted EBITDA, was $6.4 million for the three months ended March 31, 2023, an increase of $0.1 million compared to Segment Adjusted EBITDA of $6.3 million for the three months ended March 31, 2022. Excluding Adjusted EBITDA from the Discontinuing Specialty Lab, Segment Adjusted EBITDA was $6.4 million and $5.1 million for the three months ended March 31, 2023 and March 31, 2022, an increase of $1.3 million. For the three months ended March 31, 2023 and March 31, 2022 Segment Adjusted EBITDA margin was 15.0% and 15.9%, respectively. The increase in Segment Adjusted EBITDA was due to higher revenues and the margin benefit of higher pricing, whereas the decrease in Segment Adjusted EBITDA margin was due to a decrease in revenues and Adjusted EBITDA in the Discontinuing Specialty Lab. Excluding the Discontinuing Specialty Lab, Segment Adjusted EBITDA margin for the three months ended March 31, 2023 and March 31, 2022 was 15.6% and 14.9%, respectively, reflecting strong demand for our testing services and the benefit of pricing.

Remediation and Reuse Segment Adjusted EBITDA for the three months ended March 31, 2023 was $5.3 million, a decrease of $2.7 million compared to Segment Adjusted EBITDA for the three months ended March 31, 2022 of $8.0 million. For the three months ended March 31, 2023 and March 31, 2022 Segment Adjusted EBITDA margin was 14.4% and 16.2%, respectively. The decrease in Segment Adjusted EBITDA and Segment Adjusted EBITDA margin was a result of expected lower revenues.

Corporate and other costs were $9.3 million for the three months ended March 31, 2023 compared to $7.5 million for the three months ended March 31, 2022. The cost increase was driven by higher investments in IT infrastructure and information security in the three months ended March 31, 2023, a $0.5 million credit for bad debt in the prior year period, and the timing of certain third-party expenses.

40

Liquidity and Capital Resources

Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, other commitments and contractual obligations. We consider liquidity in terms of cash flows from operations and other sources, including availability under our credit facility, and their sufficiency to fund our operating and investing activities.

Our principal sources of liquidity have been borrowings under our credit facilities, other borrowing arrangements, proceeds from the issuance of common and preferred stock and cash generated by operating activities. Historically, we have financed our operations and acquisitions from a combination of cash generated from operations, periodic borrowings under senior secured credit facilities, and proceeds from the issuance of common and preferred stock. Our primary cash needs are for day to day operations, to fund working capital requirements, to fund our acquisition strategy and any related cash earn-out obligations, to pay interest and principal on our indebtedness and dividends on our Series A-2 preferred stock, and to make capital expenditures. Additionally, in connection with certain acquisitions, we agree to earn-out provisions and other purchase price adjustments that may require future payments. For example, the CTEH acquisition agreement included an earn-out provision that provided for the payment of contingent consideration based on CTEH’s results in excess of a specified target. CTEH fully achieved the target in 2021 and the $30.0 million payment was paid in cash in the first quarter of 2022. We may also make up to $9.5 million in aggregate earn-out payments between the years 2023 and 2026 in connection with the acquisitions of Vista, Sensible, Environmental Standards, Huco, and EAI, of which up to $2.6 million may be paid only in cash, up to $5.5 million may be paid only in common stock and up to $1.5 million may be paid in cash or, at our option, in common stock. See Note 7 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”

We expect to continue to fund our liquidity requirements, including any cash earn-out payments that may be required in connection with acquisitions, through cash generated from operations and borrowings under our credit facility. We believe these sources will be sufficient to fund our cash needs for the short- and long-term.

Cash Flows

The following table summarizes our cash flows for the periods presented:

	Three Months Ended March 31,
(in thousands)	2023			2022
Consolidated Statement of Cash Flows Data:
Net cash provided by (used in) operating activities	$	3,029		$	(18,328	)
Net cash used in investing activities		(11,727	)		(15,005	)
Net cash used in financing activities		(4,654	)		(19,715	)
Change in cash and cash equivalents	$	(13,352	)	$	(53,048	)

Operating Activities

Cash flows from operating activities can fluctuate from period-to-period as earnings, working capital needs and the timing of payments for contingent consideration, taxes, bonus payments and other operating items impact reported cash flows.

For the three months ended March 31, 2023, net cash provided by operating activities was $3.0 million compared to net cash used in operating activities of $18.3 million for the three months ended March 31, 2022. Cash used in operating activities for the three months ended March 31, 2022 includes payment of contingent consideration of $19.5 million. Excluding payment of contingent consideration, cash provided by operating activities was $1.2 million in the prior year period. The period-over-period increase of $1.8 million, excluding the impact of contingent consideration, was primarily due to an increase in working capital in the current period of $9.7 million versus an increase in working capital in the prior year period of $12.5 million, partially offset by lower earnings before non-cash items of $0.9 million.

41

Working capital increased by $9.7 million in the three months ended March 31, 2023, primarily due to a decrease in accounts payable and other accrued liabilities of $11.6 million, (primarily as a result of lower contract liabilities due to the timing of project completion), a decrease in accrued payroll and benefits of $4.4 million, and an increase in prepaid expenses and other current assets of $3.4 million, partially offset by a decrease in accounts receivable and contract assets of $9.6 million.

Investing Activities

For the three months ended March 31, 2023, net cash used in investing activities was $11.7 million, primarily driven by cash paid for the acquisitions of Frontier and EAI, net of cash acquired, of $6.5 million, as well as purchases of property and equipment for cash consideration and proprietary software development of $4.8 million and payment of assumed purchase price obligations of $0.5 million.

For the three months ended March 31, 2022, net cash used in investing activities was $15.0 million, primarily driven by cash paid for the acquisitions of Environmental Standards and IAG, net of cash acquired, of $14.3 million, as well as payment of assumed purchase price obligations of $0.6 million.

Financing Activities

For the three months ended March 31, 2023, net cash used in financing activities was $4.7 million. Cash used in financing activities was driven by the quarterly dividends on the Series A-2 preferred stock of $4.1 million, the term loan amortization payments of $2.2 million related to our 2021 Credit Facility, and the repayment of finance leases of $1.0 million, partially offset by proceeds received from the exercise of stock options of $2.7 million.

For the three months ended March 31, 2022, net cash used in financing activities was $19.7 million. Cash used in financing activities was driven by the payment of acquisition-related contingent consideration of $10.5 million, term loan amortization payments of $4.4 million related to our 2021 Credit Facility, the payment of the quarterly dividend on the Series A-2 preferred stock of $4.1
million, and the repayment of finance leases of $0.9 million, partially offset by proceeds received from the exercise of stock options of $0.4 million.

Credit Facilities

2021 Credit Facility

On April 27, 2021, we entered into a Senior Secured Credit Agreement, or the 2021 Credit Facility, providing for a $300.0 million credit facility comprised of a $175.0 million term loan and a $125.0 million revolving credit facility, and used a portion of the proceeds to repay all amounts outstanding under the prior credit facility. The 2021 revolving credit facility includes a $20.0 million sublimit for the issuance of letters of credit. Subject to certain exceptions, all amounts under the 2021 Credit Facility will become due on April 27, 2026. We have the option to borrow incremental term loans or request an increase in the aggregate commitments under the revolving credit facility up to an aggregate amount of $150.0 million subject to the satisfaction of certain conditions.

The 2021 Credit Facility term loan must be repaid in quarterly installments. The 2021 Credit Facility term loan and the revolver bear interest subject to the Company’s leverage ratio and LIBOR. The Company is currently in discussions regarding the transition of LIBOR to an adjusted benchmark rate to be effective on or before June 30, 2023. The transition to an adjusted interest rate is not expected to materially impact the interest rate paid by the Company.

On January 27, 2022, the Company entered into an interest rate swap transaction fixing the floating component of the interest rate on $100.0 million of borrowings to 1.39% until January 27, 2025. Additionally, effective September 1, 2022, the Company received an interest rate reduction of 0.05% under the 2021 Credit Facility based on the Company’s achievement of certain sustainability and environmental, social and governance related objectives as provided for in the 2021 Credit Facility.

Our obligations under the 2021 Credit Facility are guaranteed by certain of our existing and future direct and indirect subsidiaries, and such obligations are secured by substantially all of our assets. The 2021 Credit Facility includes a number of covenants imposing certain restrictions on our business. The 2021 Credit Facility also includes financial covenants requiring us to remain below a maximum total net leverage ratio and a minimum fixed charge coverage ratio. As of March 31, 2023 and March 31, 2022, our consolidated total leverage ratio was 1.4 times and 1.8 times, respectively, and we were in compliance with all covenants under the 2021 Credit Facility.

The weighted average interest rate on the 2021 Credit Facility for the three months ended March 31, 2023 and March 31, 2022 was 6.1% and 1.8%, respectively.

42

The 2021 Credit Facility contains a mandatory prepayment feature upon a number of events, including with the proceeds of certain asset sales and proceeds from the issuance of any debt.

See Note 12 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Series A-2 Preferred Stock

On April 13, 2020, we issued 17,500 shares of the Series A-2 preferred stock with a par value of $0.0001 per share and a warrant to purchase common stock, in exchange for $175.0 million. The Series A-2 preferred stock does not mature or have a cash repayment obligation; however, it is redeemable at our option. The Series A-2 preferred stock becomes convertible into our common stock beginning on the four-year anniversary of the Series A-2 preferred stock issuance. Upon the four-year anniversary of the issuance, holders of Series A-2 preferred stock may convert up to $60.0 million of such shares into our common stock at a conversion rate discounted to 85.0% of the volume weighted average trading value, with the permitted amount of Series A-2 preferred stock to be converted increasing at each subsequent anniversary of the issuance until the sixth anniversary, after which all of the Series A-2 preferred stock may be converted at the holder’s option. The Series A-2 preferred stock is subject to a 9.0% interest rate per annum with required quarterly cash payments. If permitted under our existing debt facilities, we must pay the Series A-2 preferred stock dividend in cash each quarter.

With respect to any redemption of any share of the Series A-2 preferred stock prior to April 13, 2023, we are subject to a make whole penalty in which the holder is guaranteed at least three years of dividend payments on the redeemed amount.

See Note 15 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Critical Accounting Policies and Estimates

Our 2022 Form10-K includes a summary of the critical accounting policies and estimates we believe are the most important to aid in understanding our financial results. There have been no material changes to those critical accounting policies and estimates as disclosed therein, other than as described in Note 2 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

43

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Interest Rate Risk

We have market risk exposure arising from changes in interest rates on our credit facility, which bears interest at rates that are benchmarked subject to the Company’s leverage ratio and LIBOR. Based on our overall interest rate exposure to variable rate debt outstanding as of March 31, 2023, which factors in our interest rate swap on $100.0 million of debt, a 1.0% increase or decrease in interest rates on the term loan and revolver would increase annual income (loss) before income taxes by approximately $0.6 million.

Inflation Risk

We experienced higher labor and significantly higher travel and other direct costs in the fiscal year ended December 31, 2022 as a result of inflation, particularly in our Measurement and Analysis and Remediation and Reuse segments. We believe we have successfully raised prices in businesses with short term contracts to offset these inflationary effects. We also have and are continuing to raise prices on medium term (one to four quarter) contracts as these contracts are renewed or new contracts are won, but the timing of these price increases has lagged behind our cost increases due to the longer term nature of these contracts. We expect to continue to raise prices if direct costs continue to increase. Although inflation has increased our Selling, general and administrative expense, impacting margins and Segment Adjusted EBITDA, in the three months ended March 31, 2023, we do not believe over a longer period of time that inflation will have a material effect on our business, financial condition or results of operations. If our costs were to become subject to additional and unanticipated significant sustained inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could adversely affect our business, financial condition and results of operations.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act), as of March 31, 2023, the end of the period covered by this Quarterly Report on Form 10-Q. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2023, the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective at the reasonable assurance level.

Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our system of internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed or operated, can provide only reasonable, but not absolute, assurance that the objectives of the system of internal control are met. The design of our control system reflects the fact that there are resource constraints, and that the benefits of such control system must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control failures and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the intentional acts of individuals, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part on certain assumptions about the likelihood of future events, and there can be no assurance that the design of any particular control will always succeed in achieving its objective under all potential future conditions.

44

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we are subject to various legal proceedings that arise in the normal course of our business activities, including those involving labor and employment, anti-discrimination, commercial disputes and other matters. We are not a party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our results of operations or financial position. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors.

There have been no material changes to our risk factors from the risk factors disclosed in our 2022 Form 10-K. The risks described in our 2022 Form 10-K, in addition to the other information set forth in this Quarterly Report on Form 10-Q, are not the only risks facing we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

45

Item 6. Exhibits.

Exhibit Number	Description
31.1*	Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document
101.SCH*	Inline XBRL Taxonomy Extension Schema Document
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*	Cover Page Interactive Data File – The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 is formatted in Inline XBRL (included as Exhibit 101)

* Filed herewith.

** Exhibit is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

46

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Montrose Environmental Group, Inc.
Date: May 10, 2023	By:	/s/ Allan Dicks
		Allan Dicks
		Chief Financial Officer

47

EX-31

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Vijay Manthripragada, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Montrose Environmental Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2023	By:	/s/ Vijay Manthripragada
		Vijay Manthripragada
		Chief Executive Officer (Principal Executive Officer)

EX-31

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Allan Dicks, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Montrose Environmental Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2023	By:	/s/ Allan Dicks
		Allan Dicks
		Chief Financial Officer (Principal Financial Officer)

EX-32

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Montrose Environmental Group, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Vijay Manthripragada, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2023	By:	/s/ Vijay Manthripragada
		Vijay Manthripragada
		Chief Executive Officer (Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to Montrose Environmental Group, Inc. and will be retained by Montrose Environmental Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Montrose Environmental Group, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Allan Dicks, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2023	By:	/s/ Allan Dicks
		Allan Dicks
		Chief Financial Officer (Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to Montrose Environmental Group, Inc. and will be retained by Montrose Environmental Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 04, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2023
Document Quarterly Report	true
Document Transition Report	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Trading Symbol	MEG
Entity Registrant Name	Montrose Environmental Group, Inc.
Entity Central Index Key	0001643615
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		30,078,195
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-39394
Entity Tax Identification Number	46-4195044
Entity Incorporation State Country Code	DE
Entity Address Address Line1	5120 Northshore Drive
Entity Address City Or Town	North Little Rock
Entity Address State Or Province	AR
Entity Address Postal Zip Code	72118
City Area Code	501
Local Phone Number	900-6400
Security12b Title	Common Stock, par value $0.000004 per share
Security Exchange Name	NYSE

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 76,794	$ 89,828
Accounts receivable—net	85,472	94,711
Contract assets	53,563	52,403
Prepaid and other current assets	15,178	10,986
Total current assets	231,007	247,928
NON-CURRENT ASSETS:
Property and equipment—net	40,685	36,045
Operating lease right-of-use asset—net	31,214	26,038
Finance lease right-of-use asset—net	11,391	9,840
Goodwill	326,498	323,868
Other intangible assets—net	137,271	142,107
Other assets	5,111	6,088
TOTAL ASSETS	783,177	791,914
CURRENT LIABILITIES:
Accounts payable and other accrued liabilities	55,420	63,412
Accrued payroll and benefits	16,352	20,528
Business acquisitions contingent consideration, current	4,734	3,801
Current portion of operating lease liabilities	8,570	7,895
Current portion of finance lease liabilities	4,130	3,775
Current portion of long-term debt	13,125	12,031
Total current liabilities	102,331	111,442
NON-CURRENT LIABILITIES:
Business acquisitions contingent consideration, long-term	3,121	4,454
Other non-current liabilities	3	13
Deferred tax liabilities—net	7,111	5,742
Operating lease liability—net of current portion	24,093	19,437
Finance lease liability—net of current portion	7,507	6,486
Long-term debt—net of deferred financing fees	149,342	152,494
Total liabilities	320,144	325,799
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY:
Additional paid-in-capital	504,301	492,676
Accumulated deficit	(194,216)	(179,497)
Accumulated other comprehensive income	20	8
Total stockholders’ equity	310,105	313,187
TOTAL LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS’ EQUITY	783,177	791,914
Conversion Option
NON-CURRENT LIABILITIES:
Conversion option	26,636	25,731
Convertible And Redeemable Series A-2 Preferred Stock
NON-CURRENT LIABILITIES:
REDEEMABLE SERIES PREFERRED STOCK	$ 152,928	$ 152,928

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Common stock, par value	$ 0.000004	$ 0.000004
Common stock, shares authorized	190,000,000	190,000,000
Common stock, shares issued	29,961,364	29,619,921
Common stock, shares outstanding	29,961,364	29,619,921
Convertible And Redeemable Series A-2 Preferred Stock
Temporary equity, par value	$ 0.0001	$ 0.0001
Temporary equity, shares authorized	17,500	17,500
Temporary equity, shares issued	17,500	17,500
Temporary equity, shares outstanding	17,500	17,500
Temporary equity, aggregate liquidation preference	$ 182.2	$ 182.2

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
REVENUES	$ 131,428	$ 134,680
COST OF REVENUES (exclusive of depreciation and amortization shown below)	81,633	88,386
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE	49,613	41,807
FAIR VALUE CHANGES IN BUSINESS ACQUISITIONS CONTINGENCIES	(398)	(21)
DEPRECIATION AND AMORTIZATION	10,555	12,144
LOSS FROM OPERATIONS	(9,975)	(7,636)
OTHER (EXPENSE) INCOME
Other (expense) income	(1,836)	2,461
Interest expense—net	(1,541)	(1,092)
Total other (expense) income - net	(3,377)	1,369
LOSS BEFORE EXPENSE FROM INCOME TAXES	(13,352)	(6,267)
INCOME TAX EXPENSE	1,367	1,269
NET LOSS	(14,719)	(7,536)
EQUITY ADJUSTMENT FROM FOREIGN CURRENCY TRANSLATION	12	81
COMPREHENSIVE LOSS	(14,707)	(7,455)
CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK DIVIDEND	(4,100)	(4,100)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$ (18,819)	$ (11,636)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC	29,857	29,662
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - DILUTED	29,857	29,662
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS - BASIC	$ (0.63)	$ (0.39)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS - DILUTED	$ (0.63)	$ (0.39)

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Convertible And Redeemable Series A-2 Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance at Dec. 31, 2021	$ 316,501			$ 464,143	$ (147,678)	$ 36
Beginning balance, shares at Dec. 31, 2021			29,619,921
Beginning balance at Dec. 31, 2021		$ 152,928
Beginning balance, shares at Dec. 31, 2021		17,500
Net loss	(7,536)				(7,536)
Stock-based compensation	10,425			10,425
Dividend payment to the Series A-2 preferred shareholders	(4,100)	$ (4,100)		(4,100)
Common stock issued	$ 429			429
Common stock issued, shares	55,896		55,896
Accumulated other comprehensive income	$ 45					45
Ending balance at Mar. 31, 2022	315,764			470,897	(155,214)	81
Ending balance, shares at Mar. 31, 2022		17,500
Ending balance at Mar. 31, 2022		$ 152,928
Ending balance, shares at Mar. 31, 2022			29,675,817
Beginning balance at Dec. 31, 2022	313,187			492,676	(179,497)	8
Beginning balance, shares at Dec. 31, 2022			29,746,793
Beginning balance at Dec. 31, 2022		$ 152,928
Beginning balance, shares at Dec. 31, 2022		17,500
Net loss	(14,719)				(14,719)
Stock-based compensation	13,035			13,035
Dividend payment to the Series A-2 preferred shareholders	(4,100)	$ (4,100)		(4,100)
Common stock issued	$ 2,690			2,690
Common stock issued, shares	214,571		214,571
Accumulated other comprehensive income	$ 12					12
Ending balance at Mar. 31, 2023	$ 310,105			$ 504,301	$ (194,216)	$ 20
Ending balance, shares at Mar. 31, 2023		17,500
Ending balance at Mar. 31, 2023		$ 152,928
Ending balance, shares at Mar. 31, 2023			29,961,364

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
OPERATING ACTIVITIES:
Net loss	$ (14,719)	$ (7,536)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Provision (recovery) for bad debt	444	(528)	$ (1,097)
Depreciation and amortization	10,555	12,144
Amortization of right-of-use asset	2,491	2,271
Stock-based compensation expense	13,035	10,425
Fair value changes in financial instruments	1,873	(2,449)
Fair value changes in business acquisition contingencies	(398)	(21)
Deferred income taxes	1,367	1,269
Other	458	143
Changes in operating assets and liabilities—net of acquisitions:
Accounts receivable and contract assets	9,615	10,037
Prepaid expenses and other current assets	(3,363)	(1,776)
Accounts payable and other accrued liabilities	(11,643)	(12,852)
Accrued payroll and benefits	(4,350)	(7,876)
Payment of contingent consideration		(19,457)
Change in operating leases	(2,336)	(2,122)
Net cash provided by (used in) operating activities	3,029	(18,328)
INVESTING ACTIVITIES:
Purchases of property and equipment	(4,134)	(262)
Proprietary software development and other software costs	(638)	(50)
Proceeds from insurance	75	266
Payment of purchase price true ups	(505)	(631)
Cash paid for acquisitions—net of cash acquired	(6,525)	(14,328)
Net cash used in investing activities	(11,727)	(15,005)
FINANCING ACTIVITIES:
Repayment of term loan	(2,188)	(4,375)
Payment of contingent consideration	(27)	(10,543)
Repayment of finance leases	(1,029)	(943)
Proceeds from issuance of common stock for exercised stock options	2,690	429
Dividend payment to the Series A-2 shareholders	(4,100)	(4,100)
Payments of deferred offering costs		(183)
Net cash used in financing activities	(4,654)	(19,715)
CHANGE IN CASH AND CASH EQUIVALENTS	(13,352)	(53,048)
Foreign exchange impact on cash balance	318	98
CASH AND CASH EQUIVALENTS:
Beginning of year	89,828	146,741	146,741
End of period	76,794	93,791	$ 89,828
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:
Cash paid for interest	1,347	184
Cash paid for income tax	155
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued purchases of property and equipment	3,096	1,144
Property and equipment purchased under finance leases	2,405	512
Acquisitions unpaid contingent consideration	$ 7,855	$ 6,995

XML

Description of the Business and Basis of Presentation

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of the Business and Basis of Presentation

1. DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

Description of the Business—Montrose Environmental Group, Inc. (“Montrose” or the “Company”) is a corporation formed on November 2013, under the laws of the State of Delaware. The Company has approximately 80 offices across the United States, Canada and Australia and approximately 3,000 employees as of March 31, 2023.

Montrose is an environmental services company serving the recurring environmental needs of a diverse client base, including Fortune 500 companies and federal, state and local governments through the following three segments:

Assessment, Permitting and Response—Through its Assessment, Permitting and Response segment, Montrose provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects and development projects. The Company’s technical advisory and consulting offerings include regulatory compliance support and planning, environmental, ecosystem and toxicological assessments and support during responses to environmental disruption. Montrose helps clients navigate regulations at the local, state, provincial and federal levels.

Measurement and Analysis—Through its Measurement and Analysis segment, Montrose’s teams test and analyze air, water and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna and human health. Montrose’s offerings include source and ambient air testing and monitoring, leak detection and repair and advanced analytical laboratory services such as air, storm water, wastewater and drinking water analysis.

Remediation and Reuse—Through its Remediation and Reuse segment, Montrose provides clients with engineering, design, and implementation services, primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. The Company does not own the properties or facilities at which it implements these projects or the underlying liabilities, nor does it own material amounts of the equipment used in projects; instead, the Company assists clients in designing solutions, managing projects and mitigating their environmental risks and liabilities at their locations.

Basis of Presentation—The unaudited condensed consolidated financial statements include the operations of the Company and its wholly-owned subsidiaries. These unaudited condensed consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The unaudited condensed consolidated financial statements include all accounts of the Company and, in the opinion of management, include all recurring adjustments and normal accruals necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the dates and periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended December 31, 2022. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. All intercompany transactions, accounts and profits, have been eliminated in the unaudited condensed consolidated financial statements.

XML

Summary of New Accounting Pronouncements

3 Months Ended

Mar. 31, 2023

Accounting Standards Update and Change in Accounting Principle [Abstract]

Summary of New Accounting Pronouncements

2. SUMMARY OF NEW ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements—In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance was adopted as of January 1, 2022 and did not have a material impact on the Company’s unaudited condensed consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what contract assets and/or contract liabilities it would have recorded under ASC 606 (the revenue guidance) as of the acquisition date, as if the acquirer had entered into the original contract at the same date and on the same terms as the acquiree. The new guidance was adopted as of January 1, 2023 and did not have a material impact on the Company’s unaudited condensed consolidated financial statements; however it may impact the accounting for future acquisitions. The future impact of this new guidance will be primarily a function of the facts and circumstances specific to any acquisitions consummated after adoption and therefore cannot be predicted.

XML

Revenues and Accounts Receivable

3 Months Ended

Mar. 31, 2023

Revenues And Accounts Receivable [Abstract]

Revenues and Accounts Receivable

3. REVENUES AND ACCOUNTS RECEIVABLE

The Company’s main revenue sources derive from the following revenue streams:

Assessment, Permitting and Response Revenues—Assessment, Permitting and Response revenues are generated from multidisciplinary environmental consulting services. The majority of the contracts are fixed-price or time and material based.

Measurement and Analysis Revenues—Measurement and Analysis revenues are generated from emissions sampling, testing and reporting services, leak detection services, ambient air monitoring services and laboratory testing services. The majority of the contracts are fixed-price or time-and-materials based.

Remediation and Reuse Revenues—Remediation and Reuse revenues are generated from engineering, design, implementation and operating and maintenance (“O&M”) services primarily to treat contaminated water, remove contaminants from soil or create biogas from waste. Engineering, design and implementation contracts are predominantly fixed-fee and time-and-materials based. Services on the majority of O&M contracts are provided under long-term fixed-fee contracts.

Disaggregation of Revenue—The Company disaggregates revenue by its operating segments. The Company believes disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, and uncertainty of revenue and cash flows are affected by economic factors. Disaggregated revenue disclosures are provided in Note 18.

Contract Balances—The Company presents contract balances for unbilled receivables (contract assets), as well as customer advances, deposits and deferred revenue (contract liabilities) within contract assets and accounts payable and other accrued expenses, respectively, on the unaudited condensed consolidated statements of financial position. Amounts are generally billed at periodic intervals (e.g. weekly, bi-weekly or monthly) as work progresses in accordance with agreed-upon contractual terms. The Company utilizes the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component as the period between when the Company transfers services to a customer and when the customer pays for those services is one year or less. Amounts recorded as unbilled receivables are generally for services the Company is not entitled to bill based on the passage of time. Under certain contracts, billing occurs subsequent to revenue recognition, resulting in contract assets. The Company sometimes receives advances or deposits from customers before revenue is recognized, resulting in contract liabilities.

The following table presents the Company’s contract balances:

	March 31,		December 31,
	2023		2022
Contract assets	$	53,563	$	52,403
Contract liabilities		10,932		18,549

Contract assets acquired through business acquisitions amounted to $0.2 million and $1.7 million as of March 31, 2023 and December 31, 2022, respectively. No contract liabilities were acquired through business acquisitions as of March 31, 2023 and December 31, 2022.

Revenue recognized during the three months ended March 31, 2023, included in the contract liabilities balance at the beginning of the year was $12.8 million. The revenue recognized from the contract liabilities consisted of the Company satisfying performance obligations during the normal course of business.

The amount of revenue recognized from changes in the transaction price associated with performance obligations satisfied in prior periods during the three months ended March 31, 2023 was not material.

Remaining Unsatisfied Performance Obligations—Remaining unsatisfied performance obligations represent the total dollar value of work to be performed on contracts awarded and in progress. The amount of remaining unsatisfied performance obligations increases with new contracts or additions to existing contracts and decreases as revenue is recognized on existing contracts. Contracts are included in the amount of remaining unsatisfied performance obligations when an enforceable agreement has been reached. As of March 31, 2023 and December 31, 2022, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $98.2 million and $100.4 million, respectively. As of March 31, 2023, the Company expected to recognize approximately $79.1 million of this amount as revenue within a year and $19.1 million the year after.

Accounts Receivable, Net—The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business. Accounts receivable, net consisted of the following:

	March 31, 2023			December 31, 2022
Accounts receivable, invoiced	$	87,261		$	95,055
Accounts receivable, other		503			1,571
Allowance for doubtful accounts		(2,292	)		(1,915	)
Accounts receivable—net	$	85,472		$	94,711

The Company did not have any customers that exceeded 10.0% of its gross receivables as of March 31, 2023 and December 31, 2022. During the three months ended March 31, 2023 the Company did not have any customers that exceeded 10.0% of its revenue. During the three months ended March 31, 2022, the Company had one customer who accounted for 17.3% of revenue. The Company performs ongoing credit evaluations and based on past collection experience, the Company believes that the receivable balances from these largest customers do not represent a significant credit risk.

The allowance for doubtful accounts consisted of the following:

	Beginning Balance		Bad Debt Expense (Recovery)			Charged to Allowance			Other(1)		Ending Balance
There months ended March 31, 2023	$	1,915	$	444		$	(67	)	$	—	$	2,292
Year ended December 31, 2022		4,581		(1,097	)		(1,696	)		127		1,915

____________________

(1)This amount consists of additions to the allowance due to business acquisitions.

XML

Prepaid and Other Current Assets

3 Months Ended

Mar. 31, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepaid and Other Current Assets

4. PREPAID AND OTHER CURRENT ASSETS

Prepaid and other current assets consisted of the following:

	March 31,		December 31,
	2023		2022
Deposits	$	1,366	$	1,394
Prepaid expenses		9,167		5,266
Supplies		4,074		3,632
Income tax receivable		571		694
Prepaid and other current assets	$	15,178	$	10,986

XML

Property and Equipment, Net

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

5. PROPERTY AND EQUIPMENT, NET

Property and equipment are stated at cost or estimated fair value for assets acquired through business combinations. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term, including options that are deemed to be reasonably assured, or the estimated useful life of the improvement.

Property and equipment, net, consisted of the following:

	Estimated	March 31,			December 31,
	Useful Life	2023			2022
Lab and test equipment	7 years	$	22,992		$	21,171
Vehicles	5 years		5,841			5,732
Equipment	3-7 years		42,819			40,940
Furniture and fixtures	7 years		2,853			2,841
Leasehold improvements	7 years		8,837			8,576
Aircraft	10 years		—			931
Building	39 years		6,112			2,975
			89,454			83,166
Land			725			725
Construction in progress			3,092			3,150
Less accumulated depreciation			(52,586	)		(50,996	)
Total property and equipment—    net		$	40,685		$	36,045

Total depreciation expense included in the unaudited condensed consolidated statements of operations was $2.2 million and $1.8 million for the three months ended March 31, 2023 and March 31, 2022, respectively.

XML

Leases

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Leases

6. LEASES

Leases are classified as either finance leases or operating leases based on criteria in ASC 842. The Company has finance leases for its vehicle and equipment leases and operating leases for its real estate space and office equipment leases. The Company’s operating and finance leases generally have original lease terms between 1 year and 15 years, and in some instances include one or more options to renew. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company currently considers some of its renewal options to be reasonably certain to be exercised. Some leases also include early termination options, which can be exercised under specific conditions. The Company does not have material residual value guarantees or restrictive covenants associated with its leases.

Finance and operating lease assets represent the right to use an underlying asset for the lease term, and finance and operating lease liabilities represent the obligation to make lease payments arising from the lease.

The Company calculates the present value of its finance and operating leases using an estimated incremental borrowing rate (“IBR”), which requires judgment. For real estate operating leases, the Company estimates the IBR based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. For all other leases, the Company estimates the IBR based on the stated interest rate on the contract. Since many of the inputs used to calculate the rate implicit in the leases are not readily determinable from the lessee’s perspective, the Company does not use the implicit interest rate.

Certain leases contain variable payments, these payments are expensed as incurred and not included in the Company’s operating lease right-of-use assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance and are excluded from the present value of the Company’s lease obligations.

The Company does not record operating lease right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also combines lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.

The components of lease expense were as follows:

		For the Three Months Ended March 31,
	Statement of Operations Location	2023		2022
Operating lease cost
Lease cost	Selling, general and administrative expense	$	2,741	$	2,451
Variable lease cost	Selling, general and administrative expense		326		367
Total operating lease cost			3,067		2,818
Finance lease cost
Amortization of right of use assets	Depreciation and amortization		1,154		939
Interest on lease liabilities	Interest expense—net		130		112
Total finance lease cost			1,284		1,051
Total lease cost		$	4,351	$	3,869

Supplemental cash flows information related to leases was as follows:

	For the Three Months Ended March 31,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in operating leases	$	2,557	$	2,302
Operating cash flows used in finance leases		130		112
Financing cash flows used in finance leases		1,029		944
Lease liabilities arising from new ROU assets:
Operating leases		7,999		8,815
Finance leases		2,405		512

Weighted average remaining lease terms and weighted average discount rates were:

	March 31, 2023
	Operating Leases			Finance Leases
Weighted average remaining lease term (years)	4.62				3.43
Weighted average discount rate		3.31	%		5.57	%
	March 31, 2022
	Operating Leases			Finance Leases
Weighted average remaining lease term (years)	4.86				3.03
Weighted average discount rate		2.50	%		4.98	%

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year:

	Operating Leases			Finance Leases
Remainder of 2023	$	7,117		$	3,657
2024		8,554			3,543
2025		6,507			2,612
2026		5,006			1,902
2027		3,385			967
2028 and thereafter		4,787			135
Total undiscounted future minimum lease payments		35,356			12,816
Less imputed interest		(2,693	)		(1,179	)
Total discounted future minimum lease payments	$	32,663		$	11,637

XML

Business Acquisitions

3 Months Ended

Mar. 31, 2023

Business Combinations [Abstract]

Business Acquisitions

7. BUSINESS ACQUISITIONS

In line with the Company’s strategic growth initiatives, the Company acquired certain businesses during the three months ended March 31, 2023 and during the year ended December 31, 2022. The results of each of those acquired businesses are included in the unaudited condensed consolidated financial statements beginning on the acquisition date. Each transaction qualified as an acquisition of a business and was accounted for as a business combination. All acquisitions resulted in the recognition of goodwill. The Company paid these premiums resulting in such goodwill for a number of reasons, including expected synergies from combining operations of the acquiree and the Company while also growing the Company’s customer base, acquiring assembled workforces, expanding its presence in certain markets and expanding and advancing its product and service offerings. The Company recorded the assets acquired and liabilities assumed at their acquisition date fair value, with the difference between the fair value of the net assets acquired and the acquisition consideration reflected as goodwill.

The identifiable intangible assets for significant acquisitions are valued using the excess earnings method discounted cash flow approach for customer relationships, the relief from royalty method for trade names, the patent and external proprietary software and developed technology, the “with and without” method for covenants not to compete and the replacement cost method for the internal proprietary software by incorporating Level 3 inputs as described under the fair value hierarchy of ASC 820. These unobservable inputs reflect the Company’s own assumptions about which assumptions market participants would use in pricing an asset on a non-recurring basis. These assets will be amortized over their respective estimated useful lives.

Other purchase price obligations (primarily deferred purchase price liabilities and target working capital liabilities or receivables) are included on the unaudited condensed consolidated statements of financial position in accounts payable and other accrued liabilities, other non-current liabilities or accounts receivable-net in the case of working capital deficits. Contingent consideration outstanding from acquisitions are included on the unaudited condensed consolidated statements of financial position in business acquisition contingent consideration, current or in business acquisitions contingent consideration, long-term. The contingent consideration elements of the purchase price of the acquisitions are related to earn-outs which are based on the expected achievement of revenue or earnings thresholds as of the date of the acquisition and for which the maximum potential amount is limited.

The Company considers several factors when determining whether or not contingent consideration liabilities are part of the purchase price, including the following: (i) the valuation of its acquisitions is not supported solely by the initial consideration paid, (ii) the former stockholders of acquired companies that remain as key employees receive compensation other than contingent consideration payments at a reasonable level compared with the compensation of the Company’s other key employees and (iii) contingent consideration payments are not affected by employment termination. The Company reviews and assesses the estimated fair value of contingent consideration at each reporting period.

The Company may be required to make up to $9.5 million in aggregate earn-out payments between the years 2023 and 2026 in connection with certain of its business acquisitions, of which up to $2.6 million may be paid only in cash, up to $5.5 million may be paid only in common stock and up to $1.5 million may be paid, at the Company’s option, in cash or common stock.

Transaction costs related to business combinations totaled $0.8 million and $0.5 million for the three months ended March 31, 2023 and March 31, 2022, respectively. These costs are expensed within selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations.

Acquisitions Completed During the Three Months Ended March 31, 2023

Frontier Analytical Laboratories (“Frontier”) —In January 2023, the Company completed the acquisition of Frontier by acquiring certain of its assets and operations. Frontier is a specialized environmental laboratory based in El Dorado Hills, CA.

Environmental Alliance, Inc. (“EAI”)—In February 2023, the Company completed the acquisition of EAI by acquiring 100.0% of its common stock. EAI provides environmental remediation and consulting services, and is based in Wilmington, DE.

The following table summarizes the elements of the purchase price of the acquisitions completed during the three months ended March 31, 2023:

	Cash		Common Stock		Other Purchase Price Components			Contingent Consideration		Total Purchase Price
Frontier	$	1,146	$	—	$	—		$	—	$	1,146
EAI		5,390		—		(342	)		25		5,073
Total	$	6,536	$	—	$	(342	)	$	25	$	6,219

The upfront cash payment made to acquire both of these acquisitions was funded through cash on hand. The other purchase price components of the EAI purchase price mainly consist of surplus working capital amounts.

The preliminary purchase price attributable to the acquisitions was allocated as follows:

	Frontier		EAI		Total(1)
Cash	$	—	$	11	$	11
Accounts receivable		—		1,502		1,502
Other current assets		—		121		121
Current assets		—		1,634		1,634
Property and equipment		302		191		493
Customer relationships		—		1,402		1,402
Trade names		—		106		106
Covenants not to compete		—		263		263
Goodwill		844		1,965		2,809
Total assets		1,146		5,561		6,707
Current liabilities		—		488		488
Total liabilities		—		488		488
Purchase price	$	1,146	$	5,073	$	6,219

___________________________________

(1) The Company is continuing to obtain information to complete the valuation of certain of these acquisitions' assets and liabilities.

Goodwill associated with the Frontier acquisition is deductible for income tax purposes. The weighted average useful lives for EAI identifiable customer relationships, tradenames and covenants not to compete are 7 years, 2 years and 5 years, respectively.

Frontier is included in the Company’s Measurement and Analysis segment and EAI is included in the Remediation and Reuse segment.

For the acquisitions completed during the three months ended March 31, 2023, the results of operations since the acquisition dates have been combined with those of the Company. The Company’s unaudited condensed consolidated statement of operations for the three months ended March 31, 2023 includes revenue of $1.0 million, and pre-tax income of $0.1 million, related to these acquisitions.

Acquisitions Completed During the Year Ended December 31, 2022

Environmental Standards, Inc. (“Environmental Standards”)—In January 2022, the Company completed the acquisition of Environmental Standards, Inc. by acquiring 100.0% of its common stock. Environmental Standards is a provider of environmental consulting and data validation services. Environmental Standards is based in Valley Forge, PA with satellite locations nationwide.

Industrial Automation Group, Inc. (“IAG”)—In January 2022, the Company completed the acquisition of Industrial Automation Group, Inc. by acquiring certain of its employees and a covenant not to compete. IAG is based in Atlanta, GA. IAG provides highly specialized engineering services which are additive to the Company’s water treatment and renewable energy technology implementations.

TriAD Environmental Consultants, Inc. (“TriAD”)—In August 2022, the Company completed the acquisition of TriAD Environmental Consultants, Inc. by acquiring 100.0% of its common stock. TriAD is a provider of environmental consulting services. TriAD is based in Nashville, TN.

AirKinetics, Inc. (“AirKinetics”)—In September 2022, the Company completed the acquisition of AirKinetics, Inc. by acquiring 100.0% of its common stock. AirKinetics is a provider of emissions testing services. AirKinetics is based in Anaheim, CA.

Huco Consulting, Inc. (“Huco”)—In November 2022, the Company completed the acquisition of Huco Consulting, Inc. by acquiring 100.0% of its common stock. Huco primarily specializes in the implementation of environment, health and safety software for industrial, commercial and government clients. Huco is based in Houston, TX.

Environmental Standards and Huco are included in the Company’s Assessment, Permitting and Response segment, IAG and TriAD are included in the Remediation and Reuse segment and AirKinetics is included in the Measurement and Analysis segment.

For the acquisitions completed during the three months ended March 31, 2022, the results of operations since the acquisition dates have been combined with those of the Company. The Company’s unaudited condensed consolidated statement of operations for the three months ended March 31, 2022 includes revenue of $3.3 million and pre-tax income of $0.8 million.

During the three months ended March 31, 2023, measurement period adjustments of $0.2 million were recorded to goodwill as a result of the Company’s efforts to complete the valuation of certain acquired assets and assumed liabilities (Note 8).

Supplemental Unaudited Pro-Forma—The unaudited condensed consolidated financial information summarized in the following table gives effect to the 2023 and the 2022 acquisitions discussed above assuming they occurred on January 1, 2022. These unaudited consolidated pro forma operating results do not assume any impact from revenue, cost or other operating synergies that are expected or may have been realized as a result of the acquisitions. These unaudited consolidated pro forma operating results are presented for illustrative purposes only and are not indicative of the operating results that would have been achieved had the acquisitions occurred on January 1, 2022, nor does the information purport to reflect results for any future period.

	For the Three Months Ended March 31,
	2023									2022
	As reported			Acquisitions Pro-Forma (Unaudited)			Consolidated Pro-Forma (Unaudited)			As reported			Acquisitions Pro-Forma (Unaudited)		Consolidated Pro-Forma (Unaudited)
Revenues	$	131,428		$	433		$	131,861		$	134,680		$	5,625	$	140,305
Net (loss) income		(14,719	)		(67	)		(14,786	)		(7,536	)		722		(6,814	)

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

8. GOODWILL AND INTANGIBLE ASSETS

Amounts related to goodwill are as follows:

	Assessment, Permitting and Response			Measurement and Analysis			Remediation and Reuse		Total
Balance as of December 31, 2022	$	185,116		$	86,205		$	52,547	$	323,868
Goodwill acquired during the period		—			844			1,965		2,809
Acquisitions measurement period adjustments		(169	)		(10	)		—		(179	)
Balance as of March 31, 2023	$	184,947		$	87,039		$	54,512	$	326,498

Amounts related to finite-lived intangible assets are as follows:

March 31, 2023	Estimated Useful Life	Gross Balance		Accumulated Amortization		Total Intangible Assets—Net
Finite lived intangible assets
Customer relationships	2-15 years	$	209,426	$	100,404	$	109,022
Covenants not to compete	4-5 years		33,805		29,020		4,785
Trade names	1-5 years		22,167		18,708		3,459
Proprietary software	3-5 years		23,324		16,942		6,382
Patent	16 years		17,479		3,856		13,623
Total other intangible assets    —net		$	306,201	$	168,930	$	137,271

December 31, 2022	Estimated Useful Life	Gross Balance		Accumulated Amortization		Total Intangible Assets—Net
Finite lived intangible assets
Customer relationships	2-15 years	$	208,024	$	95,768	$	112,256
Covenants not to compete	4-5 years		33,542		28,280		5,262
Trade names	1-5 years		22,061		18,256		3,805
Proprietary software	3-5 years		22,698		15,810		6,888
Patent	16 years		17,479		3,583		13,896
Total other intangible assets    —net		$	303,804	$	161,697	$	142,107

Intangible assets with finite lives are stated at cost, less accumulated amortization and impairment losses, if any. These intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.

Amortization expense was $7.2 million and $9.4 million for the three months ended March 31, 2023 and March 31, 2022, respectively.

Future amortization expense is estimated to be as follows for each of the five following years and thereafter:

December 31,
2023 (remaining)		20,920
2024		24,607
2025		17,727
2026		13,952
2027		13,429
Thereafter		46,636
Total	$	137,271

XML

Accounts Payable and Other Accrued Liabilities

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Accounts Payable and Other Accrued Liabilities

9. ACCOUNTS PAYABLE AND OTHER ACCRUED LIABILITIES

Accounts payable and other accrued liabilities consisted of the following:

	March 31,		December 31,
	2023		2022
Accounts payable	$	24,399	$	25,353
Accrued expenses		16,311		14,754
Other business acquisitions purchase    price obligations		450		1,185
Contract liabilities		10,932		18,549
Other current liabilities		3,328		3,571
Total accounts payable and    other accrued liabilities	$	55,420	$	63,412

XML

Accrued Payroll and Benefits

3 Months Ended

Mar. 31, 2023

Statement of Financial Position [Abstract]

Accrued Payroll and Benefits

10. ACCRUED PAYROLL AND BENEFITS

Accrued payroll and benefits consisted of the following:

	March 31,		December 31,
	2023		2022
Accrued bonuses	$	3,559	$	8,624
Accrued paid time off		1,161		1,088
Accrued payroll		9,084		8,410
Accrued other		2,548		2,406
Total accrued payroll and benefits	$	16,352	$	20,528

XML

Income Taxes

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

11. INCOME TAXES

The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting (“ASC 270”), and ASC 740. The Company’s effective tax rate (“ETR”) from continuing operations was (10.2)% and (20.2)% for the three months ended March 31, 2023 and March 31, 2022, respectively. Income tax expense recorded by the Company during the three months ended March 31, 2023 and March 31, 2022 was $1.4 million and $1.3 million, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to items recorded for U.S. GAAP but permanently disallowed for U.S. federal income tax purposes, recognition of a U.S. federal and state valuation allowance and state and foreign income tax provisions.

A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. As of March 31, 2023, the Company’s U.S. federal, state and various foreign net deferred tax assets are not more-likely-than-not to be realized and a full valuation allowance is maintained.

The Company records uncertain tax positions in accordance with ASC 740, on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it has no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense.

XML

Debt

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Debt

12. DEBT

Debt consisted of the following:

	March 31,			December 31,
	2023			2022
Term loan facility	$	164,062		$	166,250
Revolving line of credit		—			—
Less deferred debt issuance costs		(1,595	)		(1,725	)
Total debt		162,467			164,525
Less current portion of long-term debt		(13,125	)		(12,031	)
Long-term debt, less current portion	$	149,342		$	152,494

Deferred Financing Costs—Costs relating to debt issuance have been deferred and are presented as discounted against the underlying debt instrument. These costs are amortized to interest expense over the terms of the underlying debt instruments.

2021 Credit Facility—On April 27, 2021, the Company entered into a Senior Secured Credit Agreement providing for a $300.0 million credit facility comprised of a $175.0 million term loan and a $125.0 million revolving line of credit (the “2021 Credit Facility”), and used a portion of the proceeds from the 2021 Credit Facility to repay all amounts outstanding under the prior credit facility. The revolving line of credit portion of the 2021 Credit Facility includes a $20.0 million sublimit for the issuance of letters of credit. Subject to certain exceptions, all amounts under the 2021 Credit Facility will become due on April 27, 2026. The Company has the option to borrow incremental term loans or request an increase in the aggregate commitments under the revolving credit facility up to an aggregate amount of $150.0 million subject to the satisfaction of certain conditions.

The 2021 Credit Facility term loan must be repaid in quarterly installments and shall amortize at the following future quarterly rates:

Date	Quarterly Installment Rate
June 30, 2023	1.25%
September 30, 2023	1.25%
December 31, 2023	1.88%
March 31, 2024	1.88%
June 30, 2024	1.88%
September 30, 2024	1.88%
December 31, 2024	1.88%
March 31, 2025	1.88%
June 30, 2025	1.88%
September 30, 2025	1.88%
December 31, 2025	2.50%
March 31, 2026	2.50%
April 27, 2026	Remaining balance

Repayments of quarterly installments were scheduled to begin with the quarter ended December 31, 2021. The first quarterly installment repayment, amounting to $2.2 million, was paid in January 2022. Exclusive of the payment made in respect of the quarter ended December 31, 2021, the quarterly installment repayments for the three months ended March 31, 2022 amounted to $2.2 million. The December 31, 2022 installment repayment, amounting to $2.2 million, was paid in January 2023. The March 31, 2023 installment repayment, amounting to $2.2 million, was paid in April 2023.

The 2021 Credit Facility term loan and the revolver bear interest subject to the Company’s leverage ratio and LIBOR as follows:

Pricing Tier	Consolidated Leverage Ratio	Senior Credit Facilities LIBOR			Senior Credit Facilities Base Rate			Commitment Fee			Letter of Credit Fee
1	≥ 3.75x to 1.0		2.50	%		1.50	%		0.25	%		2.50	%
2	< 3.75x to 1.0 but ≥ 3.25 to 1.0		2.25			1.25			0.23			2.25
3	<3.25x to 1.0 but ≥ 2.50 to 1.0		2.00			1.00			0.20			2.00
4	<2.50x to 1.0 but ≥ 1.75 to 1.0		1.75			0.75			0.15			1.75
5	<1.75x to 1.0		1.50			0.50		0.15				1.50

The Company is currently in discussions regarding the transition of LIBOR to an adjusted benchmark rate to be effective on or before June 30, 2023. The transition to an adjusted interest rate is not expected to materially impact the interest rate paid by the Company.

On January 27, 2022, the Company entered into an interest rate swap transaction fixing the floating component of the interest rate on $100.0 million of borrowings to 1.39% until January 27, 2025. Additionally, effective September 1, 2022, the Company received an interest rate reduction of 0.05% under the 2021 Credit Facility based on the Company’s achievement of certain sustainability and environmental, social and governance related objectives as provided for in the 2021 Credit Facility.

The 2021 Credit Facility includes a number of covenants imposing certain restrictions on the Company’s business, including, among other things, restrictions on the Company’s ability, subject to certain exceptions and baskets, to incur indebtedness, incur liens on its assets, agree to any additional negative pledges, pay dividends or repurchase stock, limit the ability of its subsidiaries to pay dividends or distribute assets, make investments, enter into any transaction of merger or consolidation, liquidate, wind-up or dissolve, or convey any part of its business, assets or property, or acquire the business, property or assets of another person, enter into sale and leaseback transactions, enter into certain transactions with affiliates, engage in any material line of business substantially different from those engaged on the closing date, modify the terms of indebtedness subordinated to the loans incurred under the 2021 Credit Facility and modify the terms of its organizational documents. The 2021 Credit Facility also includes financial covenants which required the Company to remain below a maximum total net leverage ratio of 4.25 times until the fiscal quarter ended September 31, 2022, which stepped down to 4.00 times during the fiscal quarter ending December 31, 2022 and applies through and including the fiscal quarter ending September 30, 2023 and then further steps down to 3.75 times beginning with the fiscal quarter ending December 31, 2023, and a minimum fixed charge coverage ratio of 1.25 times. As of March 31, 2023 and December 31, 2022, the Company’s consolidated total leverage ratio (as defined in the 2021 Credit Facility) was 1.4 times and 1.3 times, respectively, and the Company was in compliance with all covenants under the 2021 Credit Facility.

The 2021 Credit Facility requires customary mandatory prepayments of the term loan and revolver and cash collateralization of letters of credit, subject to customary exceptions, including 100.0% of the proceeds of debt not permitted by the 2021 Credit Facility, 100.0% of the proceeds of certain dispositions, subject to customary reinvestment rights, where applicable, and 100.0% of insurance or condemnation proceeds, subject to customary reinvestment rights, where applicable. The 2021 Credit Facility also includes customary events of default and related acceleration and termination rights.

The weighted average interest rate on the 2021 Credit Facility for the three months ended March 31, 2023 and March 31, 2022 was 6.1% and 1.8%, respectively.

The Company’s obligations under the 2021 Credit Facility are guaranteed by certain of the Company’s existing and future direct and indirect subsidiaries, and such obligations are secured by substantially all of the Company’s assets, including the capital stock or other equity interests in those subsidiaries.

Equipment Line of Credit—The Company had a $10.0 million equipment leasing facility for the purchase of equipment and related freight, installation costs and taxes paid. Any unused capacity on this equipment leasing facility expired on March 31, 2023. Interest on the line of credit was determined based on a three-year swap rate at the time of funding. Equipment leased through this line of credit met the finance lease criteria as per ASC 842 and accordingly is accounted for as finance lease right-of-use assets and finance lease liabilities (Note 6).

The following is a schedule of the aggregate annual maturities of long-term debt presented on the unaudited condensed consolidated statement of financial position, based on the terms of the 2021 Credit Facility:

March 31,
2024	$	13,125
2025		13,125
2026		15,312
2027		122,500
2028		—
Total	$	164,062

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

13. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following financial instruments are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):

	March 31,		December 31,
	2023		2022
Interest rate swap(1)	$	5,078	$	6,046
Total assets	$	5,078	$	6,046
Business acquisitions contingent consideration,    current	$	4,734	$	3,801
Business acquisitions contingent consideration,    long-term		3,121		4,454
Conversion option		26,636		25,731
Total liabilities	$	34,491	$	33,986

_____________________________
 

(1) Included in other assets in the unaudited condensed consolidated statement of financial position.

The estimated fair value amounts shown above are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instrument.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis:

	Interest Rate Swap			Total Assets			Business Acquisitions Contingent Consideration, Current			Business Acquisitions Contingent Consideration, Long-term			Conversion    Option		Total Liabilities
Balance—at January 1, 2022	$	—		$	—		$	31,450		$	4,350		$	23,081	$	58,881
Acquisitions		—			—			—			1,216			—		1,216
Changes in fair value included in earnings		3,005			3,005			(21	)		—			556		535
Payment of contingent consideration        payable		—			—			(30,000	)		—			—		(30,000	)
Balance—at March 31, 2022	$	3,005		$	3,005		$	1,429		$	5,566		$	23,637	$	30,632
Balance—at January 1, 2023	$	6,046		$	6,046		$	3,801		$	4,454		$	25,731	$	33,986
Acquisitions		—			—			25			—			—		25
Changes in fair value included in earnings		(968	)		(968	)		(515	)		117			905		507
Payment of contingent consideration        payable		—			—			(27	)		—			—		(27	)
Reclass of long term to short term       contingent liabilities		—			—			1,450			(1,450	)		—		—
Balance—at March 31, 2023	$	5,078		$	5,078		$	4,734		$	3,121		$	26,636	$	34,491

Quantitative Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3):

Interest Rate Swap—The interest rate swap fair value is estimated based on a mid-market price for the swap as of the close of business of the reporting period. The fair value is prepared by discounting future cash flows of the swap to arrive at a current value of the swap. Forward curves and volatility levels inputs are determined on the basis of observable market inputs when available and on the basis of estimates when observable market inputs are not available. The Company does not apply hedge accounting but instead recognizes the instrument at fair value on the unaudited condensed consolidated statement of financial position within other assets, with changes in fair value recognized as other income (expense) in each reporting period.

Business Acquisitions Contingent Consideration—The fair value of the contingent consideration payable associated with the acquisitions of CTEH and Sensible was determined using a Monte Carlo simulation of earnings in a risk-neutral Geometric Brownian Motion framework. The fair value of the contingent consideration payable associated with the acquisition of Environmental Standards was determined using a Probabilistic (Scenario Based) method. The fair values of the contingent consideration payables for the other acquisitions were calculated based on expected target achievement amounts, which are measured quarterly and then subsequently adjusted to actuals at the target measurement date. The method used to price these liabilities is considered level 3 due to the subjective nature of the unobservable inputs used to determine the fair value. The input is the expected achievement of earn-out thresholds.

Conversion Option—The fair value of the conversion option associated with the issuance of the Convertible and Redeemable Series A-2 Preferred Stock (Note 15) was estimated using a “with-and-without” method. The “with-and-without” methodology considers the value of the security on an as-is basis and then without the embedded conversion premium. The difference between the two scenarios is the implied fair value of the embedded derivative. The unobservable input is the required rate of return on the Series A-2. The considerable quantifiable inputs in the valuation relate to the timing of conversions or redemptions.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

14. COMMITMENTS AND CONTINGENCIES

Leases—The Company leases office facilities over various terms expiring through 2031. Certain of these operating leases contain rent escalation clauses. The Company also has office equipment leases that expire through 2028 (Note 6 and 12).

Other Commitments—The Company has commitments under the 2021 Credit Facility, its equipment line of credit and its lease obligations (Note 6 and 12).

Contingencies—The Company is subject to purchase price contingencies related to earn-outs associated with certain acquisitions (Note 7 and 13).

Legal—In the normal course of business, the Company is at times subject to pending and threatened legal actions. In management’s opinion, the potential loss resulting from the resolution of these matters is not expected to have a material effect on the unaudited condensed consolidated results of operations, financial position or cash flows of the Company.

XML

Convertible and Redeemable Series A-2 Preferred Stock

3 Months Ended

Mar. 31, 2023

Temporary Equity Disclosure [Abstract]

Convertible and Redeemable Series A-2 Preferred Stock

15. CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK

On April 13, 2020, the Company entered into an agreement to issue 17,500 shares of the Convertible and Redeemable Series A-2 Preferred Stock with a par value of $0.0001 per share and a detachable warrant to purchase shares of the Company’s common stock with a 10-year life, in exchange for gross proceeds of $175.0 million, net of $1.3 million debt issuance costs. The Convertible and Redeemable Series A-2 Preferred Stock warrants were exercised in full on July 30, 2020. The Company paid dividends on shares of the Convertible and Redeemable Series A-2 Preferred Stock of $4.1 million during both the three months ended March 31, 2023 and March 31, 2022.

The Convertible and Redeemable Series A-2 Preferred Stock terms include the following: (i) no mandatory redemption, (ii) no stated value cash repayment obligation other than in the event of certain defined liquidation events, (iii) only redeemable at the Company’s option, (iv) convertible into common stock beginning on the four year anniversary of issuance at a 15.0% discount to the common stock market price (with a limit of $60.0 million in stated value of Convertible and Redeemable Series A-2 Preferred Stock eligible to be converted in any 60-day period prior to the seventh anniversary of issuance and the amount of stated value of the Convertible and Redeemable Series A-2 Preferred Stock eligible for conversion limited to $60.0 million during year 5 and $120.0 million (which includes the aggregate amount of the stated value of the Convertible and Redeemable Series A-2 Preferred Stock and any accrued but unpaid dividends added to such stated value of any shares of Convertible and Redeemable Series A-2 Preferred Stock converted in year 5) during year 6), (v) 9.0% dividend rate per year with required quarterly cash payments, (vi) in an event of noncompliance, the dividend rate shall increase to 12.0% per annum for the first 90-day period from and including the date the noncompliance event occurred, and thereafter shall increase to 14.0% per annum, (vii) debt incurrence test ratio of 4.5 times, and (viii) minimum repayment amount of $25.0 million.

The Company may, at its option on any one or more dates, redeem all or a minimum portion (the lesser of (i) $25.0 million in aggregate stated value of the Convertible and Redeemable Series A-2 Preferred Stock and (ii) all of the Convertible and Redeemable Series A-2 Preferred Stock then outstanding) of the outstanding Convertible and Redeemable Series A-2 Preferred Stock in cash.

With respect to any redemption of any share of the Convertible and Redeemable Series A-2 Preferred Stock prior to the third-year anniversary, the Company is subject to a make whole penalty in which the holders of the Convertible and Redeemable Series A-2 Preferred Stock are guaranteed a minimum repayment equal to outstanding redeemed stated value plus three years of dividends accrued or accruable thereon.

The Convertible and Redeemable Series A-2 Preferred Stock does not meet the definition of a liability pursuant to “ASC 480- Distinguishing Liabilities from Equity.” However, as (i) the instrument is redeemable upon a change of control as defined in the certificate of designations governing the terms of the Convertible and Redeemable Series A-2 Preferred Stock, and (ii) the Company cannot assert it would have sufficient authorized and unissued shares of common stock to settle all future conversion requests due to the variable conversion terms, the instrument is redeemable upon the occurrence of events that are not solely within the control of the Company, and therefore the Company classifies the Convertible and Redeemable Series A-2 Preferred Stock as mezzanine equity. Subsequent adjustment of the carrying value of the instrument is required if the instrument is probable of becoming redeemable. As of March 31, 2023, the Company has determined that a change of control is not probable. Additionally, as of March 31, 2023, the Company has determined that it is not probable that there will be a future conversion request that the Company is unable to settle with authorized and issued shares based on the Company’s current stock price and available shares as well as the Company’s monitoring efforts to ensure there are a sufficient number of shares available to settle any conversion request. Therefore, as of March 31, 2023, the Company has determined that the instrument is not probable of becoming redeemable, and does not believe subsequent adjustment of the carrying value of the instrument will be necessary.

The Convertible and Redeemable Series A-2 Preferred Stock contains a conversion option of the preferred shares to shares of common stock beginning on the fourth-year anniversary of the issuance date. As of March 31, 2023 and December 31, 2022, this conversion embedded feature had a net fair value of $26.6 million and $25.7 million, respectively. The change in net fair value of $0.9 million and $0.6 million for the three months ended March 31, 2023 and March 31, 2022, respectively, was recorded to other expense.

XML

Stockholder's Equity

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Stockholders' Equity

16. STOCKHOLDERS’ EQUITY

Authorized Capital Stock—The Company was authorized to issue 190,000,000 shares of common stock, with a par value of $0.000004 per share as of March 31, 2023 and December 31, 2022.

Common Stock Issuances—The Company issued the following shares of common stock:

	Three Months Ended March 31,
	2023						2022
	Shares		Average Price per Share		Total		Shares		Average Price per Share		Total
Exercise of options		124,455	$	21.61	$	2,690		30,607	$	14.03	$	429
Restricted shares, net (1)		90,116		36.81		—		25,289		66.58		—
Total		214,571	$	27.99	$	2,690		55,896	$	37.81	$	429

(1) Represents the non-cash release of common shares due to the vesting of restricted stock.

Employee Equity Incentive Plans—The Company has two plans under which stock-based awards have been issued: (i) the Montrose Amended & Restated 2017 Stock Incentive Plan (“2017 Plan”) and (ii) the Montrose Amended & Restated 2013 Stock Option Plan (“2013 Plan”) (collectively the “Plans”).

As of March 31, 2023, and March 31, 2022, there was $146.6 million and $173.1 million, respectively, of total unrecognized stock compensation expense related to unvested options, restricted stock and stock appreciation rights granted under the Plans. Such unrecognized expense is expected to be recognized over a weighted-average four year period. The following number of shares were authorized to be issued and available for grant:

	March 31, 2023
	2017 Plan		2013 Plan		Total
Shares authorized to be issued		6,329,913		2,037,019		8,366,932
Shares available for grant(1)		893,522		—		893,522
	March 31, 2022
	2017 Plan		2013 Plan		Total
Shares authorized to be issued		8,272,487		1,904,644		10,177,131
Shares available for grant(1)		577,139		—		577,139

(1) In January 2023 and January 2022 the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. Shares available for grant exclude awards of stock appreciation rights approved in December 2021 that are subject to vesting based on the achievement of certain market conditions, which have not yet been, and may not be, achieved. See footnote 1 to the table in Common Stock Reserved for Future Issuance below for additional information on stock appreciation rights.

Total stock compensation expense for the Plans was as follows:

	Three Months Ended March 31,
	2023										2022
	2017 plan						2013 plan				2017 plan						2013 plan
	Options		Restricted Stock		SARs		Options		Total		Options		Restricted Stock		SARs		Options		Total
Cost of revenue	$	349	$	543	$	—	$	—	$	892	$	294	$	—	$	—	$	—	$	294
Selling, general and    administrative expense		1,724		8,154		2,265		—		12,143		1,979		5,792		2,360		—		10,131
Total	$	2,073	$	8,697	$	2,265	$	—	$	13,035	$	2,273	$	5,792	$	2,360	$	—	$	10,425

Montrose Amended & Restated 2017 Stock Incentive Plan

Restricted Stock Awards and Restricted Stock Units—The Company issues restricted stock awards ("RSAs") to certain 2017 Plan participants as Director’s compensation. There were 17,346 and 10,920 RSAs granted during the three months ended March 31, 2023 and March 31, 2022, respectively. These RSAs vest one year from the date of grant, or, in each case, in full upon a change in control, subject to the

participant’s continued service as a Director throughout such date, or upon retirement. Members of the Board of Directors that receive stock-based compensation are treated as employees for accounting purposes.

In the first quarter of 2023, the Board of Directors approved the grant of 200,423 restricted stock units (“RSUs”) to certain senior non-executive employees of the Company, in lieu of options. These RSUs represent the right to receive one share of the Company’s common stock upon vesting. These RSUs vest annually over a 4-year period from the date of grant, subject to continued service through each such date.

In the first quarter of 2023 and 2022, the Board of Directors approved the grant of RSUs under certain supplemental incentive plans ("SI Plans"). There were 246,417 and 95,404 RSUs issued under these SI Plans during the three months ended March 31, 2023 and March 31, 2022, respectively. The majority of the RSUs issued in the first quarter of 2023 vested 1/3 on the date of grant, and will vest 1/3 on the one-year anniversary of the grant, and 1/3 on the two-year anniversary of the grant, subject to continued service through each such date. The remaining RSUs vest annually over a 4-year period from the date of grant, subject to continued service through each such date.

RSAs and RSUs activity was as follows:

	Three Months Ended March 31,
	2023						2022
	Shares		Average Price per Share		Fair Value		Shares		Average Price per Share		Fair Value
Awards granted		464,186	$	32.62	$	15,140		106,324	$	46.82	$	4,978

There were an aggregate of 90,116 and 25,289 shares underlying RSAs and RSUs that became fully vested and were released as unrestricted shares of common stock during the three months ended March 31, 2023 and March 31, 2022, respectively. There were no forfeitures of RSAs or RSUs during the three months ended March 31, 2023 and March 31, 2022. There were an aggregate of 2,528,383 and 2,064,197 shares underlying outstanding RSAs and RSUs awards as of March 31, 2023 and March 31, 2022, respectively.

Stock Appreciation Rights— As of March 31, 2023, there were 3,000,000 units of stock appreciation rights (“SARs”) outstanding under the 2017 Plan. These SARs represent the right to receive, upon exercise, a payment equal to the excess of (a) the fair market value of one share of the Company’s common stock, over (b) an exercise price of $66.79, payable, at the Company’s election, in cash or shares of common stock. These SARs vest on the 5th anniversary of the date of grant based on achievement of performance hurdles over a five year period, subject to continued service on the vesting date. The performance hurdles are as follows:

SARs Stock Price Performance Hurdle		Portion of SARs Subject to Performance Hurdle
$	133.58	1/3
$	166.98	1/3
$	200.37	1/3

The performance hurdles shall be deemed achieved if the average trading price per share of the Company’s common stock equals or exceeds the applicable stock price performance hurdle set forth above for the trading days falling in a consecutive 20-day period prior to the vesting date. None of the market conditions have been achieved as of March 31, 2023.

The SARs expire 10 years after the grant date. The fair value of these SARs at the grant date was $46.0 million. The weighted average remaining contract life of these SARs as of March 31, 2023 was 8.71 years.

Options—Options issued to all optionees under the 2017 Plan vest over 4-years from the date of issuance (or earlier vesting start date, as determined by the Board of Directors) as follows: one half on the second anniversary of date of grant and the remaining half on the fourth anniversary of the date of grant, with the exception of certain annual grants to certain executive officers, which vest annually over a 3-year and 1-year period. The following summarizes the options activity of the 2017 Plan:

	Options to Purchase Common Stock			Weighted- Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The- Money Options (in Thousands)
Outstanding as of January 1, 2022		2,036,729		$	26	$	14		8.30	$	91,030
Granted		547,884			44		16		—		—
Forfeited/ cancelled		(23,082	)		36		—		—		—
Exercised		(11,547	)		27		—		—		313
Outstanding as of March 31, 2022		2,549,984			30		14		8.46		59,955
Outstanding as of January 1, 2023		2,579,566		$	31	$	15		7.76	$	37,292
Granted		233,955			32		14		—		—
Forfeited/ cancelled		(34,619	)		35		—		—		—
Exercised		(101,279	)		25		—		—		2,467
Outstanding as of March 31, 2023		2,677,623		$	31	$	15		7.78	$	21,127
Exercisable at March 31, 2023		1,305,511			29		—		7.19		11,880

The following weighted-average assumptions were used in the Black-Sholes option-pricing model calculation:

	March 31,			March 31,
	2023			2022
Common stock value (per share)	$	32.16		$	44.11
Expected volatility		33.79	%		33.45	%
Risk-free interest rate		3.72	%		1.74	%
Expected life (years)		7.00			6.33
Forfeiture rate	None			None
Dividend rate	None			None

Montrose Amended & Restated 2013 Stock Option Plan—The following summarizes the activity of the 2013 Plan:

	Options to Purchase Common Stock			Weighted- Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The- Money Options (in Thousands)
Outstanding as of January 1, 2022		897,674		$	6	$	2		4.37	$	57,529
Exercised		(19,060	)		6		—		—		821
Outstanding as of March 31, 2022		878,614			6		2		4.13		40,860
Outstanding as of January 1, 2023		855,695		$	6	$	2		3.31	$	32,478
Exercised		(23,176	)		9		—		—		963
Outstanding as of March 31, 2023		832,519		$	6	$	2		3.03	$	24,393
Exercisable at March 31, 2023		832,519			6		—		3.03		24,393

Total shares outstanding from exercised options were 1,434,885 shares and 1,239,697 shares as of March 31, 2023 and March 31, 2022, respectively.

Common Stock Reserved for Future Issuances—The Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:

	March 31,
	2023		2022
Montrose 2013 Stock Incentive Plan		832,519		878,614
Montrose 2017 Stock Incentive Plan(1)		8,722,930		7,893,918
Total		9,555,449		8,772,532

(1) In January 2023 and 2022, the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards. Shares reserved for future issuance include 3,000,000 shares underlying the 3,000,000 performance SARs granted in December 2021 that are subject to vesting based on the achievement of certain market conditions. Assuming achievement at the highest price performance hurdle, approximately 2,000,000 shares of common stock would be issued upon vesting of these performance SARs. To date, none of the market conditions have been achieved.

XML

Net Loss Per Share

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Net Loss Per Share

17. NET LOSS PER SHARE

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during each period. The Convertible and Redeemable Series A-2 Preferred Stock is considered a participating security during the applicable period. Net losses are not allocated to the Convertible and Redeemable Series A-2 stockholders, as they were not contractually obligated to share in the Company’s losses.

Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding for the period using the treasury-stock method or the as-converted method. Potentially dilutive shares are comprised of RSAs, RSUs, SARs and shares of common stock underlying stock options outstanding under the Plans. During the three months ended March 31, 2023 and March 31, 2022, there is no difference in the number of shares used to calculate basic and diluted shares outstanding during the applicable period due to the Company’s net loss attributable to common stockholders and potentially dilutive shares being anti-dilutive.

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:

	Three Months Ended
	March 31,
(In thousands, except for net loss per share)	2023			2022
Net loss	$	(14,719	)	$	(7,536	)
Convertible and redeemable series A-2 preferred    stock dividend		(4,100	)		(4,100	)
Net loss attributable to common stockholders    –basic and diluted		(18,819	)		(11,636	)
Weighted-average common shares outstanding –    basic and diluted		29,857			29,662
Net loss per share attributable to common    stockholders –basic and diluted	$	(0.63	)	$	(0.39	)

The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive:

	March 31,
	2023(1)		2022(1)
Stock options		3,510,142		2,034,041
Restricted stock		2,151,785		1,777,958
Series A-2		4,735,220		4,329,640
SARs		3,000,000		3,000,000

_____________________________

(1) Includes 7,362,459 and 5,008,269 common stock equivalents that are out of the money as of March 31, 2023 and March 31, 2022, respectively.

XML

Segment Information

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Information

18. SEGMENT INFORMATION

The Company has three operating and reportable segments: Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. These segments are monitored separately by management for performance against budget and prior year and are consistent with internal financial reporting. The Company’s operating segments are organized based upon primary services provided, the nature of the production process, their type of customers, methods used to distribute the products and the nature of the regulatory environment.

Segment Adjusted EBITDA is the primary measure of operating performance for all three operating segments. Segment Adjusted EBITDA is the calculated Company’s Earnings before Interest, Tax, Depreciation and Amortization (“EBITDA”), adjusted to exclude certain transactions such as stock-based compensation, acquisition costs and fair value changes in financial instruments, amongst others. Beginning in the first quarter of 2023, the calculation of Segment adjusted EBITDA no longer adjusts for start-up losses and investment in new services as the Chief Operating Decision Maker (“CODM”) no longer reviews the Segment Adjusted EBITDA measure without these costs. The CODM does not review segment assets as a measure of segment performance.

During the first quarter of 2023, the Company determined to sell one of its specialty service lines within the lab testing business (the "Discontinuing Specialty Lab"), whose performance has been sporadic and whose service offering is non-core to the Company’s business. The Company expects the sale process to be completed by December 31, 2023. The discontinuation of this specialty service line, which is part of the Company's Measurement and Analysis segment, did not represent a strategic shift that had (or will have) a major effect on the Company’s operations and financial results, therefore it did not meet the requirements to be classified as discontinued operations.

Corporate and Other includes costs associated with general corporate overhead (including executive, legal, finance, safety, human resources, marketing and IT related costs) that are not directly related to supporting operations. Overhead costs that are directly related to supporting operations (such as insurance, software, licenses, shared services and payroll processing costs) are allocated to the operating segments on a basis that reasonably approximates an estimate of the use of these services.

Segment revenues and Adjusted EBITDA consisted of the following:

	Three Months Ended March 31,
	2023						2022
				Segment						Segment
	Segment			Adjusted			Segment			Adjusted
	Revenues			EBITDA			Revenues			EBITDA(3)
Assessment, Permitting and Response	$	52,214		$	14,266		$	45,600		$	9,623
Measurement and Analysis		42,527	(1)		6,387			39,761	(1)		6,322		(2)
Remediation and Reuse		36,687			5,278			49,319			7,993
Total Operating Segments		131,428			25,931			134,680			23,938
Corporate and Other		—			(9,328	)		—			(7,487	)
Total	$	131,428		$	16,603		$	134,680		$	16,451

_____________________________________

(1) Includes revenue of $1.4 million and $5.6 million from the Discontinuing Specialty Lab, for the three months ended March 31, 2023 and March 31, 2022, respectively.
(2) Includes Adjusted EBITDA of $1.3 million from the Discontinuing Specialty Lab.

(3) Includes the add back of start-up losses and investment in new services of $0.8 million.

Presented below is a reconciliation of the Company’s segment measure to net loss:

	For the Three Months Ended March 31,
	2023				2022
Total	$	16,603			$	16,451
Interest expense, net		(1,541	)			(1,092	)
Income tax expense		(1,367	)			(1,269	)
Depreciation and amortization		(10,555	)			(12,144	)
Stock-based compensation		(13,035	)			(10,425	)
Start-up losses and investment in new services		—				(786	)
Acquisition costs		(775	)			(467	)
Fair value changes in financial instruments		(1,873	)			2,449
Fair value changes in business acquisition    contingencies		398				21
Expenses related to financing transactions		(4	)			(7	)
Discontinuing Specialty Lab		(2,436	)	(1)		—
Other losses or expenses		(134	)			(267	)
Net loss	$	(14,719	)		$	(7,536	)

__________________________

(1) Amounts consist of operating losses before depreciation related to the Discontinuing Specialty Lab.

XML

Related-Party Transactions

3 Months Ended

Mar. 31, 2023

Related Party Transactions [Abstract]

Related-Party Transactions

19. RELATED-PARTY TRANSACTIONS

The Company did not have any related party transactions during the three months ended March 31, 2023 and March 31, 2022.

XML

Defined Contribution Plan

3 Months Ended

Mar. 31, 2023

Retirement Benefits [Abstract]

Defined Contribution Plan

20. DEFINED CONTRIBUTION PLAN

On January 1, 2014, the Company established the Montrose Environmental Group 401(k) Savings Plan (the “401(k) Savings Plan”). As of March 31, 2023, and December 31, 2022, plan participants may defer up to 85.0% of their eligible wages for the year, up to the Internal Revenue Service dollar limit and catch-up contribution allowed by law. The Company provided employer matching contributions equal to 100.0% of the first 3.0% of the participant’s compensation and 50.0% of the participant’s elective deferrals that exceed 3.0% but do not exceed 5.0% of the participant’s compensation. Employer contributions under the 401(k) Savings Plan were $2.1 million and $1.7 million for the three months ended March 31, 2023 and March 31, 2022, respectively, and are included within selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2023

Subsequent Events [Abstract]

Subsequent Events

21. SUBSEQUENT EVENTS

Business Acquisitions—On May 1, 2023, the Company completed the business acquisition of GreenPath Energy LTD ("GreenPath") by acquiring 100.0% of its common stock. GreenPath is a leading optical gas imaging and fugitive emissions management services firm and is based in Calgary, Canada.

On April 28, 2023, the Company signed an arrangement agreement which provides for the acquisition of Matrix Solutions, Inc. ("Matrix") by acquiring 100.0% of its common stock. Matrix is one of Canada’s leading environmental and engineering consulting companies and is based in Calgary, Canada. This business acquisition is expected to close by the end of the second quarter 2023.

These transactions qualify as business acquisitions and will be accounted for as business combinations. The following table summarizes the main elements of the purchase price of these acquisitions:

						Total
	Cash (in CAD Dollars)			Common Stock (in CAD Dollars)		Purchase Price (in CAD Dollars)
GreenPath	$	16,580	(1)		3,520	$	20,100
Matrix		65,191	(2)		—		65,191

_________________________________________
(1) The cash portion of this acquisition's purchase price was funded through cash on hand.

(2) Upon closing, the cash portion of this acquisition's purchase price will funded through a combination of cash on hand and proceeds received from our revolving credit facility.

XML

Description of the Business and Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation—The unaudited condensed consolidated financial statements include the operations of the Company and its wholly-owned subsidiaries. These unaudited condensed consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The unaudited condensed consolidated financial statements include all accounts of the Company and, in the opinion of management, include all recurring adjustments and normal accruals necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the dates and periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended December 31, 2022. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. All intercompany transactions, accounts and profits, have been eliminated in the unaudited condensed consolidated financial statements.

Recently Adopted Accounting Pronouncements /Recently Issued Accounting Pronouncements Not Yet Adopted

Recently Adopted Accounting Pronouncements—In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance was adopted as of January 1, 2022 and did not have a material impact on the Company’s unaudited condensed consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what contract assets and/or contract liabilities it would have recorded under ASC 606 (the revenue guidance) as of the acquisition date, as if the acquirer had entered into the original contract at the same date and on the same terms as the acquiree. The new guidance was adopted as of January 1, 2023 and did not have a material impact on the Company’s unaudited condensed consolidated financial statements; however it may impact the accounting for future acquisitions. The future impact of this new guidance will be primarily a function of the facts and circumstances specific to any acquisitions consummated after adoption and therefore cannot be predicted.

XML

Revenues and Accounts Receivable (Tables)

3 Months Ended

Mar. 31, 2023

Revenues And Accounts Receivable [Abstract]

Schedule of Contract Balances

The following table presents the Company’s contract balances:

	March 31,		December 31,
	2023		2022
Contract assets	$	53,563	$	52,403
Contract liabilities		10,932		18,549

Schedule of Accounts Receivable, Net

Accounts Receivable, NetAccounts receivable, net consisted of the following:

	March 31, 2023			December 31, 2022
Accounts receivable, invoiced	$	87,261		$	95,055
Accounts receivable, other		503			1,571
Allowance for doubtful accounts		(2,292	)		(1,915	)
Accounts receivable—net	$	85,472		$	94,711

Schedule of Allowance for Doubtful Accounts

The allowance for doubtful accounts consisted of the following:

	Beginning Balance		Bad Debt Expense (Recovery)			Charged to Allowance			Other(1)		Ending Balance
There months ended March 31, 2023	$	1,915	$	444		$	(67	)	$	—	$	2,292
Year ended December 31, 2022		4,581		(1,097	)		(1,696	)		127		1,915

____________________

(1)This amount consists of additions to the allowance due to business acquisitions.

XML

Prepaid and Other Current Assets (Tables)

3 Months Ended

Mar. 31, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Prepaid and Other Current Assets

Prepaid and other current assets consisted of the following:

	March 31,		December 31,
	2023		2022
Deposits	$	1,366	$	1,394
Prepaid expenses		9,167		5,266
Supplies		4,074		3,632
Income tax receivable		571		694
Prepaid and other current assets	$	15,178	$	10,986

XML

Property and Equipment, Net (Tables)

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

Property and equipment, net, consisted of the following:

	Estimated	March 31,			December 31,
	Useful Life	2023			2022
Lab and test equipment	7 years	$	22,992		$	21,171
Vehicles	5 years		5,841			5,732
Equipment	3-7 years		42,819			40,940
Furniture and fixtures	7 years		2,853			2,841
Leasehold improvements	7 years		8,837			8,576
Aircraft	10 years		—			931
Building	39 years		6,112			2,975
			89,454			83,166
Land			725			725
Construction in progress			3,092			3,150
Less accumulated depreciation			(52,586	)		(50,996	)
Total property and equipment—    net		$	40,685		$	36,045

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Summary of Components of Lease Expense

The components of lease expense were as follows:

		For the Three Months Ended March 31,
	Statement of Operations Location	2023		2022
Operating lease cost
Lease cost	Selling, general and administrative expense	$	2,741	$	2,451
Variable lease cost	Selling, general and administrative expense		326		367
Total operating lease cost			3,067		2,818
Finance lease cost
Amortization of right of use assets	Depreciation and amortization		1,154		939
Interest on lease liabilities	Interest expense—net		130		112
Total finance lease cost			1,284		1,051
Total lease cost		$	4,351	$	3,869

Summary of Supplemental Cash Flow Information Related To Leases

Supplemental cash flows information related to leases was as follows:

	For the Three Months Ended March 31,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in operating leases	$	2,557	$	2,302
Operating cash flows used in finance leases		130		112
Financing cash flows used in finance leases		1,029		944
Lease liabilities arising from new ROU assets:
Operating leases		7,999		8,815
Finance leases		2,405		512

Summary of Weighted Average Remaining Lease Terms and Weighted Average Discount Rates

Weighted average remaining lease terms and weighted average discount rates were:

	March 31, 2023
	Operating Leases			Finance Leases
Weighted average remaining lease term (years)	4.62				3.43
Weighted average discount rate		3.31	%		5.57	%
	March 31, 2022
	Operating Leases			Finance Leases
Weighted average remaining lease term (years)	4.86				3.03
Weighted average discount rate		2.50	%		4.98	%

Schedule of Maturities of Lease Liabilities

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year:

	Operating Leases			Finance Leases
Remainder of 2023	$	7,117		$	3,657
2024		8,554			3,543
2025		6,507			2,612
2026		5,006			1,902
2027		3,385			967
2028 and thereafter		4,787			135
Total undiscounted future minimum lease payments		35,356			12,816
Less imputed interest		(2,693	)		(1,179	)
Total discounted future minimum lease payments	$	32,663		$	11,637

XML

Business Acquisitions (Tables)

3 Months Ended

Mar. 31, 2023

Business Acquisition [Line Items]

Summary of Supplemental Unaudited Pro-Forma Information

The unaudited condensed consolidated financial information summarized in the following table gives effect to the 2023 and the 2022 acquisitions discussed above assuming they occurred on January 1, 2022. These unaudited consolidated pro forma operating results do not assume any impact from revenue, cost or other operating synergies that are expected or may have been realized as a result of the acquisitions. These unaudited consolidated pro forma operating results are presented for illustrative purposes only and are not indicative of the operating results that would have been achieved had the acquisitions occurred on January 1, 2022, nor does the information purport to reflect results for any future period.

	For the Three Months Ended March 31,
	2023									2022
	As reported			Acquisitions Pro-Forma (Unaudited)			Consolidated Pro-Forma (Unaudited)			As reported			Acquisitions Pro-Forma (Unaudited)		Consolidated Pro-Forma (Unaudited)
Revenues	$	131,428		$	433		$	131,861		$	134,680		$	5,625	$	140,305
Net (loss) income		(14,719	)		(67	)		(14,786	)		(7,536	)		722		(6,814	)

Frontier and EAI

Business Acquisition [Line Items]

Summary of Main Elements of Purchase Price of Acquisitions

The following table summarizes the elements of the purchase price of the acquisitions completed during the three months ended March 31, 2023:

	Cash		Common Stock		Other Purchase Price Components			Contingent Consideration		Total Purchase Price
Frontier	$	1,146	$	—	$	—		$	—	$	1,146
EAI		5,390		—		(342	)		25		5,073
Total	$	6,536	$	—	$	(342	)	$	25	$	6,219

Summary of Purchase Price Attributable to Acquisitions

The preliminary purchase price attributable to the acquisitions was allocated as follows:

	Frontier		EAI		Total(1)
Cash	$	—	$	11	$	11
Accounts receivable		—		1,502		1,502
Other current assets		—		121		121
Current assets		—		1,634		1,634
Property and equipment		302		191		493
Customer relationships		—		1,402		1,402
Trade names		—		106		106
Covenants not to compete		—		263		263
Goodwill		844		1,965		2,809
Total assets		1,146		5,561		6,707
Current liabilities		—		488		488
Total liabilities		—		488		488
Purchase price	$	1,146	$	5,073	$	6,219

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Amounts Related to Goodwill

Amounts related to goodwill are as follows:

	Assessment, Permitting and Response			Measurement and Analysis			Remediation and Reuse		Total
Balance as of December 31, 2022	$	185,116		$	86,205		$	52,547	$	323,868
Goodwill acquired during the period		—			844			1,965		2,809
Acquisitions measurement period adjustments		(169	)		(10	)		—		(179	)
Balance as of March 31, 2023	$	184,947		$	87,039		$	54,512	$	326,498

Schedule of Amounts Related to Finite-Lived Intangible Assets

Amounts related to finite-lived intangible assets are as follows:

March 31, 2023	Estimated Useful Life	Gross Balance		Accumulated Amortization		Total Intangible Assets—Net
Finite lived intangible assets
Customer relationships	2-15 years	$	209,426	$	100,404	$	109,022
Covenants not to compete	4-5 years		33,805		29,020		4,785
Trade names	1-5 years		22,167		18,708		3,459
Proprietary software	3-5 years		23,324		16,942		6,382
Patent	16 years		17,479		3,856		13,623
Total other intangible assets    —net		$	306,201	$	168,930	$	137,271

December 31, 2022	Estimated Useful Life	Gross Balance		Accumulated Amortization		Total Intangible Assets—Net
Finite lived intangible assets
Customer relationships	2-15 years	$	208,024	$	95,768	$	112,256
Covenants not to compete	4-5 years		33,542		28,280		5,262
Trade names	1-5 years		22,061		18,256		3,805
Proprietary software	3-5 years		22,698		15,810		6,888
Patent	16 years		17,479		3,583		13,896
Total other intangible assets    —net		$	303,804	$	161,697	$	142,107

Schedule of Future Amortization Expense

Future amortization expense is estimated to be as follows for each of the five following years and thereafter:

December 31,
2023 (remaining)		20,920
2024		24,607
2025		17,727
2026		13,952
2027		13,429
Thereafter		46,636
Total	$	137,271

XML

Accounts Payable and Other Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Summary of Accounts Payable and Other Accrued Liabilities

Accounts payable and other accrued liabilities consisted of the following:

	March 31,		December 31,
	2023		2022
Accounts payable	$	24,399	$	25,353
Accrued expenses		16,311		14,754
Other business acquisitions purchase    price obligations		450		1,185
Contract liabilities		10,932		18,549
Other current liabilities		3,328		3,571
Total accounts payable and    other accrued liabilities	$	55,420	$	63,412

XML

Accrued Payroll and Benefits (Tables)

3 Months Ended

Mar. 31, 2023

Statement of Financial Position [Abstract]

Schedule of Accrued Payroll and Benefits

Accrued payroll and benefits consisted of the following:

	March 31,		December 31,
	2023		2022
Accrued bonuses	$	3,559	$	8,624
Accrued paid time off		1,161		1,088
Accrued payroll		9,084		8,410
Accrued other		2,548		2,406
Total accrued payroll and benefits	$	16,352	$	20,528

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Schedule of Debt

Debt consisted of the following:

	March 31,			December 31,
	2023			2022
Term loan facility	$	164,062		$	166,250
Revolving line of credit		—			—
Less deferred debt issuance costs		(1,595	)		(1,725	)
Total debt		162,467			164,525
Less current portion of long-term debt		(13,125	)		(12,031	)
Long-term debt, less current portion	$	149,342		$	152,494

Summary of Term Loan Amortization

The 2021 Credit Facility term loan must be repaid in quarterly installments and shall amortize at the following future quarterly rates:

Date	Quarterly Installment Rate
June 30, 2023	1.25%
September 30, 2023	1.25%
December 31, 2023	1.88%
March 31, 2024	1.88%
June 30, 2024	1.88%
September 30, 2024	1.88%
December 31, 2024	1.88%
March 31, 2025	1.88%
June 30, 2025	1.88%
September 30, 2025	1.88%
December 31, 2025	2.50%
March 31, 2026	2.50%
April 27, 2026	Remaining balance

Summary of 2021 Credit Facility Interest Rate Subject to Leverage Ratio and LIBOR

The 2021 Credit Facility term loan and the revolver bear interest subject to the Company’s leverage ratio and LIBOR as follows:

Pricing Tier	Consolidated Leverage Ratio	Senior Credit Facilities LIBOR			Senior Credit Facilities Base Rate			Commitment Fee			Letter of Credit Fee
1	≥ 3.75x to 1.0		2.50	%		1.50	%		0.25	%		2.50	%
2	< 3.75x to 1.0 but ≥ 3.25 to 1.0		2.25			1.25			0.23			2.25
3	<3.25x to 1.0 but ≥ 2.50 to 1.0		2.00			1.00			0.20			2.00
4	<2.50x to 1.0 but ≥ 1.75 to 1.0		1.75			0.75			0.15			1.75
5	<1.75x to 1.0		1.50			0.50		0.15				1.50

Schedule of Aggregate Annual Maturities of Long-Term Debt

The following is a schedule of the aggregate annual maturities of long-term debt presented on the unaudited condensed consolidated statement of financial position, based on the terms of the 2021 Credit Facility:

March 31,
2024	$	13,125
2025		13,125
2026		15,312
2027		122,500
2028		—
Total	$	164,062

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following financial instruments are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):

	March 31,		December 31,
	2023		2022
Interest rate swap(1)	$	5,078	$	6,046
Total assets	$	5,078	$	6,046
Business acquisitions contingent consideration,    current	$	4,734	$	3,801
Business acquisitions contingent consideration,    long-term		3,121		4,454
Conversion option		26,636		25,731
Total liabilities	$	34,491	$	33,986

_____________________________
 

(1) Included in other assets in the unaudited condensed consolidated statement of financial position.

The estimated fair value amounts shown above are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instrument.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis:

	Interest Rate Swap			Total Assets			Business Acquisitions Contingent Consideration, Current			Business Acquisitions Contingent Consideration, Long-term			Conversion    Option		Total Liabilities
Balance—at January 1, 2022	$	—		$	—		$	31,450		$	4,350		$	23,081	$	58,881
Acquisitions		—			—			—			1,216			—		1,216
Changes in fair value included in earnings		3,005			3,005			(21	)		—			556		535
Payment of contingent consideration        payable		—			—			(30,000	)		—			—		(30,000	)
Balance—at March 31, 2022	$	3,005		$	3,005		$	1,429		$	5,566		$	23,637	$	30,632
Balance—at January 1, 2023	$	6,046		$	6,046		$	3,801		$	4,454		$	25,731	$	33,986
Acquisitions		—			—			25			—			—		25
Changes in fair value included in earnings		(968	)		(968	)		(515	)		117			905		507
Payment of contingent consideration        payable		—			—			(27	)		—			—		(27	)
Reclass of long term to short term       contingent liabilities		—			—			1,450			(1,450	)		—		—
Balance—at March 31, 2023	$	5,078		$	5,078		$	4,734		$	3,121		$	26,636	$	34,491

XML

Stockholder's Equity (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Issued Shares of Common Stock

The Company issued the following shares of common stock:

	Three Months Ended March 31,
	2023						2022
	Shares		Average Price per Share		Total		Shares		Average Price per Share		Total
Exercise of options		124,455	$	21.61	$	2,690		30,607	$	14.03	$	429
Restricted shares, net (1)		90,116		36.81		—		25,289		66.58		—
Total		214,571	$	27.99	$	2,690		55,896	$	37.81	$	429

(1) Represents the non-cash release of common shares due to the vesting of restricted stock.

Schedule of Share Authorized to be Issue and Available for Grant

The following number of shares were authorized to be issued and available for grant:

	March 31, 2023
	2017 Plan		2013 Plan		Total
Shares authorized to be issued		6,329,913		2,037,019		8,366,932
Shares available for grant(1)		893,522		—		893,522
	March 31, 2022
	2017 Plan		2013 Plan		Total
Shares authorized to be issued		8,272,487		1,904,644		10,177,131
Shares available for grant(1)		577,139		—		577,139

(1) In January 2023 and January 2022 the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. Shares available for grant exclude awards of stock appreciation rights approved in December 2021 that are subject to vesting based on the achievement of certain market conditions, which have not yet been, and may not be, achieved. See footnote 1 to the table in Common Stock Reserved for Future Issuance below for additional information on stock appreciation rights.

Schedule of Stock Compensation Expense

Total stock compensation expense for the Plans was as follows:

	Three Months Ended March 31,
	2023										2022
	2017 plan						2013 plan				2017 plan						2013 plan
	Options		Restricted Stock		SARs		Options		Total		Options		Restricted Stock		SARs		Options		Total
Cost of revenue	$	349	$	543	$	—	$	—	$	892	$	294	$	—	$	—	$	—	$	294
Selling, general and    administrative expense		1,724		8,154		2,265		—		12,143		1,979		5,792		2,360		—		10,131
Total	$	2,073	$	8,697	$	2,265	$	—	$	13,035	$	2,273	$	5,792	$	2,360	$	—	$	10,425

Summary of Performance Hurdles

The performance hurdles are as follows:

SARs Stock Price Performance Hurdle		Portion of SARs Subject to Performance Hurdle
$	133.58	1/3
$	166.98	1/3
$	200.37	1/3

Summary of Weighted Average Assumptions Used in Black-Sholes Option-pricing Model

The following weighted-average assumptions were used in the Black-Sholes option-pricing model calculation:

	March 31,			March 31,
	2023			2022
Common stock value (per share)	$	32.16		$	44.11
Expected volatility		33.79	%		33.45	%
Risk-free interest rate		3.72	%		1.74	%
Expected life (years)		7.00			6.33
Forfeiture rate	None			None
Dividend rate	None			None

Schedule of Common Stock Reserved for Future Issuance

The Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:

	March 31,
	2023		2022
Montrose 2013 Stock Incentive Plan		832,519		878,614
Montrose 2017 Stock Incentive Plan(1)		8,722,930		7,893,918
Total		9,555,449		8,772,532

(1) In January 2023 and 2022, the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards. Shares reserved for future issuance include 3,000,000 shares underlying the 3,000,000 performance SARs granted in December 2021 that are subject to vesting based on the achievement of certain market conditions. Assuming achievement at the highest price performance hurdle, approximately 2,000,000 shares of common stock would be issued upon vesting of these performance SARs. To date, none of the market conditions have been achieved.

Montrose Amended & Restated 2017 Stock Incentive Plan

Schedule of Restricted Stock Activity

RSAs and RSUs activity was as follows:

	Three Months Ended March 31,
	2023						2022
	Shares		Average Price per Share		Fair Value		Shares		Average Price per Share		Fair Value
Awards granted		464,186	$	32.62	$	15,140		106,324	$	46.82	$	4,978

Summary of Stock Option Activity

The following summarizes the options activity of the 2017 Plan:

	Options to Purchase Common Stock			Weighted- Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The- Money Options (in Thousands)
Outstanding as of January 1, 2022		2,036,729		$	26	$	14		8.30	$	91,030
Granted		547,884			44		16		—		—
Forfeited/ cancelled		(23,082	)		36		—		—		—
Exercised		(11,547	)		27		—		—		313
Outstanding as of March 31, 2022		2,549,984			30		14		8.46		59,955
Outstanding as of January 1, 2023		2,579,566		$	31	$	15		7.76	$	37,292
Granted		233,955			32		14		—		—
Forfeited/ cancelled		(34,619	)		35		—		—		—
Exercised		(101,279	)		25		—		—		2,467
Outstanding as of March 31, 2023		2,677,623		$	31	$	15		7.78	$	21,127
Exercisable at March 31, 2023		1,305,511			29		—		7.19		11,880

Montrose Amended and Restated 2013 Stock Option Plan

Summary of Stock Option Activity

The following summarizes the activity of the 2013 Plan:

	Options to Purchase Common Stock			Weighted- Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The- Money Options (in Thousands)
Outstanding as of January 1, 2022		897,674		$	6	$	2		4.37	$	57,529
Exercised		(19,060	)		6		—		—		821
Outstanding as of March 31, 2022		878,614			6		2		4.13		40,860
Outstanding as of January 1, 2023		855,695		$	6	$	2		3.31	$	32,478
Exercised		(23,176	)		9		—		—		963
Outstanding as of March 31, 2023		832,519		$	6	$	2		3.03	$	24,393
Exercisable at March 31, 2023		832,519			6		—		3.03		24,393

XML

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:

	Three Months Ended
	March 31,
(In thousands, except for net loss per share)	2023			2022
Net loss	$	(14,719	)	$	(7,536	)
Convertible and redeemable series A-2 preferred    stock dividend		(4,100	)		(4,100	)
Net loss attributable to common stockholders    –basic and diluted		(18,819	)		(11,636	)
Weighted-average common shares outstanding –    basic and diluted		29,857			29,662
Net loss per share attributable to common    stockholders –basic and diluted	$	(0.63	)	$	(0.39	)

Common Stock Equivalents Excluded from Calculation of Diluted Loss Per Share Attributable to Common Stockholders

The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive:

	March 31,
	2023(1)		2022(1)
Stock options		3,510,142		2,034,041
Restricted stock		2,151,785		1,777,958
Series A-2		4,735,220		4,329,640
SARs		3,000,000		3,000,000

_____________________________

(1) Includes 7,362,459 and 5,008,269 common stock equivalents that are out of the money as of March 31, 2023 and March 31, 2022, respectively.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Components of Segment Revenues and Adjusted EBITDA

Segment revenues and Adjusted EBITDA consisted of the following:

	Three Months Ended March 31,
	2023						2022
				Segment						Segment
	Segment			Adjusted			Segment			Adjusted
	Revenues			EBITDA			Revenues			EBITDA(3)
Assessment, Permitting and Response	$	52,214		$	14,266		$	45,600		$	9,623
Measurement and Analysis		42,527	(1)		6,387			39,761	(1)		6,322		(2)
Remediation and Reuse		36,687			5,278			49,319			7,993
Total Operating Segments		131,428			25,931			134,680			23,938
Corporate and Other		—			(9,328	)		—			(7,487	)
Total	$	131,428		$	16,603		$	134,680		$	16,451

_____________________________________

(1) Includes revenue of $1.4 million and $5.6 million from the Discontinuing Specialty Lab, for the three months ended March 31, 2023 and March 31, 2022, respectively.
(2) Includes Adjusted EBITDA of $1.3 million from the Discontinuing Specialty Lab.

(3) Includes the add back of start-up losses and investment in new services of $0.8 million.

Reconciliation of Segment Measure to Net Loss

Presented below is a reconciliation of the Company’s segment measure to net loss:

	For the Three Months Ended March 31,
	2023				2022
Total	$	16,603			$	16,451
Interest expense, net		(1,541	)			(1,092	)
Income tax expense		(1,367	)			(1,269	)
Depreciation and amortization		(10,555	)			(12,144	)
Stock-based compensation		(13,035	)			(10,425	)
Start-up losses and investment in new services		—				(786	)
Acquisition costs		(775	)			(467	)
Fair value changes in financial instruments		(1,873	)			2,449
Fair value changes in business acquisition    contingencies		398				21
Expenses related to financing transactions		(4	)			(7	)
Discontinuing Specialty Lab		(2,436	)	(1)		—
Other losses or expenses		(134	)			(267	)
Net loss	$	(14,719	)		$	(7,536	)

__________________________

(1) Amounts consist of operating losses before depreciation related to the Discontinuing Specialty Lab.

XML

Subsequent Events (Tables)

3 Months Ended

Mar. 31, 2023

Matrix

Subsequent Event [Line Items]

Summary of Main Elements of Purchase Price of Acquisitions

The following table summarizes the main elements of the purchase price of these acquisitions:

						Total
	Cash (in CAD Dollars)			Common Stock (in CAD Dollars)		Purchase Price (in CAD Dollars)
GreenPath	$	16,580	(1)		3,520	$	20,100
Matrix		65,191	(2)		—		65,191

_________________________________________
(1) The cash portion of this acquisition's purchase price was funded through cash on hand.

(2) Upon closing, the cash portion of this acquisition's purchase price will funded through a combination of cash on hand and proceeds received from our revolving credit facility.

XML

Description of the Business and Basis of Presentation - Additional Information (Details)	3 Months Ended
	Mar. 31, 2023 Employee Office Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Entity formation, month and year	2013-11
Number of offices in which entity operates | Office	80
Entity number of employees | Employee	3,000
Number of operating segments | Segment	3

XML

Summary of New Accounting Pronouncements - Additional Information (Details)	Mar. 31, 2023
Accounting Standards Update 2020-06
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted	true
Change in accounting principle, accounting standards update, adoption date	Jan. 01, 2022
Change in accounting principle, accounting standards update, immaterial effect	true
Accounting Standards Update 2021-08
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted	true
Change in accounting principle, accounting standards update, adoption date	Jan. 01, 2023
Change in accounting principle, accounting standards update, immaterial effect	true

XML

Revenues and Accounts Receivable - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Revenues And Accounts Receivable [Abstract]
Contract assets	$ 53,563	$ 52,403
Contract liabilities	$ 10,932	$ 18,549

XML

Revenues and Accounts Receivable - Additional Information (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) Customer	Mar. 31, 2022 Customer	Dec. 31, 2022 USD ($) Customer
Accounts Notes And Loans Receivable [Line Items]
Contracts assets acquired through business acquisitions	$ 200,000		$ 1,700,000
Contract liabilities acquired through business acquisitions	0		0
Contract with customer liabilities, revenue recognized	12,800,000
Revenue remaining performance obligations	$ 98,200,000		$ 100,400,000
Customer Concentration Risk | Accounts Receivable | Significant Customer
Accounts Notes And Loans Receivable [Line Items]
Concentration risk percentage	10.00%		10.00%
Number of customers | Customer	0		0
Customer Concentration Risk | Revenue | Significant Customer
Accounts Notes And Loans Receivable [Line Items]
Concentration risk percentage	10.00%	17.30%
Number of customers | Customer	0	1

XML

Revenues and Accounts Receivable - Additional Information (Details1) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligations	$ 98.2	$ 100.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligations	$ 79.1
Revenue remaining performance obligations, satisfaction period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligations	$ 19.1
Revenue remaining performance obligations, satisfaction period

XML

Revenues and Accounts Receivable - Schedule of Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues And Accounts Receivable [Abstract]
Accounts receivable, invoiced	$ 87,261	$ 95,055
Accounts receivable, other	503	1,571
Allowance for doubtful accounts	(2,292)	(1,915)	$ (4,581)
Accounts receivable—net	$ 85,472	$ 94,711

XML

Revenues and Accounts Receivable - Schedule of Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands		3 Months Ended		12 Months Ended
		Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Revenues And Accounts Receivable [Abstract]
Beginning Balance		$ 1,915	$ 4,581	$ 4,581
Bad Debt Expense (Recovery)		444	$ (528)	(1,097)
Charged to Allowance		(67)		(1,696)
Other	[1]	0		127
Ending Balance		$ 2,292		$ 1,915

[1] This amount consists of additions to the allowance due to business acquisitions.

XML

Prepaid and Other Current Assets - Schedule of Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Deposits	$ 1,366	$ 1,394
Prepaid expenses	9,167	5,266
Supplies	4,074	3,632
Income tax receivable	571	694
Prepaid and other current assets	$ 15,178	$ 10,986

XML

Property and Equipment, Net - Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 89,454	$ 83,166
Less accumulated depreciation	(52,586)	(50,996)
Total property and equipment— net	$ 40,685	36,045
Lab and test equipment
Property Plant And Equipment [Line Items]
Estimated Useful Life	7 years
Property and equipment, gross	$ 22,992	21,171
Vehicles
Property Plant And Equipment [Line Items]
Estimated Useful Life	5 years
Property and equipment, gross	$ 5,841	5,732
Equipment
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 42,819	40,940
Equipment | Minimum
Property Plant And Equipment [Line Items]
Estimated Useful Life	3 years
Equipment | Maximum
Property Plant And Equipment [Line Items]
Estimated Useful Life	7 years
Furniture and fixtures
Property Plant And Equipment [Line Items]
Estimated Useful Life	7 years
Property and equipment, gross	$ 2,853	2,841
Leasehold improvements
Property Plant And Equipment [Line Items]
Estimated Useful Life	7 years
Property and equipment, gross	$ 8,837	8,576
Aircraft
Property Plant And Equipment [Line Items]
Estimated Useful Life	10 years
Property and equipment, gross		931
Building
Property Plant And Equipment [Line Items]
Estimated Useful Life	39 years
Property and equipment, gross	$ 6,112	2,975
Land
Property Plant And Equipment [Line Items]
Property and equipment, gross	725	725
Construction in Progress
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 3,092	$ 3,150

XML

Property and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property Plant And Equipment [Line Items]
Depreciation expense	$ 2.2	$ 1.8

XML

Leases - Additional Information (Details)	3 Months Ended
	Mar. 31, 2023
Minimum
Lessee Lease Description [Line Items]
Lessee operating and finance lease term	1 year
Maximum
Lessee Lease Description [Line Items]
Lessee operating and finance lease term	15 years

XML

Leases - Summary of Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Lessee Lease Description [Line Items]
Total operating lease cost	$ 3,067	$ 2,818
Total finance lease cost	1,284	1,051
Total lease cost	4,351	3,869
Selling, General and Administrative Expenses
Lessee Lease Description [Line Items]
Lease cost	2,741	2,451
Variable lease cost	326	367
Depreciation and Amortization
Lessee Lease Description [Line Items]
Amortization of right of use assets	1,154	939
Interest Expense, Net
Lessee Lease Description [Line Items]
Interest on lease liabilities	$ 130	$ 112

XML

Leases - Summary of Supplemental Cash Flow Information Related To Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating cash flows used in operating leases	$ 2,557	$ 2,302
Operating cash flows used in finance leases	130	112
Financing cash flows used in finance leases	1,029	944
Operating leases	7,999	8,815
Finance leases	$ 2,405	$ 512

XML

Leases - Summary of Weighted Average Remaining Lease Terms and Weighted Average Discount Rates (Details)	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Weighted average remaining lease term, Operating Leases	4 years 7 months 13 days	4 years 10 months 9 days
Weighted average remaining lease term, Finance Leases	3 years 5 months 4 days	3 years 10 days
Weighted average discount rate, Operating Leases	3.31%	2.50%
Weighted average discount rate, Finance Leases	5.57%	4.98%

XML

Leases - Summary of Maturities of Lease Liabilities (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Leases [Abstract]
Operating Leases, Remainder of 2023	$ 7,117
Operating Leases, 2024	8,554
Operating Leases, 2025	6,507
Operating Leases, 2026	5,006
Operating Leases, 2027	3,385
Operating Leases, 2028 and thereafter	4,787
Operating Leases, Total undiscounted future minimum lease payments	35,356
Operating Leases, Less imputed interest	(2,693)
Operating Leases, Total discounted future minimum lease payments	32,663
Finance Leases, Remainder of 2023	3,657
Finance Leases, 2024	3,543
Finance Leases, 2025	2,612
Finance Leases, 2026	1,902
Finance Leases, 2027	967
Finance Leases, 2028 and thereafter	135
Finance Leases, Total undiscounted future minimum lease payments	12,816
Finance Leases, Less imputed interest	(1,179)
Finance Leases, Total discounted future minimum lease payments	$ 11,637

XML

Business Acquisitions - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Feb. 28, 2023	Nov. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Transaction costs related to business combinations	$ 775	$ 467
Business combination, paid in cash	6,536
Acquisitions measurement period adjustments	(179)
EnvStd
Business Acquisition [Line Items]
Percentage of interests acquired							100.00%
EAI
Business Acquisition [Line Items]
Percentage of interests acquired			100.00%
Business combination, paid in cash	$ 5,390
EAI | Customer Relationships
Business Acquisition [Line Items]
Weighted average useful lives for acquired intangible assets	7 years
EAI | Trade Names
Business Acquisition [Line Items]
Weighted average useful lives for acquired intangible assets	2 years
EAI | Covenants Not to Compete
Business Acquisition [Line Items]
Weighted average useful lives for acquired intangible assets	5 years
Frontier and EAI
Business Acquisition [Line Items]
Revenue	$ 1,000
Pre-tax income (loss)	100
TriAD
Business Acquisition [Line Items]
Percentage of interests acquired						100.00%
AirKinetics
Business Acquisition [Line Items]
Percentage of interests acquired					100.00%
Huco
Business Acquisition [Line Items]
Percentage of interests acquired				100.00%
EnvStd and IAG | 2026 Earn Out
Business Acquisition [Line Items]
Payment through cash or common stock	1,500
Common Stock	5,500
Business combination, earn-out payment, maximum	9,500
Business combination, paid in cash	$ 2,600
EnvStd, IAG, TriAD, AirKinetics and Huco
Business Acquisition [Line Items]
Revenue		3,300
Pre-tax income (loss)		$ 800

XML

Business Acquisitions - Summary of Elements of Purchase Price of Acquisitions (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Business Acquisition [Line Items]
Cash	$ 6,536
Other Purchase Price Components	(342)
Contingent Consideration	25
Total Purchase Price	6,219
Frontier
Business Acquisition [Line Items]
Cash	1,146
Total Purchase Price	1,146
EAI
Business Acquisition [Line Items]
Cash	5,390
Other Purchase Price Components	(342)
Contingent Consideration	25
Total Purchase Price	$ 5,073

XML

Business Acquisitions - Summary of Purchase Price Attributable to Acquisitions (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Business Acquisition [Line Items]
Cash	$ 11	[1]
Accounts receivable	1,502	[1]
Other current assets	121	[1]
Current assets	1,634	[1]
Property and equipment	493	[1]
Goodwill	2,809	[1]
Total assets	6,707	[1]
Current liabilities	488	[1]
Total liabilities	488	[1]
Purchase price	6,219	[1]
Frontier
Business Acquisition [Line Items]
Property and equipment	302
Goodwill	844
Total assets	1,146
Purchase price	1,146
EAI
Business Acquisition [Line Items]
Cash	11
Accounts receivable	1,502
Other current assets	121
Current assets	1,634
Property and equipment	191
Goodwill	1,965
Total assets	5,561
Current liabilities	488
Total liabilities	488
Purchase price	5,073
Customer Relationships
Business Acquisition [Line Items]
Intangible assets	1,402	[1]
Customer Relationships | EAI
Business Acquisition [Line Items]
Intangible assets	1,402
Trade Names
Business Acquisition [Line Items]
Intangible assets	106	[1]
Trade Names | EAI
Business Acquisition [Line Items]
Intangible assets	106
Covenants Not to Compete
Business Acquisition [Line Items]
Intangible assets	263	[1]
Covenants Not to Compete | EAI
Business Acquisition [Line Items]
Intangible assets	$ 263

[1] The Company is continuing to obtain information to complete the valuation of certain of these acquisitions' assets and liabilities.

XML

Business Acquisitions - Summary of Supplemental Unaudited Pro-Forma Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Business Acquisition [Line Items]
Revenues	$ 131,428	$ 134,680
Net (loss) income	(14,719)	(7,536)
Acquisition Proforma
Business Acquisition [Line Items]
Revenues	433	5,625
Net (loss) income	(67)	722
Consolidated Proforma
Business Acquisition [Line Items]
Revenues	131,861	140,305
Net (loss) income	$ (14,786)	$ (6,814)

XML

Goodwill and Intangible Assets - Schedule of Amounts Related to Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Line Items]
Beginning balance	$ 323,868
Goodwill acquired during the period	2,809
Acquisitions measurement period adjustments	(179)
Ending balance	326,498
Assessment, Permitting and Response
Goodwill [Line Items]
Beginning balance	185,116
Acquisitions measurement period adjustments	(169)
Ending balance	184,947
Measurement and Analysis
Goodwill [Line Items]
Beginning balance	86,205
Goodwill acquired during the period	844
Acquisitions measurement period adjustments	(10)
Ending balance	87,039
Remediation and Reuse Segment
Goodwill [Line Items]
Beginning balance	52,547
Goodwill acquired during the period	1,965
Ending balance	$ 54,512

XML

Goodwill and Intangible Assets - Schedule of Amounts Related to Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Balance	$ 306,201	$ 303,804
Accumulated Amortization	168,930	161,697
Total Intangible Assets—Net	137,271	142,107
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Balance	209,426	208,024
Accumulated Amortization	100,404	95,768
Total Intangible Assets—Net	$ 109,022	$ 112,256
Customer Relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	2 years	2 years
Customer Relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	15 years	15 years
Covenants Not to Compete
Finite-Lived Intangible Assets [Line Items]
Gross Balance	$ 33,805	$ 33,542
Accumulated Amortization	29,020	28,280
Total Intangible Assets—Net	$ 4,785	$ 5,262
Covenants Not to Compete | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	4 years	4 years
Covenants Not to Compete | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years	5 years
Trade Names
Finite-Lived Intangible Assets [Line Items]
Gross Balance	$ 22,167	$ 22,061
Accumulated Amortization	18,708	18,256
Total Intangible Assets—Net	$ 3,459	$ 3,805
Trade Names | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	1 year	1 year
Trade Names | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years	5 years
Proprietary Software
Finite-Lived Intangible Assets [Line Items]
Gross Balance	$ 23,324	$ 22,698
Accumulated Amortization	16,942	15,810
Total Intangible Assets—Net	$ 6,382	$ 6,888
Proprietary Software | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	3 years	3 years
Proprietary Software | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years	5 years
Patent
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	16 years	16 years
Gross Balance	$ 17,479	$ 17,479
Accumulated Amortization	3,856	3,583
Total Intangible Assets—Net	$ 13,623	$ 13,896

XML

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 7.2	$ 9.4

XML

Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remaining)	$ 20,920
2024	24,607
2025	17,727
2026	13,952
2027	13,429
Thereafter	46,636
Total Intangible Assets—Net	$ 137,271	$ 142,107

XML

Accounts Payable and Other Accrued Liabilities - Summary of Accounts Payable and Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 24,399	$ 25,353
Accrued expenses	16,311	14,754
Other business acquisitions purchase price obligations	450	1,185
Contract liabilities	10,932	18,549
Other current liabilities	3,328	3,571
Total accounts payable and other accrued liabilities	$ 55,420	$ 63,412

XML

Accrued Payroll and Benefits - Schedule of Accrued Payroll and Benefits (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accrued bonuses	$ 3,559	$ 8,624
Accrued paid time off	1,161	1,088
Accrued payroll	9,084	8,410
Accrued other	2,548	2,406
Total accrued payroll and benefits	$ 16,352	$ 20,528

XML

Income Taxes - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Annual effective tax rate ("ETR") from continuing operations	10.20%	(20.20%)
Income tax (benefit) expense	$ 1,367,000	$ 1,269,000
Federal statutory rate	21.00%
Uncertain tax positions	$ 0

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Line Of Credit Facility [Line Items]
Less deferred debt issuance costs	$ (1,595)	$ (1,725)
Total debt	162,467	164,525
Less current portion of long-term debt	(13,125)	(12,031)
Long-term debt, less current portion	149,342	152,494
Term Loan Facility
Line Of Credit Facility [Line Items]
Total debt	$ 164,062	$ 166,250

XML

Debt - Additional Information (Details) - USD ($)				1 Months Ended		3 Months Ended		7 Months Ended	12 Months Ended
	Jan. 27, 2022	Jan. 26, 2022	Apr. 27, 2021	Apr. 30, 2023	Jan. 31, 2023	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Floating Component | Interest Rate Swap
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	$ 100,000,000.0
Credit facility maturity date	Jan. 27, 2025
Interest rate	1.39%
2021 Credit Facility
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 300,000,000.0
Credit facility maturity date			Apr. 27, 2026
Percentage of interest rate reduction								0.05%
Maximum net leverage ratio			425.00%
Maximum net leverage ratio year two			400.00%
Maximum net leverage ratio year three			375.00%
Minimum fixed charge coverage ratio			125.00%
Consolidated total leverage ratio						140.00%			130.00%
Percentage of proceeds of debt, subject to customary exceptions						100.00%
Percentage of proceeds of certain dispositions, subject to customary reinvestment rights						100.00%
Percentage of proceeds of insurance or condemnation, subject to customary reinvestment rights						100.00%
Weighted average interest rate						6.10%	1.80%	6.10%
Incremental Term Loans
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 150,000,000.0
Equipment Line Of Credit
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									$ 10,000,000.0
Credit facility maturity date						Mar. 31, 2023
Term Loan Facility | 2021 Credit Facility
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			175,000,000.0
Installment repayment amount		$ 2,200,000		$ 2,200,000	$ 2,200,000		$ 2,200,000
Revolving Line of Credit | 2021 Credit Facility
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			125,000,000.0
Revolving Line of Credit | Letter of Credit | 2021 Credit Facility
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 20,000,000.0

XML

Debt - Summary of Term Loan Amortization (Details) - 2021 Credit Facility - Term Loan Facility	3 Months Ended
	Mar. 31, 2023
Subsequent Event [Line Items]
Debt instrument, quarterly installment rate, June 30, 2023	1.25%
Debt instrument, quarterly installment rate, September 30, 2023	1.25%
Debt instrument, quarterly installment rate, December 31, 2023	1.88%
Debt instrument, quarterly installment rate, March 31, 2024	1.88%
Debt instrument, quarterly installment rate, June 30, 2024	1.88%
Debt instrument, quarterly installment rate, September 30, 2024	1.88%
Debt instrument, quarterly installment rate, December 31, 2024	1.88%
Debt instrument, quarterly installment rate, March 31, 2025	1.88%
Debt instrument, quarterly installment rate, June 30, 2025	1.88%
Debt instrument, quarterly installment rate, September 30, 2025	1.88%
Debt instrument, quarterly installment rate, December 31, 2025	2.50%
Debt instrument, quarterly installment rate, March 31, 2026	2.50%
Debt instrument, quarterly installment rate, April 27, 2026	Remaining balance

XML

Debt - Summary of 2021 Credit Facility Interest Rate Subject to Leverage Ratio and LIBOR (Details) - 2021 Credit Facility	Apr. 27, 2021
Pricing Tier1
Subsequent Event [Line Items]
Commitment Fee	0.25%
Letter of Credit Fee	2.50%
Pricing Tier1 | Minimum
Subsequent Event [Line Items]
Net Leverage Ratio	375.00%
Pricing Tier1 | LIBOR Plus
Subsequent Event [Line Items]
Interest rate	2.50%
Pricing Tier1 | Base Rate Plus
Subsequent Event [Line Items]
Interest rate	1.50%
Pricing Tier2
Subsequent Event [Line Items]
Commitment Fee	0.23%
Letter of Credit Fee	2.25%
Pricing Tier2 | Maximum
Subsequent Event [Line Items]
Net Leverage Ratio	375.00%
Pricing Tier2 | Minimum
Subsequent Event [Line Items]
Net Leverage Ratio	325.00%
Pricing Tier2 | LIBOR Plus
Subsequent Event [Line Items]
Interest rate	2.25%
Pricing Tier2 | Base Rate Plus
Subsequent Event [Line Items]
Interest rate	1.25%
Pricing Tier3
Subsequent Event [Line Items]
Commitment Fee	0.20%
Letter of Credit Fee	2.00%
Pricing Tier3 | Maximum
Subsequent Event [Line Items]
Net Leverage Ratio	325.00%
Pricing Tier3 | Minimum
Subsequent Event [Line Items]
Net Leverage Ratio	250.00%
Pricing Tier3 | LIBOR Plus
Subsequent Event [Line Items]
Interest rate	2.00%
Pricing Tier3 | Base Rate Plus
Subsequent Event [Line Items]
Interest rate	1.00%
Pricing Tier4
Subsequent Event [Line Items]
Commitment Fee	0.15%
Letter of Credit Fee	1.75%
Pricing Tier4 | Maximum
Subsequent Event [Line Items]
Net Leverage Ratio	250.00%
Pricing Tier4 | Minimum
Subsequent Event [Line Items]
Net Leverage Ratio	175.00%
Pricing Tier4 | LIBOR Plus
Subsequent Event [Line Items]
Interest rate	1.75%
Pricing Tier4 | Base Rate Plus
Subsequent Event [Line Items]
Interest rate	0.75%
Pricing Tier5
Subsequent Event [Line Items]
Commitment Fee	0.15%
Letter of Credit Fee	1.50%
Pricing Tier5 | Maximum
Subsequent Event [Line Items]
Net Leverage Ratio	175.00%
Pricing Tier5 | LIBOR Plus
Subsequent Event [Line Items]
Interest rate	1.50%
Pricing Tier5 | Base Rate Plus
Subsequent Event [Line Items]
Interest rate	0.50%

XML

Debt - Schedule of Aggregate Annual Maturities of Long-Term Debt (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Debt Disclosure [Abstract]
2024	$ 13,125
2025	13,125
2026	15,312
2027	122,500
Total	$ 164,062

XML

Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Level 3) (Details) - Fair Value, Recurring - Level 3 - USD ($) $ in Thousands	Mar. 31, 2023		Dec. 31, 2022		Mar. 31, 2022	Dec. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Level 3 Liabilities	$ 34,491		$ 33,986		$ 30,632	$ 58,881
Level 3 Assets	5,078		6,046		3,005
Business Acquisitions Contingent Consideration, Current
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Level 3 Liabilities	4,734		3,801		1,429	31,450
Business Acquisitions Contingent Consideration, Long-Term
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Level 3 Liabilities	3,121		4,454		5,566	4,350
Conversion Option
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Level 3 Liabilities	26,636		25,731		23,637	$ 23,081
Interest Rate Swap
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Level 3 Assets	$ 5,078	[1]	$ 6,046	[1]	$ 3,005

[1] Included in other assets in the unaudited condensed consolidated statement of financial position.

XML

Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details) - Fair Value, Recurring - Level 3 - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023		Mar. 31, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Beginning balance		$ 33,986		$ 58,881
Total Assets, Beginning balance		6,046
Acquisitions		25		1,216
Changes in fair value included in earnings		507		535
Asset value, Changes in fair value included in earnings		(968)		3,005
Payment of contingent consideration payable		(27)		(30,000)
Ending balance		34,491		30,632
Total Assets, Ending balance		5,078		3,005
Business Acquisitions Contingent Consideration, Current
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Beginning balance		3,801		31,450
Acquisitions		25
Changes in fair value included in earnings		(515)		(21)
Payment of contingent consideration payable		(27)		(30,000)
Reclass of long term to short term contingent liabilities		1,450
Ending balance		4,734		1,429
Business Acquisitions Contingent Consideration, Long-Term
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Beginning balance		4,454		4,350
Acquisitions				1,216
Changes in fair value included in earnings		117
Reclass of long term to short term contingent liabilities		(1,450)
Ending balance		3,121		5,566
Conversion Option
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Beginning balance		25,731		23,081
Changes in fair value included in earnings		905		556
Ending balance		26,636		23,637
Interest Rate Swap
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Assets, Beginning balance	[1]	6,046
Asset value, Changes in fair value included in earnings		(968)		3,005
Total Assets, Ending balance		$ 5,078	[1]	$ 3,005

[1] Included in other assets in the unaudited condensed consolidated statement of financial position.

XML

Convertible and Redeemable Series A-2 Preferred Stock - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Apr. 13, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Temporary Equity [Line Items]
Period between issuance and expiration of outstanding warrant	10 years
Proceeds from the Series A-2 and Warrant	$ 175,000
Preferred stock, dividends paid		$ 4,100	$ 4,100
Number of debt incurrence test ratio		4.5
Compound embedded derivative, change in net fair value		$ (1,873)	2,449
Convertible And Redeemable Series A-2 Preferred Stock
Temporary Equity [Line Items]
Number of shares issued	17,500	17,500		17,500
Par value per share	$ 0.0001	$ 0.0001		$ 0.0001
Debt issuance costs, net	$ 1,300
Preferred stock, dividends paid		$ 4,100	4,100
Percentage of discount on common stock market price		15.00%
Percentage of dividend rate steps downs per year		9.00%
Percentage of dividend rate increase per annum in the event of noncompliance		12.00%
Number of days dividend increase rate applicable noncompliance event occurred		90 days
Percentage of dividend rate increase per annum upon noncompliance occurred and thereafter		14.00%
Minimum repayment amount		$ 25,000
Temporary equity description		The Company may, at its option on any one or more dates, redeem all or a minimum portion (the lesser of (i) $25.0 million in aggregate stated value of the Convertible and Redeemable Series A-2 Preferred Stock and (ii) all of the Convertible and Redeemable Series A-2 Preferred Stock then outstanding) of the outstanding Convertible and Redeemable Series A-2 Preferred Stock in cash.With respect to any redemption of any share of the Convertible and Redeemable Series A-2 Preferred Stock prior to the third-year anniversary, the Company is subject to a make whole penalty in which the holders of the Convertible and Redeemable Series A-2 Preferred Stock are guaranteed a minimum repayment equal to outstanding redeemed stated value plus three years of dividends accrued or accruable thereon.
Aggregate stated value of stock redeemed		$ 25,000
Compound embedded derivative, fair value net		26,600		$ 25,700
Convertible And Redeemable Series A-2 Preferred Stock | Other Expense
Temporary Equity [Line Items]
Compound embedded derivative, change in net fair value		900	$ 600
Convertible And Redeemable Series A-2 Preferred Stock | 60-Day Period Prior to Seventh Anniversary
Temporary Equity [Line Items]
Temporary equity convertible into common stock		60,000
Convertible And Redeemable Series A-2 Preferred Stock | Year 5
Temporary Equity [Line Items]
Temporary equity convertible into common stock		60,000
Convertible And Redeemable Series A-2 Preferred Stock | Year 6
Temporary Equity [Line Items]
Temporary equity convertible into common stock		$ 120,000

XML

Stockholder's Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended		12 Months Ended
		Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022
Class Of Stock [Line Items]
Common stock, shares authorized		190,000,000			190,000,000
Common stock, par value		$ 0.000004			$ 0.000004
Total unrecognized stock compensation expense related to unvested options, restricted stock and stock appreciation rights granted under the Plans		$ 146.6	$ 173.1
Unrecognized expense expected to be recognized period		4 years
Restricted shares became fully vested and released as common stock		90,116	25,289
Shares, granted	[1]	90,116	25,289
Restricted shares outstanding		2,528,383	2,064,197
Montrose 2017 Stock Incentive Plan
Class Of Stock [Line Items]
Shares, granted		200,423
Restricted shares forfeited		0	0
Montrose 2017 Stock Incentive Plan | Restricted Stock
Class Of Stock [Line Items]
Shares RSAs granted		17,346	10,920
Montrose 2017 Stock Incentive Plan | Stock Options | Board of Directors
Class Of Stock [Line Items]
Shares of vested over period		4 years
Montrose 2017 Stock Incentive Plan | Stock Options | Executive Officers
Class Of Stock [Line Items]
Shares of vested over period		3 years
Vesting frequency of period		1 year
Montrose 2017 Stock Incentive Plan | Stock Options | On the two-year anniversary of the grant | Board of Directors
Class Of Stock [Line Items]
Shares, vesting rights, percentage		50.00%
Montrose 2017 Stock Incentive Plan | Stock Options | Fourth Anniversary | Board of Directors
Class Of Stock [Line Items]
Shares, vesting rights, percentage		50.00%
Montrose Amended and Restated 2013 Stock Option Plan
Class Of Stock [Line Items]
Shares outstanding from exercised options		1,434,885	1,239,697
Two Thousand Seventeen Plan | Stock Appreciation Rights (SARs)
Class Of Stock [Line Items]
Shares, granted		3,000,000
Exercise price				$ 66.79
Shares of vested over period				5 years
Remaining contractual terms		10 years
Fair value vested in period		$ 46.0
Weighted average remaining contract life		8 years 8 months 15 days
Supplemental Incentive Plans
Class Of Stock [Line Items]
Shares, granted		246,417	95,404
Supplemental Incentive Plans | RSUs
Class Of Stock [Line Items]
Shares of vested over period		4 years
Supplemental Incentive Plans | RSUs | First Quater
Class Of Stock [Line Items]
Shares, vesting rights, percentage		33.33%
Supplemental Incentive Plans | RSUs | First Anniversary
Class Of Stock [Line Items]
Shares, vesting rights, percentage		33.33%
Supplemental Incentive Plans | RSUs | Second Anniversary
Class Of Stock [Line Items]
Shares, vesting rights, percentage		33.33%

[1] Represents the non-cash release of common shares due to the vesting of restricted stock.

XML

Stockholder's Equity - Summary of Issued Shares of Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Equity [Abstract]
Exercise of options, Shares		124,455	30,607
Restricted shares, net	[1]	90,116	25,289
Total, Shares		214,571	55,896
Exercise of options, Average Price per Share		$ 21.61	$ 14.03
Restricted shares, net, Average Price per Share	[1]	36.81	66.58
Total, Average Price per Share		$ 27.99	$ 37.81
Exercise of options, Total		$ 2,690	$ 429
Total		$ 2,690	$ 429

[1] Represents the non-cash release of common shares due to the vesting of restricted stock.

XML

Stockholder's Equity - Summary of Number of Shares Authorized to be Issued and Available for Grant (Details) - shares		Mar. 31, 2023		Jan. 31, 2023	Mar. 31, 2022		Jan. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares authorized to be issued		8,366,932			10,177,131
Shares available for grant	[1]	893,522			577,139
2017 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares authorized to be issued		6,329,913			8,272,487
Shares available for grant		893,522	[1]	1,189,801	577,139	[1]	1,185,112
2013 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares authorized to be issued		2,037,019			1,904,644

[1] In January 2023 and January 2022 the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. Shares available for grant exclude awards of stock appreciation rights approved in December 2021 that are subject to vesting based on the achievement of certain market conditions, which have not yet been, and may not be, achieved. See footnote 1 to the table in Common Stock Reserved for Future Issuance below for additional information on stock appreciation rights.

XML

Stockholders' Equity - Summary of Number of Shares Authorized to be Issued and Available for Grant (Parenthetical) (Details) - shares		Mar. 31, 2023		Jan. 31, 2023	Mar. 31, 2022		Jan. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares available for grant	[1]	893,522			577,139
2017 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares available for grant		893,522	[1]	1,189,801	577,139	[1]	1,185,112

[1] In January 2023 and January 2022 the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. Shares available for grant exclude awards of stock appreciation rights approved in December 2021 that are subject to vesting based on the achievement of certain market conditions, which have not yet been, and may not be, achieved. See footnote 1 to the table in Common Stock Reserved for Future Issuance below for additional information on stock appreciation rights.

XML

Stockholder's Equity - Schedule of Stock Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	$ 13,035	$ 10,425
2017 Plan | Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	2,073	2,273
2017 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	8,697	5,792
2017 Plan | Stock Appreciation Rights (SARs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	2,265	2,360
Cost of Revenue
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	892	294
Cost of Revenue | 2017 Plan | Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	349	294
Cost of Revenue | 2017 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	543
Selling, General and Administrative Expenses
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	12,143	10,131
Selling, General and Administrative Expenses | 2017 Plan | Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	1,724	1,979
Selling, General and Administrative Expenses | 2017 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	8,154	5,792
Selling, General and Administrative Expenses | 2017 Plan | Stock Appreciation Rights (SARs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock compensation expense	$ 2,265	$ 2,360

XML

Stockholder's Equity - Schedule of Restricted Stock Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Average Price per Share	[1]	$ 36.81	$ 66.58
Montrose 2017 Stock Incentive Plan | Restricted stock units awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares		464,186	106,324
Average Price per Share		$ 32.62	$ 46.82
Fair Value		$ 15,140	$ 4,978

[1] Represents the non-cash release of common shares due to the vesting of restricted stock.

XML

Stockholders' Equity - Summary of Performance Hurdles (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares
SAR Stock Price Performance Hurdle One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
SARs Stock Price Performance Hurdle	$ 133.58
Portion of SARs Subject to Performance Hurdle	0.33%
SAR Stock Price Performance Hurdle Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
SARs Stock Price Performance Hurdle	$ 166.98
Portion of SARs Subject to Performance Hurdle	0.33%
SAR Stock Price Performance Hurdle Three
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
SARs Stock Price Performance Hurdle	$ 200.37
Portion of SARs Subject to Performance Hurdle	0.33%

XML

Stockholder's Equity - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options to Purchase Common Stock Exercised	(124,455)	(30,607)
Montrose 2017 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options to Purchase Common Stock Outstanding Beginning Balance	2,579,566	2,036,729	2,036,729
Options to Purchase Common Stock Granted	233,955	547,884
Options to Purchase Common Stock Forfeited/cancelled	(34,619)	(23,082)
Options to Purchase Common Stock Exercised	(101,279)	(11,547)
Options to Purchase Common Stock Outstanding Ending Balance	2,677,623	2,549,984	2,579,566	2,036,729
Options to Purchase Common Stock Exercisable	1,305,511
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-Average Exercise Price per Share Outstanding Beginning Balance	$ 31	$ 26	$ 26
Weighted-Average Exercise Price per Share Granted	32	44
Weighted-Average Exercise Price per Share Forfeited/cancelled	35	36
Weighted-Average Exercise Price per Share Exercised	25	27
Weighted-Average Exercise Price per Share Outstanding Ending Balance	31	30	31	$ 26
Weighted-Average Exercise Price per Share Exercisable	29
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted Average Grant Date Fair Value per Share Outstanding Beginning Balance	15	14	14
Weighted Average Grant Date Fair Value per Share Granted	14	16
Weighted Average Grant Date Fair Value per Share Ending Balance	$ 15	$ 14	$ 15	$ 14
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Contract Life (in Years) Outstanding	7 years 9 months 10 days	8 years 5 months 15 days	7 years 9 months 3 days	8 years 3 months 18 days
Weighted Average Remaining Contract Life (in Years) Exercisable	7 years 2 months 8 days
Aggregate Intrinsic Value of In-The-Money Options Outstanding	$ 21,127	$ 59,955	$ 37,292	$ 91,030
Aggregate Intrinsic Value of In-The-Money Options Exercised	2,467	$ 313
Aggregate Intrinsic Value of In-The-Money Options Exercisable	$ 11,880
Montrose Amended and Restated 2013 Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options to Purchase Common Stock Outstanding Beginning Balance	855,695	897,674	897,674
Options to Purchase Common Stock Exercised	(23,176)	(19,060)
Options to Purchase Common Stock Outstanding Ending Balance	832,519	878,614	855,695	897,674
Options to Purchase Common Stock Exercisable	832,519
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-Average Exercise Price per Share Outstanding Beginning Balance	$ 6	$ 6	$ 6
Weighted-Average Exercise Price per Share Exercised	9	6
Weighted-Average Exercise Price per Share Outstanding Ending Balance	6	6	6	$ 6
Weighted-Average Exercise Price per Share Exercisable	6
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted Average Grant Date Fair Value per Share Outstanding Beginning Balance	2	2	2
Weighted Average Grant Date Fair Value per Share Ending Balance	$ 2	$ 2	$ 2	$ 2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Contract Life (in Years) Outstanding	3 years 10 days	4 years 1 month 17 days	3 years 3 months 21 days	4 years 4 months 13 days
Weighted Average Remaining Contract Life (in Years) Exercisable	3 years 10 days
Aggregate Intrinsic Value of In-The-Money Options Outstanding	$ 24,393	$ 40,860	$ 32,478	$ 57,529
Aggregate Intrinsic Value of In-The-Money Options Exercised	963	$ 821
Aggregate Intrinsic Value of In-The-Money Options Exercisable	$ 24,393

XML

Stockholder's Equity - Summary of Weighted Average Assumptions Used in Black-Sholes Option-pricing Model (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock value (per share)	$ 32.16	$ 44.11
Expected volatility	33.79%	33.45%
Risk-free interest rate	3.72%	1.74%
Expected life (years)	7 years	6 years 3 months 29 days
Forfeiture rate	0.00%	0.00%
Dividend rate	0.00%	0.00%

XML

Stockholder's Equity - Schedule of Common Stock Reserved for Future Issuance (Details) - shares	Mar. 31, 2023		Jan. 31, 2023	Mar. 31, 2022		Jan. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for future issuance	9,555,449			8,772,532
Montrose 2013 Stock Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for future issuance	832,519			878,614
Montrose 2017 Stock Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for future issuance	8,722,930	[1]	1,189,801	7,893,918	[1]	1,185,112

[1] In January 2023 and 2022, the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards. Shares reserved for future issuance include 3,000,000 shares underlying the 3,000,000 performance SARs granted in December 2021 that are subject to vesting based on the achievement of certain market conditions. Assuming achievement at the highest price performance hurdle, approximately 2,000,000 shares of common stock would be issued upon vesting of these performance SARs. To date, none of the market conditions have been achieved.

XML

Stockholders' Equity - Schedule of Common Stock Reserved for Future Issuance (Parenthetical) (Details) - shares	1 Months Ended
	Jan. 31, 2021	Mar. 31, 2023		Jan. 31, 2023	Mar. 31, 2022		Jan. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for future issuance		9,555,449			8,772,532
Montrose 2017 Stock Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for future issuance		8,722,930	[1]	1,189,801	7,893,918	[1]	1,185,112
Stock Appreciation Rights Units Grant
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for future issuance							3,000,000
Common stock issued upon vesting of performance SARs	2,000,000

[1] In January 2023 and 2022, the Board of Directors ratified the addition of 1,189,801 and 1,185,112 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards. Shares reserved for future issuance include 3,000,000 shares underlying the 3,000,000 performance SARs granted in December 2021 that are subject to vesting based on the achievement of certain market conditions. Assuming achievement at the highest price performance hurdle, approximately 2,000,000 shares of common stock would be issued upon vesting of these performance SARs. To date, none of the market conditions have been achieved.

XML

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Net loss	$ (14,719)	$ (7,536)
Convertible and redeemable series A-2 preferred stock dividend	(4,100)	(4,100)
Net loss attributable to common stockholders -basic and diluted	$ (18,819)	$ (11,636)
Weighted-average common shares outstanding - basic	29,857	29,662
Weighted-average common shares outstanding - diluted	29,857	29,662
Net loss per share attributable to common stockholders - basic	$ (0.63)	$ (0.39)
Net loss per share attributable to common stockholders - diluted	$ (0.63)	$ (0.39)

XML

Net Loss Per Share - Common Stock Equivalents Excluded from Calculation of Diluted Loss Per Share Attributable to Common Stockholders (Details) - shares		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share amount	[1]	3,510,142	2,034,041
Restricted Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share amount	[1]	2,151,785	1,777,958
Series A-2
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share amount	[1]	4,735,220	4,329,640
Stock Appreciation Rights (SARs)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share amount	[1]	3,000,000	3,000,000

[1] Includes 7,362,459 and 5,008,269 common stock equivalents that are out of the money as of March 31, 2023 and March 31, 2022, respectively.

XML

Net Loss Per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss per Share Attributable to Common Stockholders (Parenthetical) (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Number of shares out of money	7,362,459	5,008,269

XML

Segment Information - Additional Information (Details)	3 Months Ended
	Mar. 31, 2023 Segment
Segment Reporting [Abstract]
Number of operating segments	3
Number of reportable segments	3

XML

Segment Information - Components of Segment Revenues and Adjusted EBITDA (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Segment Revenues		$ 131,428	$ 134,680
Segment Adjusted EBITDA		16,603	16,451	[1]
Operating Segments
Segment Reporting Information [Line Items]
Segment Revenues		131,428	134,680
Segment Adjusted EBITDA		25,931	23,938	[1]
Assessment, Permitting and Response | Operating Segments
Segment Reporting Information [Line Items]
Segment Revenues		52,214	45,600
Segment Adjusted EBITDA		14,266	9,623	[1]
Measurement and Analysis | Operating Segments
Segment Reporting Information [Line Items]
Segment Revenues	[2]	42,527	39,761
Segment Adjusted EBITDA		6,387	6,322	[1],[3]
Remediation and Reuse | Operating Segments
Segment Reporting Information [Line Items]
Segment Revenues		36,687	49,319
Segment Adjusted EBITDA		5,278	7,993	[1]
Corporate and Other
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA		$ (9,328)	$ (7,487)	[1]

[1] Includes the add back of start-up losses and investment in new services of $0.8 million.

[2] Includes revenue of $1.4 million and $5.6 million from the Discontinuing Specialty Lab, for the three months ended March 31, 2023 and March 31, 2022, respectively.

[3] Includes Adjusted EBITDA of $1.3 million from the Discontinuing Specialty Lab.

XML

Segment Information - Components of Segment Revenues and Adjusted EBITDA (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Segment Revenues	$ 131,428	$ 134,680
Segment Adjusted EBITDA	16,603	16,451	[1]
Discontinuing Specialty Lab
Segment Reporting Information [Line Items]
Segment Revenues	$ 1,400	5,600
Segment Adjusted EBITDA		1,300
Start-up Losses and Investment in New Services
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA		$ 800

[1] Includes the add back of start-up losses and investment in new services of $0.8 million.

XML

Segment Information - Reconciliation of Segment Measure to Net Loss (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total		$ 16,603	$ 16,451	[1]
Interest expense, net		(1,541)	(1,092)
Income tax expense		(1,367)	(1,269)
Depreciation and amortization		(10,555)	(12,144)
Stock-based compensation		(13,035)	(10,425)
Start-up losses and investment in new services			(786)
Acquisition costs		(775)	(467)
Fair value changes in financial instruments		(1,873)	2,449
Fair value changes in business acquisition contingencies		398	21
Expenses related to financing transactions		(4)	(7)
Other losses or expenses		(134)	(267)
Net loss		(14,719)	(7,536)
Discontinuing Specialty Lab
Segment Reporting Information [Line Items]
Total			$ 1,300
Other losses or expenses	[2]	$ 2,436

[1] Includes the add back of start-up losses and investment in new services of $0.8 million.

[2] Amounts consist of operating losses before depreciation related to the Discontinuing Specialty Lab.

XML

Related-Party Transactions - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Related Party Transactions [Abstract]
Related party transaction amount	$ 0	$ 0

XML

Defined Contribution Plan - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan, description	401(k) Savings Plan
Defined contribution plan, maximum annual contributions per employee, percent	85.00%		85.00%
Defined contribution plan, employer matching contribution, percent of match	100.00%
Defined contribution plan participant's compensation percent	3.00%
Defined contribution plan percentage of participant's elective deferrals	50.00%
Selling, General and Administrative Expenses
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan, employer discretionary contribution amount	$ 2.1	$ 1.7
Minimum
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan participant's compensation percent	3.00%
Maximum
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan participant's compensation percent	5.00%

XML

Subsequent Events - Additional Information (Details) - Subsequent Event	May 01, 2023	Apr. 28, 2023
GreenPath
Subsequent Event [Line Items]
Percentage of interests acquired	100.00%
Matrix
Subsequent Event [Line Items]
Percentage of interests acquired		100.00%

XML

Subsequent Events - Schedule of Main Elements of Purchase Price of Acquisitions (Details) $ in Thousands, $ in Thousands				3 Months Ended
		May 01, 2023 CAD ($)	Apr. 28, 2023 CAD ($)	Mar. 31, 2023 USD ($)
Subsequent Event [Line Items]
Cash				$ 6,536
Total Purchase Price				$ 6,219
Subsequent Event | GreenPath
Subsequent Event [Line Items]
Cash	[1]	$ 16,580
Common Stock		3,520
Total Purchase Price		$ 20,100
Subsequent Event | Matrix
Subsequent Event [Line Items]
Cash	[2]		$ 65,191
Total Purchase Price			$ 65,191

[1] The cash portion of this acquisition's purchase price was funded through cash on hand.

[2] Upon closing, the cash portion of this acquisition's purchase price will funded through a combination of cash on hand and proceeds received from our revolving credit facility.